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ABSTRACT
We have recently developed a nanocomposite based on 
polyhedral oligomeric silsesquixoane for medical device application 
for particular use in a microvascular network. Using spectroscopic 
analyses, we characterised the polymer before subjecting it to both 
in vitro and in vivo degradation. In the same setting, the foreign- 
body reaction of this polymer was determined. An in vitro 
feasibility study as to the efficacy of neo-endothelialisation was then 
performed. Next, the anti-thrombogenic nature of the 
nanocomposite was elicited. Based on the favourable outcomes of 
these experiments, nanocomposite microvessels were designed and 
fabricated to form the components of a microvascular network. Our 
results indicate that silsesquioxane is an optimal building material 
for microvascular grafts. This therefore constitutes the foundation 
on which we intend to construct an in vitro artificial capillary bed 
model.
HYPOTHESIS
6 Silsesquioxane-polyurethane nanocomposites possess the optimal 
characteristics for the construction of microvascular networks such 
as artificial capillary beds as they are biocompatible, biostable, 
strong, tensile and have thromboresistant properties.’
3
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Chapter 1
1. The roles of tissue engineering and vascularisation in the 
development of microvascular networks: a review
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1.1. INTRODUCTION
1.1.1. RECONSTRUCTIVE SURGERY
In current practice, reconstructive surgery is essential in order to achieve wound closure 
following major cancer resections and trauma. Traditionally, reconstructive surgeons have 
employed the reconstructive ladder concept; a hierarchical system by which the simplest option, 
usually skin grafting or primary closure, is chosen first. If this fails, then a slightly more 
complex procedure is selected. With the increasing demand for quality wound closure; maximal 
aesthetics with minimum morbidity, the concept o f the ‘reconstructive elevator’ {Dunn, 2001} 
is applicable. As opposed to the reconstructive ladder the best option, which in most cases is a 
flap, is chosen initially.
A flap may be defined as a segment o f tissue with an independent blood supply. These may 
be classified into local, regional and free flaps. Free flaps are based on the concept o f angiosome 
{Taylor, 1987}; an area o f tissue with an inherent vascular network supplied by a single 
vascular pedicle. Buncke and McLean performed the first microvascular tissue transplant in 
1969 {McDowell, 1978}. Since then, free flaps have revolutionised reconstructive surgery as 
they are more versatile and reliable than other flaps. Flaps are now being pre-fabricated prior to 
surgery to become more case-specific {Song, 2001}. More recently, the introduction of 
perforator flaps has improved the utility o f flaps as a reconstructive option {Kroll, 1988}. 
Nevertheless, free tissue transfer confers morbidity to the patient as one function is sacrificed for 
another {McGregor IA, 1995}. Therefore alternative sources o f tissue for reconstruction are 
needed.
11
1.1.2. TISSUE ENGINEERING AND ITS LIMITED SUCCESS
More than 21 million patients per year in the US alone rely on biomedical implants {Vacanti, 
1999}. These include bypass grafts, dental implants and artificial dermal substitutes like 
Integra®. Current technology limits the survival of these implants as they depend initially upon 
diffusion and in the later stages, on neovascularisation. Overdependence on the former limit the 
thickness o f these implants while depending on neovascularisation can cause excessive 
fibrovascular ingrowth and hence scarring. There are no tissue-engineered constructs presently 
available which have an inherent vasculature such as a capillary bed ready to be connected to 
the host vascular system. This represents a major limitation as the driving force o f living tissue 
is vascularity. Although attempts to develop small-diameter vascular grafts have been successful 
in w7ro{Seifalian, 2002;Tiwari, 2002}, it remains to be seen through clinical studies whether 
they are reliable enough to sustain flow in vivo (Kidd, 2003;Mitchell, 2003;Fields, 2002}. Even 
so, they are limited by the absence o f a viable capillary network for nutrient exchange. This 
missing link represents the bridge between the host and the tissue-engineered implant.
Most clinical studies in artificial tissue so far have utilised dermal substitutes like Integra™ 
in the treatment o f bums. After application, it undergoes imbibition, fibroblast (Fb) migration, 
neovascularisation and finally vessel maturation. This process takes weeks, after which skin 
grafts or cultured keratinocytes may be applied. One centre used it in 30 patients with good 
results (Moiemen, 2001} while others have successfully seeded cultured Fb and keratinocytes 
onto it prior to clinical application. They found superior results when it was done with 
concurrent skin grafting {Wisser, 2003}. Sheridan and co-workers developed a composite skin 
replacement (CSR) composed o f acellular allogeneic dermis which was seeded with cultured 
keratinocytes. The CSR was used in 12 paediatric bum wounds and by 14 days, 45.7 ± 14.2 % 
had vascularised as compared to 98 ± 1 % in split skin grafts {Sheridan, 2001}. However, no
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clinical studies on scaffolds with an inherent vascular network or incorporated angiogenic 
factors have been done.
1.1.3. MICRO VESSEL DEVELOPMENT
Human microvasculature begins with arteries dividing consecutively into smaller branches 
like meta-arterioles (80 -  100 pm) until finally forming capillaries ( 1 0 - 1 5  pm). These vessels 
serve to redistribute blood and its nutrients whilst lowering the pressure head. This allows blood 
to perfuse tissue allowing more efficient exchange o f metabolites. Eventually, the capillaries 
unite into post-capillary venules (PC Vs), venules and finally veins for the return o f waste 
products. The venular component o f vasculature also serve as capacitance vessels {Levick, 
2000}.
The vascular tree is formed during the early gestation. Angiogenic cells form clusters which 
coalesce to form solid tubes which eventually canalise to form blood vessels {Buschmann, 
2000}. The outer ring consists o f angioblasts which form the vessel walls. The subsequent 
differentiation of these precursor angioblasts into endothelial cells (EC) and the de novo 
formation of a vascular network are termed ‘vasculogenesis’. These vessels are capillary-like to 
begin with and eventually differentiate into either arteries or veins {Murohara, 2001}. The 
creation of this framework depends on guidance molecules within the matrix such as ephrins at 
the arterio-venous interface {Adams, 2000} and reversion-inducing cysteine-rich (RECK) 
protein for paracellular proteolysis {Welm, 2002}.
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The adult vascular network remodels itself by arteriogenesis with the opening up and then 
the subsequent enlargement o f existing collaterals (so called collateral enlargement) as well as 
the formation of completely new vessels from the already existing vessels (so called 
arterialisation) {Peirce, 2003}. Micro-vascular remodelling is a mechanistic process delineated 
to specific tissue type and specific stimuli. Therefore with the exceptions o f skeletal muscle 
responding to exercise and the female menstrual cycle itself, micro-vascular remodelling is 
limited solely to pathological situations in particular inflammation, wound healing, ischemia, 
and that of hypoxia together with a few other rare circumstances.
Remodelling is mediated by monocytes and endothelial progenitor cells (EPCs) as shown in 
figure 1.1 and is a mechanism that is dependent on changes in shear stress. Studies have shown 
that turbulent flow at low flow rates o f 1.5 dynes/cm itself activates ECs while normal laminar 
shear stress o f 8 to 15 dynes/cm2 does not {Davies, 1986}. In a rabbit femoral artery occlusion 
model, collateral recruitment occurred within a week with removal o f unwanted vessels by three 
weeks {Hoefer, 2001}. Angiogenesis is the coordinated migration and proliferation o f EC and 
pericytes from the existing vascular bed {Lindner, 2001} and their subsequent maturation and 
stabilisation by enveloping smooth muscle cells (SMC) {Felmeden, 2003}. Stimulated by 
hypoxia, these vessels proliferate by either capillary sprouting {Peirce, 2003} or 
intussusceptions {Burri, 2002} particularly into venules. Vasculogenesis occurs from migrating 
dedifferentiated EPCs which form tubules {Tepper, 2003}.
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Figure 1.1. The series o f events illustrating the dual nature o f vessel development: angiogenesis 
and arteriogenesis.
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1.1.4. TISSUE PERFUSION
Microvessels divide into numerous smaller branches over a given volume o f tissue thus 
maximising the available area for nutrient exchange. In this microenvironment, stasis of flow is 
prevented by the Fahraeus-Lindqvuist effect, repulsive charges between blood cells and vessel 
wall as well as the thin glycocalyx film on the endothelial layer (figure. 1.2) {Levick, 2000}.
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Figure 1.2. Factors preventing thrombogenicity at low-flow states.
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As blood slows down in the meta-arterioles, intra-vascular transit time increases. As this 
happens, nutrient exchange shifts from flow-limited to diffusion-limited exchange within the 
capillaries (figure 1.3). Diffusion (D ) is dependent on the concentration gradient (C), 
permeability o f the membrane (P) and surface area (S) as represented below,
D = -P .S .C
P  in turn, depends on effective pore area (A) and pore length (L). Capillary exchange is a 
mixture o f diffusion- and flow-limited exchange with the latter being important for the transfer 
o f water-soluble molecules and the former for gas transport.
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Figure 1.3. Flow- and diffusion-limited exchange.
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Plasma is a two-phase fluid consisting of solvent and solute phases. While solvents pass 
unimpeded into the extracellular matrix (ECM), solutes are transported by means o f convection 
(bulk transport) and diffusion {Hughes D, 2000}, represented by the formula,
F  = Q + D
Where F  is solute flow and Q is convective flow. Solute efflux is dependent on the rate of 
solvent transfer within the medium. Solutes like glucose are transported via convection with 
water (solvent) whilst gaseous exchange is based on Krogh’s diffusion model.
This is augmented by the 5 mmHg negative pressure as a result o f ECM hydraulic 
conductivity; the ability o f tissue to conduct water across it. Hydraulic conductivity (H) o f ECM 
is proportional to the hydraulic radius o f the gel (the ratio o f its porosity, P  to net surface area of 
the glycosaminoglycans (GAGs).
H a p / S
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The interstitial conductivity o f ECM is proportional to its hydration and is usually in the range
i n  i ^ iof 10" to 10' cm /s per dyne. This force is balanced by the intrinsic hydraulic resistivity o f the
o
ECs lining the microvessels. Studies have shown this to be in the vicinity o f 10' cm /s per dyne 
{Secomb, 1998}. Nutrient exchange depends on the balance between hydrostatic, osmotic and 
interstitial pressures {Levick, 2000}.
1.2. SEARCH METHODS
All the studies were identified by the following databases; Pubmed, Ovid Online, Infotrieve, 
Proquest, Science Direct, ISI Web o f Science, BioMed Central, Ingenita select, Elsevier texts 
and Blackwell-synergy searches between years 1966-2003 with the following key words: tissue- 
engineered blood vessels; vascularisation of acellular tissue; vascularisation o f tissue; 
angiogenesis; vascular tissue engineering; microvasculature; tissue engineered flaps; pre­
fabricated flaps; soft tissue engineering; polymers in vascular tissue engineering; capillary beds; 
microvasculature; polymers in tissue engineering; collage; Dacron; PTFE, alginate.
1.3. TISSUE ENGINEERED MICRO VESSEL BEDS
1.3.1. MICRO VASCULAR TISSUE ENGINEERING
Micro vessel beds provide the vascular infrastructure for living tissue {McGregor, 1995}.
The development o f independently vascularised artificial tissue requires a source of 
vascularisation (intrinsic existing blood vessels) and a matrix through which exuding nutrients 
can perfuse cells {Cassell, 2002}. The matrix functions as a reservoir o f growth factors to
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induce incoming blood vessel (angioinduction) as well as a scaffold to seed cells like EPCs 
which participate in the formation o f newer blood vessels by the process o f arteriogenesis 
(figure. 1.4). Microvessel networks, artificial matrices and neovascularisation constitute the triad 
of tissue vascularisation (figure 1.5).
Figure 1.4. The inter-relationship between various models o f vessel development.
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Figure 1.5. The triad o f tissue vascularisation.
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A successful microvascular system depends on the graft material and how it is arranged. The 
material would have to be non-thrombogenic, have similar compliance to native vessels to avoid 
intimal hyperplasia {Salacinski, 2001c} at its arterial end and be sufficiently porous to allow 
nutrient exchange at the capillary level. An artificial capillary network would include small 
arteries (1 to 2 mm) conducting blood into an arteriolar network (100 to 1000 pm ) which would 
eventually end in capillary-like vessels o f 10 to 15 pm. These end-capillaries would need to be 
within 150 to 200 pm of every target cell {Cassell, 2002} before converging into a venous 
collecting system. Therefore, both arteriolar and venular components o f the scaffold would have 
to be in close proximity.
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1.3.1.1. Types o f prostheses
The following section has been subdivided into macro- and microvascular grafts. The reason 
being that micro-vessels are being developed from previous technology as used in the 
development of larger macro-vessels and only rarely, are completely new material based 
approaches used to date. This discussion is necessary to deal with the issues of potential 
overlaps and discrepancies during the transition between the high flow arterial system and the 
lower flow capillary system and how in light of these, tissue engineering o f micro-vessels differs. 
The various graft options are summarised in table 1.1.
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Table 1.1. Current status o f macro- and microvascular grafts.
Authors Graft Type Subjects ID (mm) Vessels Patency rates Comments
{Harris, 2002} PTFE Rats <1 Superficial epigastric 20% at 4 weeks Vein grafts had 100 % patency
{Demiri, 1999} PTFE Rats 1 Femoral 25% at 4 weeks Vein grafts had 100 % patency
{Seifalian, 2003} CPU Dogs 5 Aorto-iliac 100% at 3.5 yrs Human trials under way
{Shinoka, 1998} Polyglactin-PGA Sheep 15 Pulmonary 100% at 7 weeks Good tissue ingrowth but increase in vessel ID
{Shum-Tim, 1999} PHA-PGA Sheep 7 Aorta 100% at 21 weeks Outer PHA ring prevented increase in vessel ID
{Meinhart, 2001} EC-seeded ePTFE Humans 6 to 7 Infra-popliteal 74% at 7 yrs Comparable to vein grafts
{Lambert, 1999} Heparin-coated Dacron Humans 6 to 7 Infra-popliteal 58% at 2.5 yrs Better results than plain Dacron
{Devine, 2001} Heparin-bonded Dacron Humans 7 to 9 Femoro-popliteal 55% at 3.5 yrs This trial shows better results than PTFE
{Weinberg, 1986} Collagen-Fb-SMC In vitro Unknown — — 92% EC coverage but weak bursting strength.
{L'Heureux, 1998} Collagen-EC-SMC-Fb In vitro 4.6
— —
Comparable bursting strengths to human vessels
{Wilson, 1995} AAM Dogs 3 to 4 Coronary 44% at 6 months All failures due to acute graft rejection
{Teebken, 2001} AAM Pigs 5 Carotid 38% at 4 months Disappointing results due to graft rejection
Keys: AAM, Allogeneic acellularised matrix; ePTFE, expanded polytetrafluoroethylene; Dacron, Polyethylene tetraphthlate; CPU, compliant polyurethane graft; ID, internal 
diameter; PHA, Polyhydroxyalkanoate; PGA, Polyglycolic acid.
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1.3.1.1.1. Macro vascular grafts
While results with PTFE and Dacron™ are satisfactory in peripheral bypass grafts 
{Meinhart, 2001}, patency is far lower in grafts 6 mm or smaller {Budd, 1991;Schmedlen, 
2003;Teebken, 2001}. The primary problem at lower flow rates is thrombogenicity and the 
increased susceptibility o f these vessels to intimal hyperplasia. Dacron™ and PTFE have been 
found to be increasingly thrombogenic at lower flow states and need surface modification. 
Luminal modification o f vessels using irradiation, presealing and antiplatelet / anticoagulant / 
growth factor incorporation {Salacinski, 2002a;Salacinski, 2003;Cassell, 2002} to reduce 
thrombogenicity has been employed {Salacinski, 2001c} but endothelialisation is better 
{Salacinski, 2000;Salacinski, 2001a}. Endothelialisation o f vascular prostheses is dependent on 
the biomaterial used and pore morphology. Matsuda and colleagues reported that pores between 
18 and 50 pm in diameter are optimal for endothelialisation {Matsuda, 1996}. Smaller pores 
would elicit an inflammatory reaction {Ko, 2001} while increasing pore sizes and porosities 
improves the radial compliance o f vessels {Kowligi, 1988} and hence reduces the likelihood of 
intimal hyperplasia.
More compliant biomaterials such as poly(carbonate-urea)urethane (PCU) are now being 
introduced. PCU, currently undergoing Phase I clinical trials in lower limb peripheral grafts, has 
been found to have similar compliance to native vessels and thus exhibit intimal hyperplasia to a 
lesser extent {Salacinski, 2002a;Tiwari, 2002}. Therefore it has the potential to be used as the 
biomaterial of choice to construct the arterial conducting component o f artificial capillary beds. 
Synthetic protein polymers cross-linked by y-irradiation represents a new generation of 
biopolymers. Preliminary reports suggest that it has similar elasticity to arteries with a 
controllable rate of degradation {Urry, 1997}. This recent trend illustrates the limitations o f 
PTFE and Dacron™ at lower flow rates and stresses the need for alternative biomaterials.
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1.3.1.1.2. Microvascular grafts (Microvessels)
Microvascular grafts are those with internal diameters o f 1mm or less and may be classified 
into conducting arterial and distributing capillary vessels. The construction o f arterial conduits is 
based on small calibre vascular graft technology. These vessels may be constructed using 1) 
newer polymers, 2) coating its lumen with heparin or endothelial cells and 3) constructing 
biological or bio-hybrid grafts in vitro prior to re-implantation {Bos, 1998}. As these vessels 
divide further, they need to branch into a distributing capillary network with larger pore sizes 
and thinner vessel walls for enhanced nutrient exchange. Although autologous vein grafts, the 
current gold standard for microvascular repairs, are compliant and non-thrombogenic, they are 
limited by the need for additional vein harvesting procedures. Furthermore, the construction of 
artificial vascularised tissue requires an inherent vascular network. Vein grafts are not suitable 
for this purpose as it is technically impossible to dissect out a capillary bed in its entirety.
As such, efforts have been under way to develop microvascular grafts using common 
biomaterials. An in vivo study in a rabbit femoral artery model showed a 20 to 25 % patency rate 
at one month with PTFE microvessels (< 1 mm) while all vein grafts in similar settings 
remained patent {Demiri, 1999;Harris, 2002}. In order to improve patency rates, luminal 
endothelialisation has been attempted. In a study, 1 mm interpositional ePTFE vascular grafts in 
rat aortas, coated with ECM and incorporated with non-tumourigenic human keratinocyte cell 
line (HaCaT) or Epstein-Barr Virus (EBV) - transformed human B-cell lymphocyte (TOU II-4) 
cell lines, showed ablumenal vascularisation with the formation o f an EC lining five weeks post­
implantation {Kidd, 2003}. While this suggests that endothelialisation of these microvessels at 
lower flow rates is optimal, it is important to note that vascular grafts within young animal
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models have been shown to endothelialise over time and as such, these results cannot be 
extrapolated to human subjects who tend to be older as well {Rashid, 2004;Tiwari, 2002}.
An in vitro biological microvascular model has been developed by Neumann and co-workers 
wherein 80 pm diameter nylon strands were used as templates onto which SMCs in a culture 
medium could attach to. After a week, this strand was physically removed and the grafts were 
perfused in a pulsatile flow chamber mimicking the arterial system (figure 1.6). After 28 days in 
culture, these vessels were shown to have 30 to 40 layers o f SMCs evenly distributed throughout 
the lumen and strong enough to withstand its own weight. Non-absorbable nylon was preferred 
to absorbable cellulose since constructs based on cellulose had irregular, uneven luminal 
surfaces {Ko, 2001}. This model has the potential to form arterioles and capillaries in vitro 
which could then be transplanted into living tissue. Further results using ECs in a similar model 
are being undertaken {Neumann, 2003}.
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Figure 1.6. A viable micro vessel perfusion system.
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Bio-hybrid microvessels have also been developed in vitro using co-cultures o f EC and 
SMC. These cells were passed through polypropylene capillaries at 3 dynes/cm2 laminar shear 
stress. ECs lined the lumen o f these tubes while SMCs managed to migrate outside these 150pm 
diameter microvessels through pores (0.5 pm) to form a two separate monolayers as in normal 
vessels {Redmond, 1995}. EC and SMC adhesion in such constructs can be improved with the 
use of cell adhesion peptide sequences such as the ‘arginine-glycine-aspartate’ (RGD) sequences 
and fibronectin-like engineered protein polymer (FEPP) {Massia, 2001;Merzkirch, 2001}. 
Although there are no reports o f artificial capillary vessels so far, the advent o f nanofabrication 
may soon see functional capillary-sized microvessels (15 to 50 pm) being developed.
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1.3.1.2. Configuration o f vessels
The limiting factor in metabolite exchange is the extra-vascular distance needed to be 
traversed. The physiological response to this is to pair up both the arteriolar and venular 
components together. Between them, numerous small capillaries run across tissue at a cross-
' j
sectional density of 1300 per mm with an inter-capillary distance o f 34 pm to form a rich 
perfusing network. This is well within the maximum diffusing distance o f oxygen, glucose, 
carbon dioxide and other waste metabolites {Levick, 2000}. In studies on rat mesentery, it was 
found that arterioles and venules travelling together formed a ‘counter-current’ system 
responsible for auto-regulation and improved nutrient exchange {Harris, 2003}. Therefore, 
arteries and veins should be paired for greater efficacy.
A study of the temporal relationship o f pre-fabricated flaps was performed by inserting a 
flap of tissue under rat abdominal skin. The femoral arterio-venous pedicles induced flap 
neovascularisation as early as two weeks post-surgery but it took up to eight weeks for the 
vascular pedicle to sustain the flap alone {Kostakoglu, 1997}. However in a similar study, the 
flap was found to survive after its pedicle was divided after three to four weeks {Ouyang, 1996}. 
Studies on hybrid flaps have also shown that the pedicle can be divided by four weeks, provided 
a highly porous biomaterial like polyethylene is used along with living tissue as a flap {Karatas, 
2000;Can, 1998}.
Tanaka and associates used the rat femoral vessel system to determine whether loop, ligated 
bundles or flow-through pedicles were most effective in initiating and sustaining tissue 
perfusion and neovascularisation. Using a collagen I dermal implant in the rat groin, they 
formed four groups. In the first group, the implant was placed on a recipient bed with no 
vascular pedicle. In the second group, a vascular loop formed of either an arterial or venous
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graft was employed. In the third group, an arteriovenous (AV) bundle ligated at one end was 
embedded within the matrix and in the fourth group, an AV flow-through graft was placed 
across the matrix (figure. 1.7). Four weeks later, the matrices were sectioned and stained. 
Matrices from group two showed the greatest increase in volume with flow rates of up to twenty 
times normal. However compared to the third group, it had less tissue organisation. AV ligation 
(group three) showed the densest vascularity and maximal tissue regeneration with predominant 
sprouting from the venous end. They concluded that while an AV loop quantitatively increased 
capillary and new tissue formation, ligating the loop ensured better tissue organisation {Tanaka, 
2003}.
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Figure 1.7. The effect o f vessel configuration on tissue vascularisation. Group I -  control
(acellular dermis), Group II -  Arterio-venous loop embedded in the matrix, Group III 
-  Arterio-venous bundle ligated within the matrix, Group IV -  flow-through graft.
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1.3.2. EXTRACELLULAR MATRIX SCAFFOLDS
Once a microvascular network is constructed, how and where do we place it ? How would 
nutrients from blood migrate across the blood-cell barrier into the surrounding areas and perfuse 
cells. This parameter is regulated by the extra-cellular matrix (ECM). In this section, we refer to 
the ECM scaffold into which a vascular network would be placed.
In the biological setting, ECM is composed o f collagen, fibronectin, laminin, GAGs and 
water {Badylak, 2002}. Fibroblasts synthesise non-cellular components o f the matrix as shown
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in table 1.2. Using acellular dermal grafts in Sprague-Dawley rat groins, matrices were pre­
fabricated by vascularising them with the superficial epigastric vessels. Histological analysis 
showed infiltration by mononuclear cells within the first 72 hours with neo-vascularisation 
occurring between days 3 and 14. Simultaneously, SMC and EC were laid along the lines of 
stress. Devascularised matrices (control group) had a 90 % hernia rate while those with an intact 
vascular pedicle within had no evidence o f a hernia (p<0.01). Therefore, it was concluded that 
vascularised scaffolds were structurally and functionally superior to non-vascularised ones 
(Chung, 2003}.
Table 1.2. Non-cellular components of ECM and their function (Badylak, 2002}.
Component Function
Collagen type I Structural framework
Collagen type IV Basement membrane for EC
attachment
Collagen type VII Keratinocyte attachment
Fibronectin Cell adhesion
Laminin Protein adhesion
GAGs Cytokine and growth factor binding
1.3.2.1. Biomaterial substitutes
The ideal matrix to sustain a vascular network should be biocompatible, porous, supportive 
to its inherent vascular network, readily available, permeable to incoming vessels or chemicals, 
non-immunogenic, biodegradable, inert, have a slow-release mechanism and lastly, it would be 
convenient if  it could be administered as an injectable. Such tissue-engineered constructs would 
act as temporary scaffolds which maintain cells in-situ whilst inducing neovascularisation.
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Eventually, the existing ECM matrix will be replaced by the products o f newer cells such as 
collagen, laminin, elastin, GAGs or fibronectin. These undergo continuous remodelling 
{Driessen, 2003} as depicted by figure 1.8 and ultimately reorganise into near-normal tissue 
{Nor, 2001}. Current ECM scaffolds can be classified into natural and synthetic types each with 
its own advantages and disadvantages. Natural biomaterials are characteristically biodegradable, 
non-immunogenic and bio-compatible. A list o f natural ECM available is summarised in table
1.3.
Figure 1.8. The effect o f cell traction on tissue patterns.
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Table 1.3. Natural materials used in ECM constructs
Biomaterials Composition Characteristics Comments Modifications References
Alginate (3-D-mannuronic acid + a-L- 
glucuronic acid
Temperature-independent gel Burst release Microsphere / bead incorporation, heparin 
cross-linkage(controlled release), RGD- 
peptide sequence incorporation
{Draget,
1997;Halberstadt, 
2002;Kikuchi, 
2002;Tanihara, 200
Agarose Agarose Solid gel Sub-optimal release Heparin addition (increase factor load) (Watanabe, 1998}
Hyaluronic 
acid (HA)
Glucuronic acid + N-acetyl D- 
glucosamine (linear GAG)
Biodegradable gel, 
biocompatible, +/- 
photopolymerisable
Angio-inhibitory, degradation 
products are angiogenic, non­
adhesive to cells
Chitosan cross-linkage (improves 
angiogenesis), RGD sequences (improve 
cell adherence), methacrylate addition
(Slevin, 2002}
Fibrin glue Fibrin monomers Injectable gel * Structurally weak Heparin cross-linkage(controlled release) (Shireman, 2000}
Collagen / 
gelatine
Type I collagen (atelocollagen) Porous and permeable. Low factor-loading capacity Heparin cross-linkage (Kuberka, 2002}
Matrigel Collagen type IV + laminin + 
entactin + proteoglycans
Inert, permeable, injectable gel Structurally weak None {Montanez, 2002}
Keys: * Ideal for local delivery.
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1.3.2.1.1. Natural
Alginate is an anionic polysaccharide composed of B-D-mannuronic acid and a-L-glucuronic 
acid cross-linked in a gel by non-toxic levels o f calcium ions. It has been incorporated with 
various growth factors like basic fibroblast growth factor (bFGF), VEGF and heparin within 
microspheres {Kawada, 1999}. Alginate gel is a hydrogel system that is independent of 
temperature changes {Draget, 1997} but tends to release its chemicals within 4 days (Elcin,
2001}. This can be overcome by incorporating microspheres and peptides {Kikuchi, 2002} or 
cross-linking with heparin {Tanihara, 2001}. Alginate gels modified with RGD peptide 
sequences {Halberstadt, 2002} and syngeneic fibroblasts formed strong gels and were more 
tissue-like {Marler, 2000}. An agarose gel cross-linked with heparin has been used to deliver 
basic FGF beads to the porcine myocardium but delivery characteristics are still sub-optimal 
{Watanabe, 1998}.
Hyaluronic acid (HA), a linear glycosaminoglycan (glucuronic acid N-acetyl D-glucosamine) 
has good biocompatibility and is degraded by hyaluronidase. However, it has poor adherence 
and inhibits EC proliferation while its degradation products are pro-angiogenic {Slevin, 2002}. 
To improve this, chitosan; a glycosaminoglycan (N-acetyl D-glucosamine), has been added to 
HA to form a composite material in the synthesis of endotheliased human skin equivalent 
{Black, 1999}. Chitosan attracts neutrophils and activates macrophages {Chupa, 2000}. 
Microspheres filled with FGF within similar constructs were used to improve neovascularisation 
in rat tissue {Elcin, 1996}. The addition o f methacrylate groups to HA, followed by exposure to 
light o f 480 -  520 nm wavelengths could photopolymerise composite HA gels into any given 
shape with minimal gel swelling. RGD sequences could also be added to the composite to 
improve cell adherence. In vitro studies on this composite showed improved fibroblast viability 
and proliferation compared to standard HA gels {Park, 2003}.
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Fibrin glue derived from blood clots is useful as an injectable medium for the local delivery 
o f growth factors like VEGF. Burst release is a problem which is overcome by the incorporation 
of heparin for better control {Shireman, 2000}. Collagen type I is highly porous (pore sizes of 
50 to 150 pm) and has been seeded with Fb or pre-adipocytes {Kuberka, 2002}. Chondrocytes 
embedded within three-dimensional collagen gels were found to be viable and capable of 
synthesising proteoglycans (PG) {Weiser, 1999}. Unfortunately, loading factors onto it is 
difficult but this can be overcome by cross-linking collagen gels with heparin. This has been 
shown to increase the incorporation o f angiogenic factors sufficiently to culture human 
umbilical vein cells (HUVEC) in vitro {Wissink, 2000}. ECM gel (Matrigel™) that is 
composed of basement membrane proteins has been used in vitro as scaffolds {Montanez, 2002} 
but has so far few clinical uses. In addition, concerns have been raised regarding its 
tumourigenic origin {Zisch, 2003}. Other natural substitutes used are porcine intestinal sub­
mucosa {Hodde, 2002}, acellular dermis, cadaveric fascia and amniotic membrane {Flodde, 
2002}. The most significant drawback o f these ECM substitutes is that they are structurally 
weak with unmodulatable hydraulic conductivity.
1.3.2.1.2. Synthetic
A broad range of polymer have been employed in developing ECM scaffolds into which 
cells could be seeded. Depending on the site of implanting these tissue engineering constructs, 
namely cartilage, bone, nerve or vascular grafts, the choice o f these polymeric component o f the 
scaffold is made. Current polymers such as poly-(propylene fumarates)/ PPF, poly-anhydrides 
(PA), polyglycolic acid (PGA), polylactic acid (PLA), poly-carbonates (PC), polylactone (PL), 
polyurethanes (PU), poly(orthoesters)/POE, polyphosphazenes (PPZ) and poly(ethylene-
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terephthalate)/PET have different physical and chemical characteristics which are then 
optimised for a specific purpose. For instance, PET is suitable for vascular grafts {Kikuchi, 
1998}. These are being used with increasing frequency in biomedical devices.
Polyglycolic acid (PGA) is inelastic polyester with high crystallinity (46-50 %). It is 
degraded by the diffusion o f water followed by hydrolysis o f the crystalline elements of the 
polymer into glycolic acid {Chu, 1981}. Polylactic acid (PLA) is less crystalline than PGA but 
more hydrophobic, making it less susceptible to hydrolysis. Poly(lactide-co-glycolide) / PLGA 
co-polymer in the amorphous form is a high porosity, open-pore system which degrades in 2 to 
6 months by means o f hydrolysis of the ester bonds {Vert, 1994}. A significant drawback is that 
angiogenic factors incorporated within it tend to leach out. This can be rectified using 
microsphere, beads or bioactive foams {Lenza, 2003} for slower release o f chemicals. 
Experiments using microspheres containing recombinant VEGF within PLGA foams which 
were then implanted into rat fascial flaps, showed a more controlled release o f growth factors 
{Linn, 2003}.
1 , 3 -  trimethylene carbonate (TMC) and D, L - lactide (DLLA) (19:81, molecular weight 
ratio) are amorphous co-polymers o f PLA. Salt-leaching these polymers produced foams o f high 
pore interconnectivity and porosity with an average pore size o f 100 pm. Cardiomyocytes grown 
on it were able to adhere and proliferate indicating that TMC-DLLA co-polymers are not 
cytotoxic. In vitro signs o f degradation occurred by four months via hydrolysis {Pego, 2003}. 
When these polymers were implanted subcutaneously in rats, degradation started at three weeks 
and by one year, 96 % of its mass was lost. These co-polymers also elicited a sterile and acute 
inflammatory reaction resulting in the formation o f a capsule in vivo {Pego, 2003}. Degradation 
was far more rapid in poly-TMC polymers (three weeks). Silica-based 
poly(dimethylsiloxane)/PDMS has been polymerised with PLA-PGA composites to form 
PLGA/TEGOMERS which have shown to be biocompatible, supportive to cell growth and non-
35
toxic {Porjazoska, 2002}.
Experiments with microvascular cell cultures mainly involve PLA, PGA or their composite 
scaffolds. These are summarised in table 1.4. PLs like poly-CL are biocompatible with 
prolonged degradation times o f up to three years in vitro {Middleton, 2000}. Combining CL 
with TMC slows down degradation o f the primary TMC polymer {Pego, 2003}. The mechanism 
of degradation is hydrolysis with caproic acid, the by-product. Its disadvantage is that it is 
structurally weak.
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Table 1.4. Synthetic materials used for ECM construction in various tissues such as bone, cartilage, skin etc.
Polymer Compressive
strength
Synthesis DT (months) By-products Advantages Disadvantage
s
References
PGA 7.5 GPa E/M/C 6-12 Glycolic acid Porous, biocompatible, non-toxic, non­
inflammatory, natural waste metabolite
Not pliable {Chu, 1981}
PLA 2.7 GPa E/M/C >24 L-lactic acid Porous, biocompatible, non-toxic, slower 
degradation, natural waste metabolite
Hydrophobic (Gunatillake,
2003}
PLGA 1.9 GPa E/M/C 12-16 D,L-lactic acid Porous, biocompatible, non-toxic, non­
inflammatory
Excessive
leakage
{Vert, 1994}
PL 0.4 GPa E/M/C >24 Caproic acid Non-toxic, biocompatible Weak structure {Middleton,
2000}
PPF 2-30 MPa Injection ~ 30 Fumarate, polyethylene glycol, 
poly (acrylic-co-fumaric) acid
Non-toxic, biocompatible, minimal 
inflammation, photo-cross linkage, strong
Not significant {Peter,
1998;Peter,
1997}
PA 1.3 MPa Thermoplastic 12 (in vitro) Dicarboxylic acids Biocompatible, thermoplastic, surface 
erosion, angioinductive
Weak {Erdmann,
2000}
PC Sufficient for 
load-bearing
Thermoplastic Very slow Tyrosine, C 0 2 
and alcohols
Porous, biocompatible, thermoplastic, 
osteoconductive
Acidic
byproducts
{Muggli,
1999}
PU (LDI) 8-40 MPa Thermoset 1-2 Lysine, glycolic acid, caproic 
acid
Biocompatible, strong, pliable Some PUs 
(TDI) are toxic
{Gunatillake,
2003}
PPZ Sufficient for 
load-bearing
" “ Phosphates and ammonia Biocompatible, osteoconductive, strong Not significant {Gunatillake,
2003}
POE Sufficient for 
load-bearing
“ Regulatable 
with lactide
Carboxylic acids Biocompatible, osteoconductive, strong Not significant {Ng, 1997}
PEEU Tensile strain 
(9-29 MPa)
“ “ “ Biocompatible, strong Poor cell 
adhesion
{Guan, 2002}
PPy " <13 “ Electrical conduction, minimal 
inflammation
“ {Jiang, 2002}
Keys: C, casting ; DT, Degradation time; E, Extrusion; M, moulding; unknown.
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PPFs are polyesters based on fiimarates. They can be injected into any space and further 
photo cross-linked by adding methacrylates {Peter, 1998}. PPFs are structurally strong and 
capable of withstanding great loads. In vitro degradation (up to 200 days) occurs following 
hydrolysis of its ester bonds to form fumaric acid; a natural metabolite, propylene glycol and 
poly (acrylic acid-co-fumarate) {Peter, 1997}. Apart from being biodegradable, PPF has also 
been found to be non-cytotoxic with minimal inflammatory reaction in vivo {Peter, 1998}.
PA forms soft tissue constructs being biocompatible, thermoplastic with controlled 
degradation characteristics (surface erosion). It is a weak polymer limiting its use in load- 
bearing devices. It may be strengthened by the addition of imide groups {Attawia, 1995}. PAs 
are degraded by hydrolysis o f its anhydride bonds by 12 months in vitro into dicarboxylic acid 
{Erdmann, 2000}. In vivo implantation o f these polymers, show evidence o f good 
vascularisation o f itself by four weeks {Laurencin, 1990}.
PCs are thermoplastic and strong enough to sustain heavy compressive loads. Their 
advantages are that they are biodegradable, biocompatible and have very low rate o f degradation. 
However, hydrolysis o f its carbonate groups culminates in the formation o f acidic by-products. 
This is an undesirable property for an ECM substitute {Gunatillake, 2003}.
Bioelastic materials; monomeric protein polymers which convert heat or chemical energy 
into mechanical energy represent the next generation o f polymers. Heat exchange, 
hydrophobicity or hydrophilicity induces a mechanical tensile force within the polymer that is 
mediated by competition between the molecules for hydration. These forces modulate cells 
within the construct to form micropattems and secrete new ECM. This process is called cellular 
tensegrity or mechanotransduction {Urry, 1999}. An example would be poly (N- 
isopropylacrylamide) which can mechanically reconfigure themselves with changes in
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hydrophilicity and temperature {Kikuchi, 1998}.
1.3.2.1.3. Sol-gel systems
Gels are composed of three components namely solute, solution and voids with the three in 
equilibrium with one another {Aamer, 2004}. A typical gel is poly-ethylene glycol (PEG). As 
shown in figure 1.9, polymer molecules are initially functionalised with adhesion factors. These 
are then cross-linked via the formation of reactive termini. Cells migrating into this matrix break 
down the cross-linking peptide leading to local degradation and hence release of the 
incorporated factors such as heparin and VEGF {Zisch, 2003}. These synthetic gels need to be 
bio-degradable and cell-responsive {Lutolf, 2003}. Using a PEG-based polymer, by shortening 
the block length from a mean molecular weight o f 930 to 6090 kDa, biodegradation of the 
hydrogel could be minimised {Shin, 2003}. The same effect has been shown in triblock co­
polymers of poly (L-lactide)/PLLA and poly(ethylene oxide) (PEO) / PLLA-PEO-PLLA 
{Aamer, 2004}.
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Figure 1.9. The synthesis o f biomimetic gels.
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Photo-polymerisable poly-vinyl alcohol (PVA) hydrogels {Nguyen, 2002} are injectable. As 
such, it is possible to place these gels in vivo using minimally invasive procedures and then 
allowing cross-linkage to occur. This gel was found to be highly elastic and strong. Since cell 
adherence was poor, these constructs were modified with the RGD peptide sequence 
{Schmedlen, 2002}. This principle was used by Cao and colleagues to immobilise ovalbumin 
within a 3-D hydrogel {Cao, 2002}. De Rosa and co-workers proposed a polyelectrolyte gel 
with a cationic surface charge across it. These charges increased the adhesion o f Fb to the gel as 
well as their proliferation thereby minimising the risk o f fibrous encapsulation {De Rosa, 2004}.
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1.3.2.2. Superstructure
Superstructure refers to the integration o f two-dimensional pores or structures into a three- 
dimensional (3-D) configuration whereby these overlap in a regular or irregular pattern. In 
polymers, the former confers crystallinity and the latter, amorphous characteristics. The 
superstructure of a polymer determines pore characteristics. Studies have shown that cells 
aggregate less within smaller pores and these smaller aggregates proliferate to a lesser extent 
{Ma, 1999}. Hence, in scaffolds with smaller pore sizes and volumes, cells spread faster {Li, 
2001 }.
Superstructures exist in three main forms namely textile (woven/knitted), open-pore and 
angiopolar systems. The angiopolar principle involves spatially orientating pores within 
matrices to induce cells, microvessels and nutrients to propagate in a given direction 
{Wintermantel, 1996}. Pores within biopolymers may be classified into macropores (~ 500 pm), 
mesopores (20 -30 pm) and micropores (<10 pm). Macropores regulate the optimum cell type 
and seeding density within a construct. Mesopores allow microvessels to infiltrate the polymer.
It has been observed in early in vivo studies on rats that arterioles and venules tend to proliferate 
on the inner surface o f mesopores while capillaries lined its outer surface {Wintermantel, 1996}. 
Lastly, micropores function as regulator of molecular transport within a polymer system. Pore 
characteristics may be modulated depending on the method of polymer synthesis like extrusion, 
leaching, casting, moulding or electrospray.
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1.3.2.3. Cells seeded onto matrices
Seeding cells onto a matrix is integral to the formation of a bio-hybrid scaffold as cells like 
fibroblasts and chondrocytes secrete extra-cellular matrix (ECM). However, long-term cell 
viability in such artificial constructs is a limiting factor as these cells have to remain viable in 
vivo until neovascularisation occurs. Fibroblasts are the most abundant cells within the ECM but 
scaffolds seeded with fibroblasts tend to contract following in vivo implantation, thus impairing 
fibroblast migration. In a study comparing pure and GAG-chitosan-collagen sponges, the latter 
minimally contracted and showed a 300 % increase in fibroblast proliferation at six weeks 
compared to pure collagen sponges {Vaissiere, 2000}. This was augmented by incorporating 
RGD-peptide sequences to improve fibroblast attachment and proliferation {Shu, 2004}. 
Engineered cartilage using chondrocytes has the potential to act as a viable ECM scaffold (as 
these cells have low metabolic rates and require minimal perfusion), into which micro-vascular 
networks can actively proliferate and grow. Embedded chondrocytes within fibrin glue showed 
that these cells can maintain viability in a non-vascularised environment {Sims, 1998} although 
chondrocytes alone forms rigid tissues. Brown and co-workers developed a hybrid chondrocyte- 
SMC with a compressive modulus between muscle and cartilage {Brown, 2000}.
Research has demonstrated that fat has potential as a bulking agent, however the difficulties 
associated with the extraction of adipocytes and their subsequent culture, this being the 
propensity for intra-cellular lipid vacuole bursting has rendered their usage in tissue engineering 
to be extremely limited. Pre-adipocytes extracted from the epididymal fat pads o f Sprague- 
Dawley rats proliferated ex vivo {Patrick, 1999} on PLGA scaffolds up to two months following 
implantation but viability decreased thereafter. However, the study did not mention whether 
these cells survived by neovascularisation or diffusion. Pre-adipocytes attached maximally to 
hyaluronic acid scaffolds with mean pore sizes of 400 pm {Halbleib, 2003}. Pre-laminating
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these cells layer onto layer in vitro improved its vascularisation characteristics {Garfein, 2003}. 
Fatty tissue from lipoaspirate (LPA) has been shown differentiate into many cell lines and hence 
form a source o f stem cells {De Ugarte, 2003}. Injecting the cDNA of VEGF into scaffolds 
further improves vascularisation prior to actual cell seeding {Soker, 2000}.
1.3.3. VASCULARISATION
While scaffolds and microvessels are essential components of a capillary bed, it is equally 
important for the tissue-engineered device to connect to the host tissue. This would entail the 
induction of incoming microvessels into the scaffold (angioinduction) as well as allow the 
inherent microvessels to grow out and meet these vessels (inosculation).
1.3.3.1. Inosculation
The presence of an inbuilt micro-vascular network itself within a matrix is insufficient 
unless the intra- and peri-vascular regions are seeded with ECs, SMCs and fibroblasts. Therefore 
for the growth of vessels within an engineered vascularised tissue construct out into the host 
tissue, it is necessary for these to either “link” or “hook-up” with the host’s vasculature, this 
process is a term described as inosculation. While ECs confer non-thrombogenicity to the graft, 
circulating haematopoietic stem cells such as EPCs are capable o f stimulating the formation of a 
vascular network (post-natal vasculogenesis) (Masuda, 2003}. Their sources are the bone 
marrow, mononuclear cells and the vessel wall. These cells can be harvested by enrichment 
following extraction or ex vivo cultures (Kalka, 2000}. Once these cells are injected into the 
circulation, EPCs move on to sites o f neovascularisation (therapeutic vasculogenesis)
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{Murohara, 2000}.
Early studies on vasculogenesis used cells like quail blastodiscs, murine embryonic stem 
cells, HUVEC and human pulmonary microvascular endothelial cells (HPMEC) grown on 
collagen, fibrin, gelatin and methylcellulose matrices (table 1.5). These cells have been shown to 
grow into capillary-like tubes (CLTs) which may be controlled by altering the growth factor 
gradient or biomechanical tension across the gel. While in culture, tissues can be genetically 
modified by transfecting them with viral vectors. Over-expression and carcinogenicity are a 
problem. Alternatively, cells like SMCs could be transduced with multiple genes and then be 
allowed to repopulate the microenvironment (transgenesis). SMCs were harvested from tissue 
enzymatically and cultured serially until differential cell adhesion molecules are removed. Next, 
the SMCs were magnetically extracted and incubated with high-titre retroviral supernatants.
99% of these cells were successfully transfected {von Degenfeld, 2003}.
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Table 1.5. In vitro developmental models of angiogenesis and vasculogenesis.
Cells CLS formation 
(day)
Morphogenesis induction Matrix Spatial
organisati
on
References
Bovine Capillary EC 2-3 Spontaneous Collagen I sandwich 3-D {Montesano, 1983}
Embryonic Stem Cells 12 Spontaneous embryoid body formation Culture dish 3-D {Doetschman,
1985}
Muscular Tissue Fragments Adipose Tissue Frag. 3-12 Spontaneous Fibrin + Collagen I 3-D {Montesano, 1987}
Bovine Aortic EC, Adrenal Capillary EC, HUVEC 1 Spontaneous Fibrin 2-D {Olander, 1985}
Bovine Capillary EC 5-15 Cytokines Collagen I 3-D {Montesano, 1986}
Bovine Capillary EC 2-3 Phorbol ester Fibrin 3-D {Montesano, 1987}
Human Umbilical Vein EC, HDMEC 1 Spontaneous Matrigel 2-D {Kubota, 1988}
Bovine Capillary EC 1-2 Spontaneous-cytokines Fn + Collagen IV + Matrigel 2-D {Ingber, 1989}
Rat Aortic Explants 7 Spontaneous Fibrin + Collagen I 3-D {Nicosia, 1990}
Bovine Aortic EC 10-18 Spontaneous Collagen I 2-D {Vernon, 1995}
Human Umbilical Vein EC 1 Spontaneous Fibrin I or II sandwich 3-D {Chalupowicz,
1995}
Rat Fat Microvessels Fragments 4-6 Spontaneous Collagen I 3-D {Hoying, 1996}
Calf Pulmonary Aortic EC 2-7 Spontaneous-cytokines Fibrin in micro-carriers 3-D {Nehls, 1996}
Human Umbilical Vein EC, Bovine Retinal EC 1-2 Spontaneous Fibrin 2-D {Vailhe, 2001}
Embryonic Stem Cells 11 Spontaneous embryoid body formation methylcellulose 3-D {Vittet, 1996}
Human Placental Blood Vessels 7-21 Spontaneous Fibrin 3-D {Brown, 1996}
Mice Microvessel Fat Pad 14 Spontaneous-cytokines Collagen gel 3-D {Vailhe, 2001}
Bovine Aortic EC, Human HUVEC 3 Spontaneous Fibrin + Collagen I 3-D {Korff, 1999}
Human Marrow Microvascular EC 21-50 Spontaneous-cytokines Fn + Collagen I 2-D {Pelletier, 2002}
HDMEC 5-7 Spontaneous Sterilised donor dermis 3-D {Sahota PS, 2003}
Keys: EC, endothelial cells; HUVEC, human umbilical vein endothelial cells; HDMEC, human dermal microvascular endothelial cells; Fn, fibronectin.
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EC have been sourced from arteries, veins, omentum, subcutaneous fat {Tiwari, 2001} and 
skin {Sahota, 2003}. Using enzymatic degradation, EC are harvested from vein grafts by either 
the cannulation or eversion technique and cultured for 5 to 6 weeks. Grenier and co-workers 
have introduced a method o f obtaining EC, SMC and fibroblasts from the same vein biopsy 
{Grenier, 2003}. Isolation o f EC from fatty tissue requires it to be minced, enzymatically 
digested, centrifuged in a Percoll gradient before extracting EC using magnetic beads {Tiwari, 
2001}. Alternatively, ECs from the microvascular environment may be derived from skin as 
HDMECs {Sahota, 2003}.
Prior to in vivo implantation, EC or EPCs would need to be seeded onto scaffolds. The 
seeding density would depend on the scaffold material, its porosity and the method of cell 
inoculation. The standard mode for promoting cell attachment is to culture cells onto the 
polymer with or without adhesion molecules. A disadvantage is that cells tend to adhere only to 
the outer layers o f the scaffold. In order to achieve more homogenous implantation throughout a 
three-dimensional scaffold, other methods like the ‘drop on’ and low-pressure centrifugation 
techniques which systematically seed cells onto scaffolds have been introduced {Halbleib, 
2003}.
Human adipose stromal cells placed within microcarriers and co-cultured with HUVECs 
were grown in a serum-free static culture model with the addition of angiogenic factors. By day 
16, stable CLTs with patent lumens were formed by outgrowing ECs. Larger loops coalesced 
while smaller ones regressed, similar to the ‘pruning’ phenomenon that is observed during 
embryological development o f the vascular system. In vitro this is termed ‘guided migration’.
Clinically, the larger the microvessel, the greater the perfusion {Hershey, 2001}. An in vivo 
model wherein HDMEC seeded onto biodegradable polymer matrices were put into
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immunodeficient mice showed the following characteristics. On day 1 EC migrated through the 
matrix, on day 5 they formed CLTs and by one week had differentiated into functional 
microvessels. Maturation occurred by 21 days and these microvessels eventually linked up with 
the host vessels {Hudon, 2003;Black, 1998}. Immunohistochemical analysis o f a murine 
myocardial model showed that monocytes / macrophages produced holes through the 
myocardium using proteolytic enzymes, the lumens of which were eventually colonised by 
EPCs (Moldovan, 2000}.
1.3.3.2. Angioinduction
The process of inducing incoming microvessel formation depends on the growth factors 
used and the method o f delivery. Their angiogenic effects were studied using in vivo models like 
chorio-allantoic membrane (CAM) (Ribatti, 2001;Borges, 2003}. FGF and VEGF are mainly 
involved in vasculogenesis. Angiogenic sprouting is mediated by transforming growth factor- p 
(TGF-P) while maturation o f vessels is via angiopoietin-1 and -2 (Ang-tie) and platelet-derived 
growth factor (PDGF) pathways (Van Den, 2003}. Their effects are summarised in table 1.6.
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Table 1.6. Role of angiogenic growth factors during vascular development {Van Den, 2003}.
Event Factor Receptor Action
Angioblast induction FGF FGFr Angioblast formation
Conversion of angioblasts to EC VEGF VEGFR2 / Flk-1 EC formation
EC formation into tubes VEGF VEGFR2 / Flk-1 Primitive vascular plexus
Angiogenic sprouting VEGF VEGFR-2 / Flk-1, VEGFR-l/Flt-1 Angiogenesis
EC activation TGF-p, ALK-1, ALK-5 Angiogenic modulation
Vessel thickening Angiopoietin-1 Tie-1 Vessel stabilisation
Smooth muscle recruitment PDGF-p PDGFR-p Vessel stabilisation
Vessel thinning Angiopoietin-2 Tie-1 and Tie-2 Antagonistic to Angiopoietin-1
Arterio-venous differentiation Ephrin B2 Eph B4 Remodelling
Keys; FGF, fibroblast growth factor; VEGF, vascular endothelial growth factor; TGF-fh, transforming growth factor beta-1; PDGF-p, platelet-derived growth 
factor-beta.
48
The primary stimulus and factor causative for the process o f capillary sprouting is 
hypoxia. Within 30 minutes o f its onset, early growth response factors (Egr-1 and -3) 
are expressed {Lyn, 2000}. VEGF modifies the ECM to allow EC and fibroblast 
migration {Cassell, 2002; Hershey, 2001}, acting on the venules, it increases their 
permeability. Subtypes A- and B- are generally involved in EC migration and 
proliferation while C- and D- subtypes are responsible for venous and lymphatic 
proliferation {Felmeden, 2003}. FGF is another angiogenic factor used. Derived from 
SMCs and ECs, FGF is stimulated by EC regeneration, hypoxia and collateral 
formation to elicit cell induction and proliferation. In pre-fabricated flaps, Bayati and 
colleagues showed that tissue viability was enhanced by using FGF {Bayati, 1998}.
MCP-1 is released following shear stress to the vessel wall. It attracts circulating 
and in-situ MCs to home in at sites of neovascularisation {Wahlberg, 2003}. GM-CSF 
acts synergistically with MCP-1 by promoting arteriogenesis, stimulating MC/MP 
release from the bone marrow as well as prolonging their life span {Buschmann, 
2000}. TGF-p described earlier also serves as a growth factor which depending on the 
receptor, either ALK-1 or ALK-5, stimulates or inhibits angiogenesis respectively 
{Goumans, 2003}. This illustrates the overlapping functions o f these mediators. The 
slow release o f these growth factors would diminish function, while excessive 
amounts would induce fibrovascular growth.
Control over spatial and temporal patterns of the chemical’s release is necessary to 
form an organised, configured and functional microvascular network. In vitro, growth 
factors may be incorporated by co-culturing them with constructs or placing these 
factors within bioartificial organs like microcarriers which allow regulated release of
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chemicals. In vivo, these factors are introduced directly into the bloodstream, 
incorporated into cells or packed into defects as beads {Berglund, 2003} or bioactive 
scaffolds (Tabata, 2003}, preferably surface-eroding scaffolds like poly(glycerol 
sebacate) / PGS {Wang, 2003}.Other methods of delivery include viral transduction 
{Chang, 2003}, direct inoculation {Springer, 2003} or genetically-modified cells 
{Von Degenfeld, 2003}.
1.4. CONCLUSION
The biggest hurdle in the construction of tissue-engineered flaps is the inability of 
existing synthetic or tissue-engineered small-diameter vascular grafts (< 6  mm) to 
sustain flow through them and more importantly, the absence o f any source of an 
incorporatable capillary bed, natural or otherwise. Current trials on EC-seeded infra- 
popliteal vessel bypass grafts have only been proven to be as successful as vein grafts 
in the same setting {Meinhart, 2001} while the development o f an artificial capillary 
bed is limited to in vitro models {Brown, 1996;Chalupowicz, 1995;Doetschman, 
1985;Hoying, 1996;Ingber, 1989;Kubota, 1988;Montesano, 1983;Montesano, 
1986;Montesano, 1987;Montesano, 1987;Nehls, 1996;Nicosia, 1990;Olander, 
1985;Vailhe, 2001;Vemon, 1995;Vittet, 1996}. However, a better understanding of 
microcontact printing {Moldovan, 2002}, microfluidics {Kaihara, 2000}, bioreactors 
{Mironov, 2003} and further breakthroughs in tissue engineering technology {Ochoa, 
2002} may make this more likely. In this thesis, the aim is to identify and develop a 
polymer as the building block for the creation o f a microvascular network. For this 
purpose, we have chosen a novel nanocomposite which will be discussed in greater 
detail in chapter 2 .
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Chapter 2
2. Syntheses and physical characterisation of polyhedral 
oligometric silsesquioxane integrated poly (carbonate- 
urea) urethane nanocomposites with single and twin 
hydroxyl-functionalised diol groups.
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2.1. INTRODUCTION
For long now, the researchers have been working towards the development of 
more biocompatible vascular access devices using conventional silicon-containing 
poly(dimethylsiloxane) (PDMS) as a coating, a surface modifying end group {Capone, 
1992;Mathur, 1997;Ward RS, 1996} and by partial incorporation into the soft 
segment of the polymer {Chun Y, 1992;Hergenrother, 1994;Shibayama M,
1991;Ward RS, 1995}. The rationale behind this approach has been that silicon has an 
unstable surface free energy which would repel protein and platelet adhesion as well 
as increase degradative resistance to hydrolysis and oxidation. As PDMS itself is a 
rigid polymer, efforts have been made to link silicon with more compliant materials 
such as rubber so as to better mimic the elastic properties o f arteries {Salacinski, 
2 0 0 1 c}.
Rubber itself possesses high elastic extensibility. Meyer proposed that the 
molecular explanation for this property in 1932 when he recognised that the 
individual atoms of the polymer chain were capable of rotation and vibration thereby 
allowing crumpled (contact) conformations which represents the equilibrium 
flexibility. A stretching force allows considerable extension o f this chain. Crystalline 
polymers are harder than rubber but not brittle like glass. They comprise rigid 
polymer chains (crystallites) embedded in an amorphous gel. However, this latter soft 
phase is vulnerable to biodegradation in vivo and accordingly, efforts have been made 
to improve this facet o f its property. An example o f this is polyurethane.
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End-capping o f urethanes containing ether segments has resulted in, silicon- 
enriched surfaces this being due to the low surface free energy coupled with the high 
mobility of PDMS {Mathur, 1997;WardRS, 1996}. Mathur and colleagues {Mathur, 
1997} showed that PDMS-end capped poly(ether)urethane evidenced no degradation 
o f the PDMS itself, but pitting and cracking was observed when the amorphous 
polytetramethylene oxide (PTMO) segments of a polyurethane co-polymer in an in 
vivo animal model was strained to 400%. It became obvious that a more flexible, 
rubber-like composite with even greater elasticity was required.
Subsequent efforts to improve the elasticity of silicon-polyurethane elastomers 
included the incorporation of PDMS into urethanes by the addition of oligomeric 
sequences (>500Da) into the amorphous segment. However, even this approach has 
had poor results both in vivo and clinically, as the PDMS does not react with the 
amorphous segment or crystalline segments resulting in increased macrophase 
separation due to the hydrophobicity of PDMS sequences. As a consequence of this, 
current silicon-polyurethane composites have extremely poor mechanical properties, 
low bio-stability, low clarity and yellowing resulting in a non-aesthetically pleasing 
material (clinically this being of extreme importance as yellowing materials are not 
suitable as biomedical interventional devices); all results of poor chemical integration 
within the polymer composite (Kao, 1994;Shibayama M, 1991}.
Nano-engineered materials integrate with its constituents at the nanoscale level 
resulting in significantly enhanced physical properties such as increased conductivity, 
mechanical strength, optical activity and catalytic activity {Merkel, 2002}. Depending 
on the extent of interaction between its components in the formation of its
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ultrastructure, nanocomposites can exist as intercalated or exfoliated. Nanocomposites 
has been classified by Novak in 1993 {Novak B, 1993} into five groups depending on 
the presence of a matrix and covalent bonds. The first generation of nanocomposites 
were predominantly in the form of carbon nanotubes and metal oxides. Over time, it 
became recognised that silica particles could also behave as nanofillers, making more 
innovative usage o f silicon compounds possible, discoveries with immense potential 
in the world of vascular biotechnology {Mark JE, 2003} as well as medicine in 
general {Fong H, 2005}.
In complete difference to siloxane, silsesquioxanes (SQS) exists as ladder- or 
cage-type nano-structures {Lim, 1994} and have recently generated great interest 
because o f their unique structure. Polyhedral oligomeric silsesquioxane (POSS), a 
hybrid nanostructured macromer is being used increasingly to synthesise hybrid 
nanocomposites due to its chemical versatility over other nanofillers such as carbon 
nanotubes and nanoclays {Joshi M, 2004}. These oligomers are formed by Si4 C>6 
monomers with the stoichometric formula (SiOi.5)0 - These molecules have an 
inorganic silica-like core surrounded by eight organic comer groups which could be 
made to react in order to form homosilsesquioxanes {Kao, 1994;Xiang K, 1998} 
dendrimers or nano-bridges {Dijkstra, 2002;Lichtenhan JD, 1995;Suresh, 2004}. 
Importantly these nano-composite cubes can be incorporated as building blocks 
{Moreau, 2003} of controllable shapes {Suresh, 2004} into polymers to form hybrid 
materials {Wada, 2005} with improved with improved properties {Sanchez C, 2001}. 
This is achieved as monodispersions in polymers such as epoxide, acrylate, norbome, 
styrene, acetoxystyrene {Xu H, 2002} and polyurethanes.
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Herein as an alternative to siloxane, our original hypothesis was that by using 
POSS attached by direct reaction onto the urethane segment, a significant 
improvement in mechanical strength could be achieved as compared to non-POSS 
integrated poly(carbonate-urea)urethane(PCU). This would then so engender 
significantly improved bio-stability, but with the attractive anti-protein adsorption 
qualities of silicon itself previously not possible with siloxane polyurethanes. In this 
paper, we tested the hypothesis using single and double hydroxyl-functionalised diol 
side-chained POSS to find which provided the optimal molecular and steric 
interaction with the urethane grouping. The syntheses, molecular characterisation and 
mechanical assessment of a series of new nanocomposites was made with particular 
emphasis placed on the interaction between the polyurethane component and the 
inorganic POSS cube core to form hybrid POSS-PCU nanocomposites {Pyun J, 2001}. 
The effect o f POSS addition to the polyurethane on the overall bulk thermal properties 
as well as its mechanical qualities were also studied.
2.2. METHOD & MATERIALS
2.2.1. SYNTHESIS
Poly-carbonate polyol and either propanediol or cyclohexane-diol linked 
octasiloxane (figure 2.1), depending on whether single- or twin-hydroxyl 
functionalised diol substituted POSS groups was being synthesised, was mixed and 
heated to 130°C before adding methylene diisocyanate (MDI), to form a pre-polymer. 
The diluent N, N-dimethyl-dimethylacetamide (DMAC) was then added with chain
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extension at 70 to 80 °C being carried out by ethylenediamine and diethylamine. By 
simply increasing the ratio of POSS-substituted groups added to polycarbonate polyol, 
POSS concentrations within the nanocomposite could be proportionately increased.
For comparison, a pure PCU was also synthesised. All the chemicals, reagents, 
glassware and associated relevant equipment were purchased from Sigma-Aldrich Co. 
Ltd. (New Road, Gillingham, UK).
Figure 2.1. Molecular structure of twin-hydroxyl functionalised cyclohexane-diol
side-chain substituted POSS.
R
ChU
I
R = CH, CHCH3
2.2.2. POLYMER CHARACTERISATION
2.2.2.1. Nuclear Magnetic Resonance Spectroscopy (NMR)
Solution state NMR(*H-NMR) on the various types o f POSS-PCU
56
nanocomposites were performed using a solution state spectrometer (Bruker Avance 
500 spectrometer, Oxford Instrumentations Ltd, UK) at 500 MHz with 7 mm zirconia 
rotors. Casted sheets o f the various nanocomposites were first dissolved in methyl 
sulfoxide-d6 solvent. Analyses were performed using 13C ('H), ’H - 'H correlation; l3C- 
'H correlation and DEPT -  l3C (’H).
Solid state NMR experiments were carried out at room temperature using a Bruker 
MSL 300 spectrometer with 7mm zirconia rotors (Oxford Instrumentation Ltd, UK). 
The respective polymers were then pulverised into a fine powder using a 
dismembranator cup oscillated at 2000 rpm for 2 minutes after being cooled in liquid 
nitrogen. The NMR glass tubes were then filled with the polymeric powder and 
subjected to solid-state NMR. The instrument was operated at resonance frequencies 
o f 75 MHZ for l3C, 30 MHZ for l5N, and 59 MHZ for 29Si and the data was then 
analysed using Fourier-transform and the Cross-Polarisation Magic Angle Spinning 
Technique (CPMAS). The spectra being run were l3C CPMAS; ,3C MAS/Decoupling 
ride; l3C CPMAS NQS; ,3C CPMAS TOSS; 29Si CPMAS and ,5N CPMAS. These 
experiments were conducted by the Department o f Chemistry, Univesity College 
London, UK.
2.2.2.2. Fourier-Transform Infra-Red Spectrometry
Using a spectrophotometric analyser (Advance 2000, Perkins-Elmer Ltd, USA), 
the surface and bottom surfaces of cast sheets of the various polymers were exposed 
to infra-red spectra o f 4200 cm '1 to 600 cm '1 wavelengths at an incident angle of 30°, 
a total of 16 times per scan. Each scan was in turn repeated six times on both surfaces
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(n = 6) as well as cut-sections to determine the bond patterns on both surfaces, the 
intervening bulk regions as well as the effect o f incremental concentrations of POSS 
nanocages to the primary PCU component.
2.2.2.3. Differential Scanning Calorimetry (DSC)
Using a heat-flux DSC thermal analysis system (Shimadzu Ltd., Japan) the glass 
transition temperature (Tg), specific heat increment (ACP), temperature at which 
softening occurs and melting temperature (Tm) of the polymers were analysed. The 
temperature ranges measured were between -100 °C and 270 °C with a heating rate of
tH10 °C/min. Tg was taken as the 50 percentile of the specific heat increment curve. All 
samples were compared to blank controls. The crystallisation temperature as well as 
the point at which softening occurs was looked for in order to determine the 
percentage crystallinity of the nanocomposite, if  present. The samples were also 
subjected strain-induced crystallisation by first heating them to 210 °C (just prior to 
heating) and then inducing thermal shock (cooling them at that temperature in liquid 
nitrogen) before being reheated to 270 °C from -100 °C.
2.2.2.4. Mechanical Testing
Two sheets o f each polymer (PCU, 2% POSS-PCU and 6% POSS-PCU) were cast 
in a vacuum oven (150 mm x 200 mm, 50 °C, 48 h) for evaluation. The tensile 
properties were assessed according to ASTM D1708. Tests were conducted on a 
Shimadzu B444 testing machine at a displacement rate of 10 mm/min. The tensile
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stress was recorded at 100% elongation and 300% elongation. The tear strength was 
measured according to ASTN D624, using the die ‘C ’ specimen geometry. Testing 
was conducted on a Shimadzu B444 test machine at a rate o f 500 mm/min. The 
specimens for both tests were cut from the polymer sheets using a template and a 
scalpel, rather then using a cutting die. A minimum of five samples o f each polymer 
were tested by each test method. For each test, samples were taken from two different 
sheets of polymer. All tests were performed at room temperature (21 °C). These tests 
were conducted at the University of Cambridge, UK.
2.3. RESULTS
2.3.1. SOLUTION-STATE NMR
2.3.1.1. I3C('H) pure PCU/DMSO 298K (Control)
A standard carbon spectrum first group of peaks is at 155.444 -  153.454 ppm 
shows the joining o f four carbonate groups. Carbonyl groups (from urea) (6), (8) 
carbonyl from urethane where carbonate has reacted with the MDI, the carbonyl for 
the carbonate itself while the fourth would be the (12) chemically identical carbonyl 
that has either reacted with urethane again (or related small peak related with chain 
extender -  diethylamine). As shown in figure 2.2, the peaks between 1 2 8 .8 - 138.5 
ppm are the aromatic carbons. Next group o f peaks 72.407 -  60.288 ppm are the ones 
close to polar groups. There are sixteen respective peaks. There are the aliphatic 
carbons first group marked on spectrum, and corresponding to 9, 9’, 5 marked on
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chemical structure. The next group o f peaks is from 29.131 ppm to 24.833 ppm.
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Figure 2.2. ^C-C'H) NMR of control PCU.
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2.3.1.2. 'H pure PCU/DMSO 298K (Control)
The first multiple group of peaks from 7.366-7.020 ppm are the aromatic groups. 
The peaks are marked on the chemical structure on figure. 2.3. The unusual splitting 
pattern is the normal one for MDI in urethanes. The carbonate hydrogens are in the 
area 4.167 ppm which are followed by peaks for ethylene diamine and urethane. The 
aliphatic hydrogens are marked 8 and 9 on the chemical structure shown in figure 2.3
—r  
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Figure 2.3. 'H-NMR spectra of control PCU.
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2.3.1.3. I3C (!H) Single hydroxyl functionalised POSS-PCU/DMSO 298K
In figure 2.4, the spectrum corresponds to the solution state carbon. The peaks at 
155.408-153.606 ppm correspond to the carbonyl peaks 6, 8 and 12 in that respective 
order. The next set o f peaks are the aromatic carbons, which are from 138.367- 
117.884 ppm and correspond to the carbons in the MDI 1.1' (a mixture thereof) and 2, 
3 and 4 (again a mixture) at 138.367-134.060 ppm, 128.771-128.703 ppm and 
118.259-117.884 ppm. The multiple peaks at 1 and 1' are due to conjugation that is 
isomerism with the urethane group. The group of peaks at 70.078-63.907 ppm 
correspond to the aliphatic carbons. The peaks correspond to 9 and 9' from the 
polycarbonate polyol then 13, 14, the CH2 and CH groups o f the pendant arm of the 
cage. The methylene group associated with the aromatic group is at 5 and is at 63.907
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ppm. The group of peaks at 39.963-38.961 ppm correspond to 7 the CH2 o f the 
ethylene diamine the chain extender and the CH2 groups of the pendant chain 15 and 
16 and 18 and 19 of the cage respectively. The group o f peaks at 28.918-27.961 ppm 
correspond to 10 from the polycarbonate polyol, 19 from the cage and 25.402-24.765 
ppm to 11 from the polycarbonate polyol respectively. The smaller peak(s) at 18.5 
ppm corresponds to the CH3 group of the cage.
Figure 2.4. I3C-(!H) NMR spectra of single-hydroxyl functionalised POSS-PCU.
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2.3.1.4. (*H) Single hydroxyl-functionalised POSS-PCU/DMSO 298K
The first set o f peaks corresponding to the aromatic groups are from 7.368-7.024 
ppm. These correspond to 1 and 2 in figure 2.5. The next set of peaks at 4.174 - 3.924 
ppm corresponds to the aliphatic protons. The protons o f the carbonate and from the 
silsesquioxane are numbered 7 and T  and 10 and 11 respectively, as it is in the same 
environment. The peaks at 3.766-3.521 ppm correspond to 3 (methylene group) and 4 
(urethane NH). The peaks at 3.402-3.370 ppm correspond to 6  o f the ethylene diamine 
chain extender and 12 and 13 o f the cage. The peak at 3.370 ppm corresponds to 
number 5. The peaks at 1.723-1.313 ppm correspond to the numbers 8  and 9. The 
peaks at 0.515-0.481 ppm to 18 and 16 while the tiny peaks at 0.086-0.0446 ppm 
correspond to the CH3 and CH2 groups o f the cage (‘R ’ groups).
Figure 2.5. 'H-NMR spectra o f single-diol functionalised POSS-PCU.
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2.3.2. SOLID-STATE NMR
2.3.2.1. 13C CPMAS Single hydroxyl-fimctionalised POSS-PCU
As in the case of PCU, the group of peaks at 158.092-155.867 ppm are equivalent 
to the carbonyl groups, urea, urethane and carbonate all clustered at these peaks -  
order is urea, urethane and carbonate. The next group(s) of peaks is the aromatic 
carbons numbered 136.292-120.184 ppm. The order respectively is due to the shift 
being generated at the carbon 1 next to the urethane group. The 1st peak is split due to 
isomerism; a form of conjugation with the aromatic ring. The 2nd and 3rd peaks should 
theoretically be equal in intensity but they are not. The next set o f peaks are the 
aliphatic carbons the first being at 68.129 ppm. This corresponds to the carbonate 
section of the polymer. The methylene peak(s) comes up at 58-60 ppm as a shoulder 
from the MDI. The next set o f peaks is at 40.851 ppm and represents the chain 
extender, the ethylene diamine. The next group of peaks at 29.241 and 26.110 ppm 
are o f the carbonate chain. In the same environment, but hidden as they are o f smaller 
amplitude. Peaks o f the pendant chain are also seen as are the CH 3 groups of the 
POSS cage at 17 ppm.
23.2.2. I3C MAS/Decoupling Ride - Single diol 2% POSS-PCU
The group of peaks at 155.727 ppm are equivalent to the carbonyl groups, urea, 
urethane and carbonate (all clustered at this peak) in the following order; urea, 
urethane and carbonate. The next group o f peaks are the aromatic carbons numbered
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145.234-119.010 ppm. The next set o f peaks is the aliphatic carbons, the first being at 
70.999 and 68.084 ppm which corresponds to the carbonate section of the polymer. 
The next set of peaks at 40.702 ppm are from the chain extender; ethylene diamine. 
The next group of peaks at 29.250-25.984 ppm are from the carbonate chain.
The group of peaks at 158.201-155.872 ppm are equivalent to the carbonyl groups 
urea, urethane and carbonate all clustered at these peaks order is urea, urethane and 
carbonate. The next group(s) of peaks is the aromatic carbons numbered 137.680-119- 
733 ppm. The order is due to the shift being generated at the carbon 1 next to the 
urethane group. The 1st peak is split due to isomerism a form of conjugation (with the 
aromatic ring). The 2nd and 3rd peaks in theory should be o f identical intensity, but 
they are not. The next set o f peaks is the aliphatic carbon the first being at 70.972 ppm 
which represents the carbonate section of the polymer. The methylene peak(s) comes 
up at 59.286 ppm as a distinct shoulder from the MDI. The next set o f peaks at 40.867 
ppm are from the chain extender; ethylene diamine.
The next group of peaks at 29.228 and 26.010 ppm are o f the carbonate chain. In 
the same environment but hidden, are the peaks of smaller amplitude while the 
unhidden components o f the cage is at 35.241 ppm, 21.810 ppm and at ~1 ppm.
2.3.2.3. 13CPMAS NQS -  Single hydroxyl-functionalised POSS-PCU
The group of peaks at 155.806 ppm are equivalent to the carbonyl groups urea, 
urethane and carbonate (all clustered at these peaks). Their order is as urea, urethane
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and carbonate. The next group(s) o f peaks is the aromatic carbons numbered 137.518 
to 129.479 ppm. The order respectively is due to the shift being generated at the 
carbon 1, next to the urethane group. The first peak is split due to isomerism a form of 
conjugation, (with the aromatic ring). The 2nd and 3rd peaks in theory should be o f 
identical intensity but they are not.
The next set o f peaks is the aliphatic carbons, the first being at 68.144 ppm of the 
carbonate component of POSS-PCU. The next group of peaks at 29.244 and 26.134 
ppm are o f the carbonate chain. No evidence o f the silsesquioxane (POSS) is visible.
23.2.4. I3C CPMAS NQS -  Twin-diol POSS-PCU
The group of peaks at 158.155 and 155.875 ppm are equivalent to the carbonyl 
groups urea, urethane and carbonate all clustered at these peaks in the following order; 
urea, urethane and carbonate. The next group(s) of peaks is the aromatic carbons 
numbered 137.577, 129.710 and 118.966 ppm. The order respectively is due to the 
shift being generated at the carbon 1, next to the urethane group. The first peak is split 
due to isomerism a form o f conjugation (with the aromatic ring) itself and again as in 
single-diol POSS-PCU, where in theory the 2nd and 3rd peaks should be equal but 
again not so in reality.
The next set o f peaks are the aliphatic carbons the first being at 70.985 ppm the 
shoulder and at 68.122 ppm the principal peak. The next group o f peaks at 29.240 and 
26.086, 21.790 ppm are o f the carbonate chain. The fully condensed silsesquioxane
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closed cage (POSS) is evidenced by the peak 5 ppm as well as 38.048 ppm, 35.248 
ppm and 21.790 ppm.
2.3.2.5. ,3C MAS/Decoupling Ride -  Twin hydroxyl-functionalised POSS-PCU
The group o f peaks at 155.732 ppm are equivalent to the carbonyl groups, urea, 
urethane and carbonate (all clustered at this single peak) order is urea, urethane and 
carbonate. The next group o f peaks are the aromatic carbons numbered 129.671- 
118.873 ppm. The next sets o f peaks are the aliphatic carbons, the first being at 
71.044 and 68.084 ppm. The next set of peaks at 40.7 ppm which arise from the chain 
extender; ethylene diamine. The next group of peaks at 29.252 and 26.002 ppm are 
from the carbonate chain. The peak seen at 1.411 ppm is the CH3 group at the cage 
itself.
2.3.2.6. I3C CPMAS TOSS -  Single hydroxyl-functionalised POSS-PCU
The group of peaks at 155.880 are equivalent to the carbonyl groups urea, 
urethane and carbonate (all clustered at these peaks). The next groups o f peaks are the 
aromatic carbons numbered 137.695 ppm to 119.813 ppm. These are four peaks are 
137.695 ppm, 129.656 ppm, 125.398 ppm and 119.813 ppm of the aromatic group of 
peaks. The order respectively is due to the shift being generated at the carbon 1, next 
to the urethane group. The first peak is split due to isomerism a form of conjugation, 
(with the aromatic ring). The peaks 2 and 3 in theory should be of identical intensity
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but they are not.
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The next set of peaks are the aliphatic carbons the first being at 68.163 ppm. This 
corresponds to 9’ of the shoulder and 9 of the carbonate section itself of the polymer. 
The peak at 41.175 ppm corresponds to 7 on both picture and figure and are from the 
chain extender the ethylene diamine. The next group o f peaks at 29.259 ppm and 
26.190 ppm are 10 and 11 of the carbonate chain. No evidence of the silsesquioxane is 
visible.
23.2.1. 13C CPMAS TOSS -  Twin hydroxyl-functionalisedl POSS-PCU
The group of peaks at 158.244 ppm are equivalent to the carbonyl groups urea, 
urethane and carbonate all clustered at these peaks in the order of urea, urethane and 
carbonate. The next groups o f peaks are the aromatic carbons numbered 137.749 ppm 
to 119.699 ppm representing the aromatic peaks. The order respectively is due to the 
shift being generated at the carbon marked 1, next to the urethane group. As before, 
the first peak is split while the 2nd and 3rd peaks are of unequal intensity. The next set 
of peaks are the aliphatic carbons, the first being the shoulder on the principal peak at 
68.141 ppm corresponding to the carbonate section of the polymer. The peak at 
40.991 ppm is from the chain extender; ethylene diamine.
2.3.2.8. 29Si CPMAS -  Single hydroxyl-functionalised POSS-PCU
This is the silsesquioxane cage made whereby within the cage itself, there is an 
unreacted primary OH group and a secondary OH group. Post reaction, these are no
70
longer present. There is now only one peak at -67.81 ppm corresponding to the silicon 
present in the cage (949.64 Mw) as shown in figure 2.6. The peak is shifted to the right 
hand side (-ve) due to the different environment the silicon atoms are present in and 
also to the larger number o f silicons present as well. As the silicon atoms are present 
in one similar environment and as the fully condensed POSS cage is symmetrical, this 
therefore leads to only one signal being evidenced.
Figure 2 .6 .29Si-CPMAS NMR of single hydroxyl-functionalised POSS-PCU
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2.3.2.9. 29Si CPMAS -  Twin hydroxyl-functionalised POSS-PCU
This is a similar cage core to that of single hydroxyl-functionalised POSS but with 
two symmetrical secondary OH groups attached via side-chains to the unreacted 
POSS cage itself, these being no longer present in the final structure as they have been 
reacted upon. There is only one peak at -67.77 ppm again corresponding to the silicon 
present in the cage. They are all present in one similar environment and as the cage is 
symmetrical (a fully condensed POSS cage), this therefore leads to only the one signal 
being evidenced. The peak is shifted to the right hand side (-ve) due to the different 
environment the silicons are present in, and also due to the larger number o f silicons 
present as well.
2.3.2.10. 15N CPMAS -  Single hydroxyl-functionalised POSS-PCU
In figure 2.7, the first peak has a shoulder and is the nitrogen present in the 
urea group linked to the aromatic ring, while the peak itself represents the adjacent 
urea group attached to ethylene diamine. The peak at -299.85 ppm is the other 
nitrogen in the urea group attached to the ethylene diamine. The urethane group o f the 
POSS-MDI group is not distinguishable.
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Figure 2.7. 15N CPMAS NMR of single hydroxyl-functionalised POSS-PCU.
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2.3.2.11. 15N CPMAS -  Twin hydroxyl-functionalised POSS-PCU
This is the silsesquioxane POSS in which prior to reaction are present two 
equivalently placed secondary OH groups which are no longer visible in the spectra 
post reaction synthesis. The second peak at -281.778 ppm is the nitrogen in the 
urethane group attached to the polycarbonate polyol. The first peak has a shoulder 
which is the nitrogen present in the urea group adjacent to the aromatic ring with the 
peak representing urea attached to ethylene diamine. The peak at -299.605 ppm is the 
nitrogen o f the urethane group attached to the polycarbonate polyol.
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2.3.2.11. 'H -'H  correlation two-dimensional spectra
In all these correlation spectra, the methyl protons attached to the silicon in the 
silsesquioxane POSS cage(s) shows up strongly at around 0 ppm, P6 = - 0.90 to + 
0.10 ppm. This is not observed in the control sample that contains no silicon. This 
confirms that the POSS nanocage integrates into the polyurethane (PCU) backbone
2.3.3. FOURIER-TRANSFORM INFRA-RED SPECTROMETRY
Analyses of the PCU control showed a sub-surface bond structure indicative o f 
v(C=0) bonds at 1740 cm '1 with the absence of the hydrogen-bonded variation at 
1709 c m 1. Urethane carbonyl groups were present at 1637 cm '1 as were the C -0-C = 0  
groups at 1253 cm '1 wavelengths. It is this latter absorption peak whereupon that its 
maximum shifts slightly toward higher frequency when the POSS is incorporated.
This pronounced effect is due to the inert diluent effect o f the POSS moiety resulting 
in a distinct reduction o f the so termed “self-association” interaction o f the PCU 
chains. An asymmetric broadening of this particular vibration band occurs at the low 
frequency of the spectrum with an absorption resulting in a lower wave number. As 
the percentage POSS content increases from 2 to 10%, this absorption shoulder 
intensity becomes longer in amplitude.
An aromatic reference peak o f 1591 cm '1 accounted for the C=C bonds o f the 
(MDI hard crystalline) segment o f the polyurethane component. The amine groups 
were also seen consistently at over 3000 cm '1 wavelength. All these results are
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consistent with our earlier tests with PCU {Seifalian, 2003}. With the addition of 
POSS nanocages within the nanocomposite, wavelengths at 1109 cm '1 appear which 
indicate the presence o f Si-O-Si bonds based on previous studies. The concentration 
o f these molecules increases proportionately with the bandwidth o f ‘Si-O-Si’ group, 
which confirmed the hypothesis. This indicates that the N H -(C =0)-0 o f PCU reacts 
with the hydroxyl groups o f the 2,3-proponediol and 2-trans-cyclohexonediol based 
terminated cores respectively. Namely this being the “so-called” ‘R ’ side chain o f the 
POSS nanocomposites respectively as was hypothesised. Thus the POSS-nanocages 
form an internal scaffold binding together the polyurethane segments whilst 
maintaining the chemical composition and hence mechanical properties o f the 
polyurethane. The PCU moiety shows characteristic carbonate and urea vibration 
bands at 1253 and 1637 cm '1 respectively.
‘Si-O-Si’ bonds; the ‘Si’ stretching peak [vs(Si-O-Si)] appear at A1109 cm '1 in all 
o f the POSS-PCU nanocomposites which is in the form of silsesquioxane inorganic 
core cage. Interestingly, as the percentage POSS composition incorporated increases 
from 2% to 6% the amplitude o f this peak significantly increases (figure 2.8a). The 
continued presence o f this Si-O-Si stretching peak confirmed that the cube POSS 
structure was consistently incorporated into the polyurethane backbone o f all the 
polymers in place o f the ‘C -0 -C = 0 ’ groups and urethane ‘C = 0 ’ bonds at 1253 cm '1 
and 1740 cm '1 wavelengths respectively (figure 2.8b). This analysis also clearly 
shows that as POSS concentrations increase from 2 to 6 %, it begins to ‘infiltrate’ 
rather than ‘integrate’ with the soft segment o f PCU, which would result in increased 
strength but decreased elastomeric properties. As indicated previously with the 
increasing amplitude o f this peak as an absorption band, the final mole fraction of
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POSS present is directly related to the initial feed ratio.
Figure 2.8a. ATR-FTIR analyses of the effect of increasing POSS feed ratios into 
PCU.
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Figure 2.8b. FTIR analysis showing the bond patterns with incremental 
concentrations o f POSS within PCU.
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In order to confirm the bonding of POSS to the urethane group of PCU, it was 
re-dissolved in DMSO to form homogenous, transparent solutions and then added to 
cyclohexane (a non-solvent for POSS-PCU), but an excellent solvent for pure POSS. 
The product that was subsequently precipitated was collected by filtering in order to 
remove any unreacted POSS. These re-dissolution/re-precipitations were undertaken 
(n = 6) whereby the final product still exhibited the characteristic spectral absorption 
peak in the region from 1050 to 1150 cm '1 with no statistically significant change in 
amplitude before o f after purification. Identical procedures were carried out on mere 
mixtures of POSS and PCU where the final material showed no characteristic peak at 
1050-1150 cm’1. This result indicates bonding by the diol grouping to the urethane 
segment o f the polyurethane.
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2.3.4. DIFFERENTIAL SCANNING CALORIMETRY (D SC )
This experiment was performed to assess the bulk characteristics o f POSS-PCU. 
DSC of PCU, 2% POSS-PCU and 6% POSS-PCU nanocomposites revealed glass 
transition temperatures (Tg) of -35.95 °C, -35.48 °C and -35.08 °C respectively with 
similar heat capacities o f 0.36 J/gK as shown in figure 2.9. T hese results showed no 
significant difference in the glass transition temperature (Tg) as well as heat capacity 
(ACP) o f POSS-PCU nanocomposites even at POSS concentrations o f up to 6 %. On 
closer inspection however of the 6% POSS-PCU tracings, it is evident that its Tg is 
beginning to shift slightly to higher temperatures as well as broaden. There was no 
evidence o f exothermic or endothermic peaks suggestive o f crystallinity although this 
may be a limitation o f DSC when studying nanocomposites {Joshi A, 2004}.
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Figure 2.9. DSC trace comparing PCU and the incremental doses of POSS to the 
resulting nanocomposite.
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Parameter PCU 2% POSS-PCU 6% POSS-PCU
Tg -35.95 °C -35.48 °C -35.08 °C
ACp 0.36 J/gK 0.36 J/gK 0.36 J/gK
2.3.5. MECHANICAL TESTING
The tensile strength of single-diol 2 % POSS-PCU was found to be significantly 
increased compared to PCU (Mann-Whitney test, p < 0.0001) at 100 % and 300 % 
elongation (figure 2 . 1 0 a) while its cross-sectional tear strength was far more 
consistent at random points along POSS-PCU with coefficients of variation of 7.35 % 
compared to PCU (24.69 %) as shown in figure 2.10b. The greater tensile strength 
could be attributed to the efficient nanoscale transmission of force across the matrix of
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the polymer in accordance in Griffin’s criteria {Kannan RY, 2005}, a finding seen in 
other POSS hybrid nanocomposites {Li GZ, 2001}. The finer nature o f POSS 
integration and distribution within PCU translates into decreased macrophase 
separation and hence, more consistent tear strength values in contrast to PCU. A 
summary o f the test results is given in the table below. The values quoted are the 
mean o f a minimum of five results and are accompanied by the standard deviation o f 
the results. The standard deviation was within the size o f the symbol used.
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Figure 2.10a. Comparison o f tensile stress between plain PCU and POSS-PCU 
nanocomposites stretched at 100% and 300 % normal showing the 
increased elastomeric property of POSS-PCU due to POSS integration.
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Parameter PCU POSS-PCU
Tensile stress at 100% elongation 
(N/mm2)
5.8+/- 1.24 8 . 8  +/- 0.29
Tensile stress at 300% elongation 
(N/mm2)
13.1 +/-3.10 17.9 +/- 0.52
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Figure 2.10b. The variation in tear strength between PCU and POSS-PCU indicating 
the improved structural homogeneity o f POSS-PCU taken at random 
points across its cross-section; a characteristic due to the nanoscale 
integration o f POSS into the PCU matrix which decreases phase 
separation and prevents the formation o f focal stress points in PCU.
110-1
■ PCU 
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A A
100-
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70-
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Statistics Tear strength (kN/m)
PCU POSS-PCU
Mean 87.83 96.67
Standard deviation 2 1 . 6 8 7.118
Standard error 2.906 8.852
Coefficient o f variation 24.69 % 7.36 %
Number 6 6
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2.4. DISCUSSION
Nanocomposites may be synthesised by a variety o f methods {Calliot T,
2004;Raki L, 2004;Tampieri A, 2004;Meneghetti P, 2004;Benfarhi S, 2004;Pacheco F, 
2004;Naka K, 2004;Pal M, 2004;Sharma DR, 2003} depending on the type o f 
nanoparticle used, to form intercalated or exfoliated nanomaterials {Meneghetti P, 
2004}. Silica nanoparticles such as POSS are increasingly being used to synthesise 
hybrid nanocomposites with a variety o f polymers. POSS hybrid nanocomposites are 
usually synthesised by polymerisation techniques at lower concentrations {Lee YJ, 
2005} with direct nucleation working only at POSS concentrations in excess o f 10 
wt% {Joshi A, 2004}. In the polymerisation method, simply increasing the feed ratios 
would elevate POSS concentrations {Xu HY, 2004}. More recent developments in 
POSS hybrid synthesis include grafting them onto previously synthesised polymers 
{Lee A, 2005}.
Monte Carlo simulations on POSS network structures have shown that by 
increasing linker length between it and the polymer backbone, the reactiveness o f 
their tethers would decreased while increasing its inter-cubic pore sizes resulting in a 
more even distribution. This prevents large mesopore and bulk cavities but this effect 
is countered if its tethers are rigid as the level of cross-linking is reduced {Choi,
2001}. In this article, we used two different linkers; propane-diol and cyclohexane- 
diol with the latter being functionalised with single- and twin-diols. The rationale for 
this was based on Capaldi’s work on POSS-polyurethane hybrids wherein it was 
found that the orientation o f the polymer backbone is dependent upon the linker 
configuration which is parallel to its surface. From the surface kinetics perspective,
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this would mean that surface mobility perpendicular to the surface is minimal while 
circumferential mobility is enhanced {Capaldi FM, 2005}, a finding that is supported 
by angle-resolved X-ray photoelectron spectroscopy (XPS) proving that these 
nanocomposites are lamellar structures {Oaten M, 2005}.
Based on this, we placed the diol groups o f the linker cyclohexane in the ortho 
position in order to modulate the surface kinetics o f this nanocomposite such that the 
conformation o f adsorbed proteins would be contorted, thus inhibiting its actions. 
Concurrent studies on other diol-functionalised nanocomposites by Turri and co­
workers have shown a lowering o f surface free energy {Turri S, 2005}, possibly as a 
result o f the end-capping property of cyclohexane-diol compacting the POSS 
nanocage {Anderson SE, 2005}. This finding is corroborated by models based on 
POSS tethered nanostructures which have shown similarities between POSS hybrids 
and surfactants {Chan ER, 2005} as well as significant mechanical reinforcement.
The POSS nanocage end-groups are o f no significance as they do not affect the 
overall structure o f POSS hybrids {Anderson SE, 2005}. NMR analyse(s) on these 
nanocomposites have shown that increasing POSS concentrations reduce molecular 
rotation as a whole thereby permitting greater strength.
Existing data shows that POSS should increase the glass transition temperature (Tg) 
as it would reduce the distance between the inorganic cases so hindering molecular 
and segment rotation with reference to the polymer. This reduces its dipole interaction 
potential and makes the polymer stronger {Haddad TS, 1999} mechanically. The 
extent to which this occurs would however depend on (i) the nature o f the host 
polymer itself and (ii) the degree o f interaction between the POSS molecule and the
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polymer. In a parallel study, octaaminophenyl-linked POSS-polyurethane hybrids 
showed significant increase in Tg {Liu HZ, 2005} unlike the POSS-PCU 
nanocomposite.
In order to explain this, we looked at the thermal characteristics o f POSS- 
polyimide hybrid nanocomposites which have been shown to be unaffected at 
concentrations o f below 15 %, an effect seen only at higher concentrations o f POSS 
(> 20 %) {Li GZ, 2005}. This would explain why the addition o f POSS at 
concentrations o f up to 6  % did not impede overall chain motion and preserves the 
overall thermal characteristics o f PCU. We believe that another reason for this 
behaviour is that when POSS molecules exists as side-chains within the 
nanocomposite, Schatzki side-chain motion of these molecules would not alter Tg as it 
does not affect polymer chain reptation unless these POSS molecules were to infiltrate 
into the polymer matrix to a significant degree. This postulate is supported by a study 
by Leu and colleagues who found that the thermal characteristics o f POSS-polyimide 
hybrids were preserved on DSC {Leu CM, 2005}. Furthermore, they found increased 
microphase separation resulting in a more ordered polymer structure, finding which 
we have replicated during atomic force microscopy (AFM) analysis o f these POSS- 
PCU nanocomposites as well.
The elastomeric properties o f POSS-polyurethane hybrids depend on the 
miscibility o f POSS molecules within the base polymer which contributes to increased 
dispersion within its matrix {Kopesky ET, 2005}, specifically within the hard 
segment {Hsiao BS, 2000}. On linear deformation, small-angle X-ray diffraction 
studies indicate that the POSS nanocrystals within the hard segments decreased whilst
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elongation-induced crystallisation occurred in the soft segments, TEM analyse(s) 
showing strain-induced hard segment destruction {Fu BX, 2001}.
In summary, the use o f POSS molecules to form hybrid nanocomposites is 
enhancing the advances in materials sciences with the key issue being the selection of 
the optimal linker molecule in order to suit its application. In the case of vascular 
devices, the substitution o f one comer group of the POSS nanocage with diol- 
functionalised cyclohexyl groups linked to carbonate-based polyurethanes has 
numerous advantages; (i) improved mechanical strength as well as flexibility, (ii) 
greater resistance to biodegradation, particularly oxidative and (iii) modulation of 
adsorbed surface proteins. We believe that these basic characteristics o f POSS- 
polyurethane nanocomposites make it the ideal vascular interface in vivo. In the 
following chapter, the resistance o f POSS-PCU nanocomposites to in vitro 
degradation was studied.
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Chapter 3
3. The degradative resistance of polyhedral 
oligomeric silsesquioxane (POSS) nanocore­
integrated polyurethanes.
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3.1. IN TRO D U CTIO N
Polyurethanes are amorphous co-polymers which consist o f a soft phase and a 
hard phase. The hard segment is formed as a result o f the interaction o f the 
isocyanates {Tang, 2002} with either diol or diamine molecules while the soft 
segment may consist o f ether, ester or carbonate groups with the latter being the most 
resistant to degradation {Salacinski, 2002b}. This dimorphic characteristic of 
polyurethanes (PU) gives it greater elasticity courtesy o f the flexible soft segment 
while the hard segment contributes strength to the co-polymer. Although PU is being 
increasingly used in biomedical devices, there have been concerns regarding its 
resistance to degradation in vivo. Recent studies on pacemaker leads explanted after 
10 years have shown ultrastructural evidence of degradation {Schubert, 1997;Wu, 
1994} indicating a need to improve the stability of existing PU.
As the soft segment is the most vulnerable {Coury, 1988;Kao, 1999;Labow, 
1999;Wu, 1994} component o f PU, efforts have been made to improve resistance by 
varying the soft segment groups. Ester groups impart greater resistance to oxidation 
but are susceptible to hydrolysis {Coury AJ, 1996} while ether groups have weak 
oxidative resistance to enzymes such as myeloperoxidase {Stokes K, 1998}. Using 
carbonate groups instead have been shown to improve the degradative resistance of 
PU {Edwards, 1998}, an effect due to the increased hydrogen bonding between all of 
the segments {Tang, 2001;Woo, 2000}, information which we capitalised on when 
synthesising poly(carbonate-urea)urethane (PCU) {Salacinski, 2002b;Salacinski, 
2002c;Seifalian, 2003}. However, both in vitro and in vivo studies by our group on 
PCU have shown that hydrolysis o f the carbonate group is still possible {Salacinski,
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2 0 0 2 b;Salacinski, 2 0 0 2 c} under certain circumstances such as peroxidation.
The principal function o f the hard segment o f a PU is to give mechanical strength 
by acting as the structural framework o f the polymer as well as having a ‘shielding’ 
effect on the soft segment {Stokes, 1995} o f the PU {Salacinski, 2002b}. According 
to Stokes, this ‘shielding effect’ depends on the distribution o f the isocyanate 
molecules within the polymer and the then resulting microstructure. Traditional PU 
have hard segments composed o f urethanes or urea but more recently, there have been 
alternatives to improve both hydrolytic and oxidative stability with the use of silicon- 
containing poly(dimethylsiloxane) (PDMS) either as a coating, a surface-modifying 
end group {Hu, 2002;Wemer, 1999} or by its interaction with the soft segment o f the 
polymer {Barbucci, 2003;Mirzadeh, 1995}. The reason for this approach is that 
PDMS has extreme resistance to hydrolysis and oxidation. However, the 
incompatibility o f PDMS integration into PU has led to poor materials which display 
low biostability {Salacinski, 2002b;Salacinski, 2002c}.
Recently, a newer generation of polymers have been developed which interact at 
the nanoscale and hence possess completely different qualities. Nanocomposites are 
materials whose components interact at a nanoscale level, a characteristic which 
confers great mechanical strength to these polymers {Zhang, 2004} due to the 
quantum-scale interaction between these molecules which also gives it an anti­
fracture properties. The reason for this according to Griffin is that when a composite 
has fillers below a critical length, their strength even if cracked, is virtually equivalent 
to that of a solid crystal. This holds true for nanocomposites and explains the relative 
immunity o f nanocomposites to fracture {Gao H, 2003}.
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As illustrated in chapter 2, we have developed a Novak type II nanocomposite 
{Novak B, 1993} using nano-sized silsesquioxane molecules namely that of 
polyhedral oligomeric silsesquioxanes (POSS) linked to a previously synthesised 
polyurethane; poly(carbonate-urea)urethane (PCU). It is our original hypotheses that 
using these nanocores would hold together all the components o f the polyurethane and 
thus repel degradation.
3.2. METHODS AND MATERIALS
3.2.1. POLYMER SYNTHESIS 
Please refer to chapter 2.
3.2.2. GRAFT FABRICATION
Using a novel polymer as synthesised above using a combination o f PCU with 
POSS nanofillers, we have fabricated 5 mm diameter POSS-PCU grafts by the cast- 
coagulation technique. 5 mm diameter stainless steel mandrels were dip-coated in 14 
% (w/v) o f the polymer solution using a mechanised dipping device at a rate o f 1 cm/s 
before being coagulated in distilled water (DW) for 24 hours. The grafts were then 
air-dried for 48 hours at room temperature before being pulled off the mandrels as 
single-lumen vascular prostheses with a closed-pore microporous vessel wall and
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lumen. The degradative resistance o f these grafts was determined by keeping them in 
oxidative, hydrolytic and physiological solutions which replicate all forms o f 
degradation in vitro.
3.2.3. DEGRADATION PROTOCOL
3.2.3.1. Hydrolysis
The degradative mechanisms in vivo were simulated using a set o f well-described 
hydrolytic and oxidative degradative tests {Zhang, 2004}. Polymeric susceptibility to 
hydrolytic lysosomal action was studied using cholesterol esterase (CE) which was 
prepared by dissolving CE powder (Sigma Chemical Co., Ltd., Poole, Dorset, UK) in 
sterile, neutral pH, 0.05 M phosphate-buffered saline (PBS). The other hydrolytic 
mechanism elicited was using phospholipase A2 solutions / PLA; (Porcine pancreatic 
phospholipase, Sigma Chemicals) dissolved in 50 mM Tris with 6 . 8  mM CaCb at pH 
8.0 at 0.18 IU/mL concentration where 1 U is its ability to hydrolyse 1 mM/min of 
phosphatidylcholine at 37 °C and pH 8.0. The sheets and grafts o f POSS-PCU 
nanocomposites exposed to these hydrolytic solutions were incubated for 70 days at 
37 °C prior to being rinsed in distilled water, dried and stored before testing.
3.2.3.2. Oxidation and peroxidation
Oxidative and peroxidative degradative solutions involved an oxygen donating
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system which was prepared by mixing 1.63 M hydrogen peroxide; H2 O2 (Stabiliser- 
free; Fluka Chemicals Ltd., Poole, UK) and 0.1 M C0 CI2 . 6 H2 O (Sigma-Aldrich Ltd., 
UK). A previously described peroxidation system using 1.63 M t-butyl hydroperoxide 
and 0.10 M C0 CI2 .6 H2O (t-but/CoCb) was prepared as was a thiyl radical 
peroxidative system with the addition of 0.10 M glutathione solution (Glut/t- 
but/CoCb). As with the hydrolytic degradation systems, the grafts and sheets of 
POSS-PCU were incubated for 70 days before being rinsed and dried, ready for 
testing.
3.2.3.3. Plasma protein fractions
In this study, we utilised Zhang’s technique which used polyethylene glycol (PEG) 
to extract the different plasma protein fractions. Into a beaker, we placed 200 mL of 
citrated human plasma (fresh frozen plasma) at 4 °C from the Blood Transfusion 
Department o f the Royal Free Hospital, London, UK to which 20g of PEG at a Mw of 
3350 (Sigma-Ultra grade; Sigma Chemical) was added. The 10% mixture (fraction I) 
was stirred every 15 minutes for an hour, 100 mL of it was removed as fraction I and 
the remaining 100 mL was centrifuged at 2000 rpm for 30 minutes. The supernatant 
was then extracted and PEG was added to it to reconstitute a 10% mixture. The 
process o f mixing and centrifugation was then repeated to form four plasma protein 
fractions (Plasma Fractions I to IV labelled herein as PF I to PF IV). Fraction I (PF I) 
is rich in fibrinogen, plasminogen, the C-3 component o f the complement and IgG, 
and b-lipoproteins. Fraction II (PF II) is rich in a2-macroglobulin, IgA, prothrombin, 
and other coagulation factors (prothrombin complex). Fraction III (PF III) contains
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mainly acid glycoprotein, transferrin, and 20% PEG. Fraction IV (PF IV) contains 
principally albumin and transferrin.
3.2.3.4. Control
As the positive control, cumene chloride was used as it is has very strong 
degradative effect on plastics in general. All degradative solutions contained 10 mg of 
streptomycin, 1 0 , 0 0 0  U o f penicillin, and 1 0  mg o f neomycin per millilitre to prevent 
bacterial and fungal infections which could affect the outcome o f the results. As 
above, 6  samples o f POSS-PCU nanocomposite sheets were placed in these solutions 
for 70 days before being washed and dried for testing.
3.2.4. FOURIER TRANSFORM INFRA-RED SPECTROSCOPY
The casted sheets o f POSS-PCU (n = 6 ) were now subjected to infra-red 
spectrophotometric analysis to assess for evidence o f sub-surface bond degradation 
following simulated in vivo degradation using the technique mentioned in chapter 2 . 
The analysis was repeated six times on both surfaces o f the sheets to determine 
whether there was a significant change in sub-surface bond patterns which indicated 
the presence and extent of bond scission, if  any.
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3.2.5. SCANNING ELECTRON MICROSCOPY
The degraded control and polymer sheets were dehydrated with ethanol/distilled 
water in increments o f 10% ethanol at 41 °C and then freeze-dried for 2 days. 
Following this, pieces o f the nanocomposite was cut out and attached to aluminium 
stubs before being coated with gold using an SC500 (EM Scope) sputter coater. Next, 
a scanning electron microscope system (Philips SEM Model 501, Netherlands) was 
used to analyse 1 0  areas on the surface o f the polymer sheets which were chosen at 
random for any evidence o f surface degradation namely pitting, Assuring, cracking 
{Wiggins, 2001} and crystalline segment shearing (‘balding’). More sensitive 
methods o f surface analyses such as AFM and XPS analyses were not used due to the 
higher probability o f artefacts developing on their surfaces following the handling 
process. All the SEM analyses in this thesis was done at the Electron Microscopy Unit, 
Royal Free UCL Medical School, London, UK.
3.2.6. RADIAL STRESS-STRAIN ANALYSES
The 5 mm diameter POSS-PCU nanocomposite grafts which were first exposed to 
degradative solution were placed in series within a flow circuit containing native 
citrated blood o f 0.40 haematocrit which was pumped at 1 Hz and at mean pressures 
o f 70 and 100 mmHg through using a variable speed pump (BioMedicus, Minnetonka, 
MN, USA) in order to simulate arterial pulsation. The entire system was placed in a 
water bath at 37 °C to reduce damping. The intraluminal pressures within these grafts 
were recorded at the mid-section o f each graft using a Millar Mikro-tip catheter tip 
transducer (Millar Instruments, Houston, Texas, USA). The mean pressure was
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regulated by varying the height o f the blood reservoir while pulse pressure was 
controlled by regulating the pulsatile pump. In this series o f experiments, no pre­
clotting was performed as no transmural leakage was observed in spite o f high 
intramural pressures o f up to 300 mmHg. In addition, all grafts were stretched to 110 
% o f their original lengths to simulate biology. The output data was then recorded 
using an analogue-to-digital data acquisition recording systems ( ADC/MacLab; AD 
instruments, Hastings, U K ) via 7.5 MHz linear array probes o f a Duplex scanner (Pie 
350; Pie Medical Systems, Maastrict, The Netherlands) which kept track o f graft wall 
distension (WallTrack, PieMedical Systems, UK).
From the mechanical perspective, the radial distension experienced by these grafts 
is directly reflective o f the strain under which it has been put while the stress within a 
cylindrical system is given by Laplace’s Law shown here below,
o = (pR)/t
where, a  refers to the circumferential stress within the graft, p refers to the maximal 
pressure within the system, ‘t ’ is the thickness of the graft wall and R is the radius of 
the graft. For the purposes o f these experiments, ‘t ’ and ‘R ’ are constants as all these 
grafts were fabricated in exactly the same way. In this system, stress (a) is therefore 
directly proportional to the maximal/systolic pressure. Based on these assumptions, a 
stress-strain curve was plotted with strain/vessel wall distension on the x-axis and 
systolic pressure representing circumferential stress on the y-axis in order to 
understand the biomechanical behaviour o f these degraded polymers and to correlate 
with classical Hookean laws.
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3.2.7. DIFFERENTIAL SCANNING CALORIMETRY
Nanocomposite samples which were found to have suffered the greatest amount of 
degradation was then studied using differential scanning calorimetry to determine 
whether the respective samples had undergone a significant change in glass transition 
temperature (Tg), melting temperature (Tm) and heat capacity at Tg (ACP). 3 by 3 mm 
sheets o f the nanocomposite taken from different parts o f the polymeric sheet were 
then subjected to heat-flux DSC (Shimadzu DSC Ltd., Japan) as described in chapter 
3. All samples were weighed pre- (W) and post-test (W ’) to confirm that there was no 
change in mass after melting. In order to achieve consistency, all specimens were run 
thrice (n = 3).
3.3. RESULT
3.3.1. SURFACE DEGRADATION
The control POSS-PCU nanocomposite showed all the characteristic bond patterns 
o f PCU with the typical wavelengths at 1740 cm ' 1 (carbonyl segments o f carbonate), 
the 1640 cm''wavelengths o f urethane carbonyl groups and bonds in the 1240 to 1250 
cm ' 1 range indicative o f the C -O -C  bonds o f the C O -O -C  segments. In addition, the 
POSS nanocages resulted in wavelengths at 1100 cm '1, the presence of which did not 
alter the existing polyurethane bonds.
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Polymer degradation o f these nanocomposites was classified into three categories 
namely hydrolytic, oxidative and plasma fractions with each of these samples being 
analysed by infra-red spectroscopy. FT1R analyses o f the nanocomposite exposed to 
differing plasma fractions I to IV showed no difference in intensity for each bond 
wavelength as compared to the control (p = ns) (figure 3.1). These results indicate that 
biological proteins have a negligible degradative effect on these POSS-PCU 
nanocomposites.
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Figure 3.1. Sub-surface bond patterns in POSS-PCU nanocomposites following
exposure to plasma protein fractions (PF I to IV) showing no difference in 
the intensities o f ‘Si-O’, ‘C-O-C’, ‘NH-CO’(urea) and 
‘(NHCO)O’(urethane) bonds although on closer inspection of PF Ill- 
degraded samples (marked in red), there is a slight left-shift in the C-0=C 
bond indicating a reduction in hydrogen bonding.
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Hydrolytic enzyme degradation and in particular, phospholipase (PLA) had a 
significant effect on silicon-associated bonds (One way ANOVA, p < 0.01) compared 
to the control. Interestingly, these had no significant effect on the remaining hard
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segment as well as the soft segment of the polymer. This suggests that the POSS 
nanocores integrated into the polyurethane via zones of intercalation which had an 
overall ‘shielding’ effect on the structure of PCU (figures 3.2 a&b). The remaining 
degradative solutions including cumene chloride, a potent degrador of plastics in 
general were no different from the undegraded polymer. In all of these samples and in 
particular PLA, we found no evidence of colour change or macroscopic signs of 
degradation indicating that although ‘Si-O’ bond were less prominent in this system, 
for some reason there was no significant degradation.
Figure 3.2a. FTIR analyses showing the sub-surface bond patterns in POSS-PCU 
nanocomposites after being degraded by hydrolytic solutions with 
significant decreases in the ‘Si-O’ bonds of the POSS nanocores in the 
PLA-degraded samples (marked in red).
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Figure 3.2b. One-way ANOVA analyses (n = 12) showed a significant decrease in
the ‘Si-O’ bonds of the PLA- degraded samples compared to the control, 
CE-degraded and cumene-degraded samples (p < 0.0001). The 
remaining bonds did not show any significant difference post­
degradation.
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Oxidative degradation on these nanocomposites showed a statistically significant 
difference between the silicon bonds o f the t-butyl H2O2/C 0 CI2 and glutathione/t-butyl 
H2 O2 /C 0 CI2 degraded-polymers as compared to the control, undegraded polymer 
(figures 3.3 a&b). Detailed analysis o f the samples showed a small left-ward shift in 
the peak o f the C-O-C bonds indicating a reduction in overall hydrogen bonding
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(figure 3.4) especially with the glut/t-butyl system. The biologically abundant H2O2 
system did not show any effect on any o f the bond structures o f the polymer. Based on 
this, we can see that t-butyl peroxide degrade the ‘Si-O’ bonds and cause macrophase 
separation within the nanocomposite as suggested by the yellowing o f the t-butyl 
peroxide degraded solutions (Shibayama M, 1991}.
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Figure 3.3a. The effect of oxidative and peroxidative degradative solutions on the 
POSS-PCU nanocomposite showing a reduction in the intensity o f ‘Si-O’ bonds of t- 
butyl/CoCl2 degraded samples (marked in red) compared to the control (marked in 
blue). Please note that there is a leftward shift of the ‘C-O-C’ bonds indicating a 
decrease in hydrogen bonding.
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Figure 3.3b. One-way ANOVA analyses o f the main bonds within the POSS-PCU
nanocomposite showing a significant decrease in ‘Si-O’ bonds following 
t-butyl/CoCb and Glut/ t-butyl/CoCh degradation with an effect on the’ 
C -0= C ’ bonds as well in the latter.
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Figure 3.4. Comparisons of PLA-, Glut/t-butyl-peroxide, t-butyl-peroxide degraded 
and control polymers.
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3.3.2. SURFACE TOPOGRAPHY
The surface ultrastructure of the polymer was assessed at ten random sites using 
SEM (640x magnification). The undegraded polymer characteristically showed a 
rough surface with numerous crystalline peaks and intervening flat areas, a consistent 
feature in all the analysed samples (figure 3 .5a). Overall as shown in table 3.1, the 
plasma fractions especially I and II resulted in the formation of minimal pit formation 
and ‘balding’ (shearing of the crystalline peaks). These effects were even more 
pronounced in the hydrolysed samples particularly with PLA (figure 3.5b).
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Correlating this observation with FTIR analyses indicate that the weakening o f the 
amide cross-linkages with the POSS segments results in the increased surface 
degradation (pit formation) with loss o f the POSS crystalline peaks (balding). This 
shearing effect was more pronounced with the t-butyl peroxidation systems (figure 
3.5c). The polymer on the whole was found to be resistant to cumene chloride; a 
potent degrador of plastics in general.
Table 3.1. SEM analyses o f the degraded samples.
Polymer Pits Fissures Cracks Balding
Control - - - -
Fraction I + - - -
Fraction II + - - +
Fraction III - - - -
Fraction IV - - - +
Cholesterol esterase + - - +
Phospholipase +++ - - +
H20 2/CoC12 - - - -
t-butyl/CoCb + - - ++
Glutathione/t-butyl/CoC^ + - - ++
Cumene chloride - - - +
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Figure 3.5a. Surface topography of undegraded POSS-PCU (control)
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Figure 3.5b. Surface topography of PLA degraded POSS-PCU nanocomposite
showing increased pitting and Assuring.
25 mM
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Figure 3.5c. Surface topography of t-butyl peroxide degraded POSS-PCU
nanocomposite revealing an increasingly glabrous surface.
25 uM
3.3.3. RADIAL STRESS-STRAIN CURVES
Stress-strain curves performed on the polymers which were most affected 
physically as well as chemically, showed that no significant difference in stress-strain 
behaviour existed between the control, PLA, CE, t-butyl-peroxide and F2-degraded 
nanocomposites. This data shows that the soft segment of the polyurethane 
nanocomposite remains intact in spite of accelerated degradation as illustrated by the 
preservation of its elasticity in the figure 3.6 below. It is important to note however 
that in the case of t-butyl-peroxide degraded nanocomposites (marked blue), the
108
vessels burst at pressures beyond 220 mmHg indicating a decrease in mechanical 
strength compared to all the other grafts. As FTIR studies have previously shown, t- 
butyl peroxide and its counterparts affected the ‘Si-O’ bonds within the graft which 
are responsible for holding together the nanocomposite by means o f intercalating 
zones between the soft, amorphous and the hard, crystalline segments o f the 
polyurethane which explains its lower burst strength. Thus, t-butyl peroxide seems to 
affect the functional side-chain o f the POSS nanocage which links it to the backbone 
of the polymer. As there was no difference in the FTIR studies between the t-butyl 
peroxide/CoCb and glut/t-butyl peroxide/CoCb solutions, the former was used as the 
reference degradative solution representing the peroxidation group in all subsequent 
studies.
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Figure 3.6. Radial stress-strain curves of the representative degradation groups 
showing their similarity in elasticity.
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3.3.4. THERMAL CHARACTERISTICS
Glass transition temperature (Tg) gives information on the amorphous segment of 
the nanocomposite while the heat capacity changes (ACP) at the Tg is a measure of the 
inter-molecular interaction between these molecules during this transition. In the 
undegraded samples, we found a mean Tg o f -37.34 °C and a mean ACP value o f 0.40 
J/gK while the t-butyl peroxide degraded samples showed a mean Tg o f -37.01 °C and 
a mean ACP value o f 0.42 J/gK, values which are almost similar to the control group. 
On closer examination o f the t-butyl peroxide-degraded samples, we found a double­
phase melting range starting at 165.5 °C followed by a second melt phase with 
softening beginning at 195.42 °C, gradually reaching a final melting point at 255.04 
°C. Comparing this to the softening in the undegraded sample starting at 226.12 °C 
and ending at 265.06 °C, this indicates that t-butyl peroxide causes greater phase 
separation between the hard and soft segments within the nanocomposite.
Based on this data, we deduced that the POSS nanocore/fillers resulted in closer 
packaging o f the polymer with greater interaction between both phases o f the 
polyurethane particularly at the aforementioned zones o f intercalation. From the 
degradation perspective, although there have been surface degradative changes 
observed in the peroxidated nanocomposites, the chemicals as such have failed to 
affect the soft segment o f the nanocomposite and dismantle the bulk superstructure of 
the nanocomposite as a whole since these DSC results showed no macroscopic 
thermal changes in the degraded nanocomposite versus the control sample. There was 
however a change in the melting temperature (Tm) between the t-butyl-peroxide 
containing samples and the control group. As Tm is more reflective o f the hard
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segment o f the polyurethane which constitutes its structural framework, we found that 
this data correlated with our FTIR studies on these degraded nanocomposites as well 
as the lower burst strength of the t-butyl peroxide-degraded grafts. This further lends 
credence to our hypothesis that these POSS nanocores/fillers ‘shield’ and so 
essentially protect the soft segments o f the polymer via the interlinkages at the zone of 
intercalation.
In the case o f the hydrolytic enzymes, although PLA seemed to show a marked 
effect on the Si-O bonds o f the POSS nanocage on FTIR, this did not translate on 
DSC into a significant change in Tg or Tm as well as change in elasticity on stress- 
strain curves. The mean Tg o f the nanocomposites was -37.35 °C with a mean ACp of 
0.40 J/gK, not dissimilar from the control while the mean Tm of these samples was 
268.7 °C. These results suggest that the ‘Si-O’ bonds which were degraded by PLA 
may not have been functionally involved in cross-linking within the polymer. This 
may be explained by the fact that the nanocore used in this polymer has seven non­
functional side-groups (2,3-propanediol) and one main functional linkage group 
(dihydroxyl-cyclohexyl pendant chain) connecting it to the main polyurethane 
backbone. All these results are graphically illustrated in figure 3.7.
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Figure 3.7. Comparison of DSC thermal analyses of t-butyl-degraded, PLA-degraded 
and undegraded polymers showing the stabilising effect o f POSS 
nanocores to PCU degradation.
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In the CE group, there were physical signs of degradation on these samples 
(‘blistering’ effect) but with no colour change indicating no phase separation.
Analysis of the Tg showed no significant decrease but the heat capacity at this 
temperature was decreased (0.28 J/gK) compared to the other samples. This shows 
that although there was a decrease in the intermolecular bonding strength within the 
soft phase at this temperature, it remained relatively stable while the Tm did not 
change on treatment with a single-phase melt process beginning at 193.83 °C, 
possibly an effect of the reduced intermolecular forces within the soft phase. We
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found that the physiological solutions did not cause any significant degradation to the 
POSS nanocomposite.
As polyurethane degradation begins as a surface phenomenon and gradually 
creeps into the substance o f the polymer {Schubert, 1997}, both FTIR as well as DSC 
analyses were performed on samples. A summary of the DSC analyses is depicted in 
table 3.2. We postulate that while t-butyl peroxide affected the linker molecule 
between the silsesquioxane nanocore and the hard segment polyurethane backbone 
thus weakening the structural network and causing an alteration o f Tm, the lipase 
action o f PLA did not affect this particular linkage. In any case, it is important to keep 
in mind that the chemicals used represent accelerated degradative solutions 
encompassing a comprehensive range o f degradative mechanisms some of which are 
not present in vivo. We hope that in this way, this study would become a reference for 
degradation in all possible situations.
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Table 3.2. Summary o f DSC results on undegraded, t-butyl-peroxide degraded and 
PLA-degraded POSS-PCU nanocomposites.
Degradative solution Colour
change
Tg ACp Softening Tm
None (control) None -37.34
°C
0.40
J/gK
226.12 °C 265.06
°C
H20 2 / CoCl2 None -36.4 °C 0.28
J/gK
245.7 °C 266.15
°C
t-butyl H20 2 / CoCl2 Yellowing -37.01
°C
0.42
J/gK
195.42 °C 255.04
°C
Glut / t-butyl H20 2 / 
CoCl2
Yellowing -37.55
°C
0.34
J/gK
235.13 °C 261.3 °C
Phospholipase (PLA) None -37.35
°C
0.42
J/gK
225.2 °C 268.7 °C
Cholesterol Esterase (CE) None -36.49
°C
0.28
J/gK
193.83 °C 269.33
°C
Cumene chloride (Cum) None -42.26
°C
0.34
J/gK
231.32 °C 257.66
°C
Plasma fraction I (PF 1) None -36.34
°C
0.32
J/gK
237.3 °C 267.8 °C
Plasma fraction 11 (PF II) None -37.29
°C
0.38
J/gK
236.1 °C 268.39
°C
Plasma fraction III (PF III) None -38.09
°C
0.26
J/gK
238.92 °C 268.9 °C
Plasma fraction IV (PF 
IV)
None -39.4 °C 0.42
J/gK
231.83 °C 262.93
°C
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3.4. DISCUSSION
PU are currently being used in a variety o f medical devices and in the field of 
cardiovascular medicine, variations of polyurethanes containing ester-, ether- and 
carbonate-based soft segments have been used as vascular grafts {Eberhart, 1999;Hsu, 
2000}. Previous studies have shown that PU has ideal elastic and compliance 
properties, characteristics which minimise intimal hyperplasia (IH) (Salacinski, 
2001c}. As alluded to earlier, there have been some concerns regarding the 
susceptibility o f PU to degradation in vivo. Our previous study on poly(carbonate- 
urea)urethane (PCU), a new generation PU, showed that these grafts were more 
biostable in the in vivo environment than its predecessors (Seifalian, 2003}. 
Nevertheless our experiments on PCU degradation reveal room for improvement in 
the stability of these polyurethanes. As existing data suggests that nanofillers 
substantially increase the mechanical strength of the composite, a new variety of 
nanocore-integrated PU were designed and synthesised by our group (Kannan, 
2004;Kannan, 2004}. The stability o f these materials as vascular grafts in vivo was 
therefore o f prime importance to prevent aneurysmal formation.
PU degradation begins as a surface phenomenon and in this study, FTIR analysis 
performed on these samples reveals that in spite of prolonged periods on incubating 
the nanocomposite, minimal surface changes were elicited. In the t-butyl peroxide 
degradation systems of t-butyl/CoC^ and glut/t-butyl/CoCh, which had shown a 
significant degradative effect on MyoLink® {Salacinski, 2002b}, apart from a small 
drop in the intensity o f the ‘Si-O’ bonds in the nanocomposite which correlated 
visually with a loss o f silicon-rich POSS segments on SEM studies, the bonds
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particularly within the soft segment were virtually unharmed. These changes included 
the development of ‘pits’ as well as a ‘balding’ effect on the nanocomposite. Based on 
this, we deduced that POSS-PCU nanocomposites extended from the hard domain of 
the polymer into the soft domains at transitory zones of intercalation akin to a ‘wire 
m esh’ which holds together the various components o f the nanocomposite and causes 
a reduction in phase separation within the polymer.
Strength and toughness/elasticity analysis of these nanocomposite vascular grafts 
revealed that in spite o f accelerated degradation, all samples had shown no significant 
difference in their elastic properties. This is an indicator o f the stability of the soft 
phase of the nanocore-integrated PU to all forms of in vitro degradation. When 
compared to the similar experiments on MyoLink®, these nanocomposite grafts 
showed greater stability in a degradative environment. These results were further 
explained on performing DSC to assess both the soft and hard phases o f the 
nanocomposite.
Thermal analysis o f even the most severely degraded POSS-PCU nanocomposites 
showed that the glass transition temperature; an indicator o f the soft phase o f a 
polymer, did not vary significantly between the non-degraded and degraded samples, 
thus seconding the data on stress-strain analysis o f the nanocomposite grafts. We 
found that the addition o f POSS nanocore/fillers to PCU increased the final melting 
temperature of the nanocomposite by approximately 30 °C while the Tg remains the 
same, for reasons which are explained in chapter 2. This is in line with the published 
literature of fillers in microcomposites, which show the negligible action o f fillers on 
Tg {Turi EA, 1981}. The similarity o f these values to MyoLink® following POSS
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degradation by t-butyl systems reveal that in the absence of these nanofillers, the 
thermal properties o f the nanocomposite are not dissimilar from PCU.
The increase in Tm and the lesser phase separation on the other hand are 
attributable to the increased nanoscale interactions between its constituents binding 
together the polymer. Furthermore, these nano-core integrated PU unlike MyoLink® 
which show three-phase melting, exhibited a single phase melting process with higher 
temperatures at which softening occurs. In the t-butyl degraded samples, the melt 
process was two-phased with lower softening temperatures. These results again signal 
that both hard and soft phases o f the polymer integrate to a far greater extent than in 
PCU due to the nanoscale interaction of the POSS-nanocages with the soft phase.
In summary, the addition o f POSS nanocore/fillers to the PU imparts a type of 
‘shielding’ effect on the soft phase of the nanocomposite thereby preserving its 
elasticity and compliant properties via zones o f intercalation. In addition, the 
extensions of these nanofillers from the hard phase into the soft phase help cross-link 
and bind together the entire composite as a single elastic unit, not unlike vulcanised 
rubber. This is exemplified by the increase in Tm compared to PCU or MyoLink®. 
These results herein indicate the immense potential o f POSS nanoparticles in 
improving the degradative resistance o f polymers.
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Chapter 4
4. The in vivo biocompatibility and biostability of 
silsesquioxane nanocomposites
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4.1. INTRODUCTION
Having now confirmed the increased degradative resistance o f this nanocomposite 
in vitro, two additional objectives were identified (a) Is it safe in a biological host ? 
and (b) Would its degradative pattern be altered in an in vivo environment ? This is a 
pertinent issue as parallel experience with silicon-based breast implants has shown us. 
The most important property o f any o f these tissue implants is interfacial 
biocompatibility; the inter-relationship between the implant and its biological host 
{Eberhart, 1987}. A biomaterial conventionally elicits a foreign-body reaction once 
implanted in vivo. However, when there is minimal interaction and bioadhesion 
{Weiwei Du, 2000} at its interface (figure 4.1) once in vivo, it is said to have 
improved biocompatiblity. Hence, understanding the behaviour of this nanocomposite 
at the biological interface is essential prior to developing it as a microvascular 
prostheses.
Figure 4.1. Schematic representation of the interplay between the biological host and 
the implant.
HOST
Biodegradation
Bioadhesion
Inflammation
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Silicone is a favoured material particularly as breast implants and finger joint 
replacements. First introduced in breast surgery during the 1960s, it is an inert 
biomaterial thought to cause minimal inflammation. However, long-term studies are 
now revealing that silicone delays wound healing {Shanklin, 1999}, causes capsular 
contracture {Wagner, 1977;Ersek, 1997;Batra, 1995;Kasper, 1994;Siggelkow, 2003}, 
is immunogenic {Bar-Meir, 1995} and in joint prostheses {McCarthy, 1988}, causes 
severe inflammation {Peters W, 1996}. Alternatively, porous polyurethane breast 
implants allow better tissue fixation {Cohney, 1997}. There have been reports that 
these implants reduce the incidence o f capsular contracture {Sinclair, 1993}. A 
possible explanation is that fibroblasts proliferate into numerous pores and when they 
contract, they counterbalance one another to minimise the occurrence of painful 
contractures {Pennisi, 1990}. This prompted the creation of silicone breast implants 
coated with porous polyurethane but its use was limited due to poor biocompatibility 
{Brohim, 1992}. Nevertheless, polyurethane implants have not gained much 
popularity because o f carcinogenic risks {Brinton, 1995}, difficulty in removing 
infected prostheses {Berrino, 1986} and significant foreign body reaction {Wagner, 
1977}. All this has caused some degree o f confusion with different implants being 
used in different parts o f the world {Muller GH, 1996}.
While it is true that silicone is relatively inert, its tendency to fragment into 
miniscule particles {Copeland, 1994} limits its interfacial biocompatibility and this 
holds true for polyurethanes as well. A solution to this problem could be the 
incorporation o f biocompatible silicon molecules as a cage-like structure; 
silsesquioxanes. Following the encouraging results from the in vitro degradative 
analyses o f the nanocomposite discussed in chapter 3, we tested the biocompatibility
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and biostability o f these nanocomposites in vivo in order to ascertain its 
biocompatibility.
4.2. METHODS AND MATERIALS
4.2.1. POLYMER SYNTHESIS
As described in chapters 2 and 3.
4.2.2. IMPLANTATION IN SHEEP
A 23 % (w/v) solution o f 2% POSS-PCU was casted into sheets o f equal 
dimensions, heated at 70 °C and the resultant sheets were then autoclaved prior to 
being placed subcutaneously into the back o f normal, healthy adult sheep for 18 
months as shown in figure 4.2. A control polymer as mentioned above, consisting o f 
linear siloxane molecules integrated with PCU of the same dimensions, was also 
implanted in similar conditions at the same setting. After 18 months, the implants 
were removed from the animals under general anaesthesia and the surrounding tissue 
and capsule if any, was taken for histopathological examination, performed at the 
Department of Pathology, Royal Free Hospital, London, UK. Throughout the period 
o f implantation, the sheep were monitored for signs o f illness or physiological 
dysfunction and international animal research guidelines were strictly adhered to. The 
implantation o f the polymer sheets was done by the Dept, o f Surgery, University o f
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Tehran, Iran.
Figure 4.2. Subcutaneous insertion of POSS-PCU casted sheets into the back of sheep 
(n = 6).
4.2.3. HISTOPATHOLOGY
In the presence of a capsule surrounding the implant, it was removed and a gross 
morphological assessment was performed. The specimens were then kept in 10 % 
formalin for histopathological examination using haematoxylin-eosin and an abridged 
version of the Van Tiemen classification system (table 4.1) (excluding tissue ingrowth 
as these sheets were non-porous) for inflammatory capsules was used to assess the 
extent of implant-host interaction {Van Tienen, 2002}. As the nanocomposite did not 
elicit any capsule formation, further tests using immunocytochemistry and enzyme
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histochemistry were not performed.
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Table 4.1. An abridged version o f the Van Tiemen classification system for 
inflammatory capsules.
PA RA M ETER GRADING CH A R A C TERISTIC
H&E matrix staining Grade I Weakly red
Grade II Red
Grade III Deep red/pink
Neovascularisation Grade 0 No vascular tissue
Grade I Minimal vascular tissue
Grade II Fibrovascular tissue
Capsule thickness (cell layers) Grade 0 Nil
Grade I 1 to 5 layer
Grade II 6 to 10 layers
Grade III 11 to 15 layers
Grade IV > 15 layers
Inflammatory cell distribution Grade 0 No inflammatory cells
Grade I Few macrophages & giant cells (GCs)
Grade II Many macrophages & GCs but no 
neutrophils
Grade III Grade II & few neutrophils
Grade IV Numerous macrophages, GCs & neutrophils
4.2.4. FOURIER TRANSFORM INFRA-RED SPECTROSCOPY
The explanted polymers (n = 6) and the control siloxane both o f which were kept 
in 10 % formalin solution were washed in saline and dried before assessment using 
the infra-red spectrophotometric analysis described in chapter 2 to determine whether 
any bonds had degraded during the period o f in vivo implantation.
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4.2.5. SCANNING ELECTRON MICROSCOPY (SEM)
Simultaneously, samples o f the explanted nanocomposites and control polymers 
were subjected to SEM observation at magnifications o f up to 640x magnification as 
described in chapter 3 at 10 randomly selected points on the surface o f the polymer 
sheets for any signs o f surface degradation such as pitting, fissuring, cracking 
{Wiggins, 2001} and crystalline segment shearing (‘balding’). AFM and XPS 
analyses on the samples were not performed as these methods are so surface-sensitive 
that the results would have been affected polymer handling peri-operatively.
4.2.6. MEASUREMENT OF EQUILIBRIUM CONTACT ANGLE
Using the sessile drop method, pure distilled water (DW) was introduced via a 
syringe onto the surface o f the nanocomposite and the dynamic contact angle o f the 
POSS-PCU nanocomposite was measured with a Rame-Hart contact angle goniometer 
(New Jersey, USA). Advanced contact angles (0a) were measured by increasing the 
volume of the drop in increments of 2 pi while receded angles ( 0 b )  were measured by 
decreasing the volume o f droplets in a similar fashion. Four independent 
measurements were performed on each sample (n = 4) and the hysteresis angles (A0) 
were calculated as the difference between 0a and 0b. The values for A0 were then 
plotted on the x-axis against the contact angles on the y-axis to determine Young’s 
angle for water on this POSS-PCU nanocomposite at the y-intercept. This work was 
conducted at the Polymer Research Centre, Sheffield, UK.
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4.2.7. FIBRINOGEN DIRECT ELISA
A comparison o f fibrinogen adsorption to both POSS-PCU and its siloxane 
counterpart was performed using direct ELISA. 100 pL of bovine fibrinogen was 
placed in 0.28 cm wells and left at 37 °C for 60 minutes to allow fibrinogen 
adsorption before being rinsed away and replaced with 100 pL o f a 1:1600 rabbit anti- 
bovine fibrinogen HRP-tagged conjugated antibody (Dako Ltd, USA) in 2% serum 
bovine albumin for a further 120 minutes. After removing the enzyme complex, a 
solution o f ortho-phenylamine diamine (ODP) in acid citrate buffer was added to the 
wells and left for 3 minutes to allow for a colour change. The reaction was finally 
terminated with 100 pL of 1% sulphuric acid. The mixture was then exposed to an 
absorption spectrum of 490 nm to assess the amount o f fibrinogen adsorbed to the 
polymer surface (Dynex MRV, Prior Laboratory Supplies Ltd, UK). This experiment 
was performed with 6 repeats (n = 6).
4.3. RESULTS
4.3.1. GROSS MORPHOLOGY
9
The implanted nanocomposites exhibited no evidence o f an inflammatory layer or 
capsule formation (figure 4.3a) even after 18 months o f implantation. This was very 
clearly evident in all 6 samples following explantation. In the case of POSS-PCU 
samples, there was no gross morphological evidence o f a capsule. Unfortunately, no 
surrounding tissue was taken for histology to confirm this . In stark contrast, the
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control siloxane resulted in the formation of a thick, fibrous and vascular capsule as 
shown in figure 4.3b which completely engulfed and was adherent to the polymer. As 
far as the nanocomposite samples were concerned, there were no overt signs of 
physical degradation such as fragmentation or cracking. On the other hand, the control 
siloxane polymers showed gross thinning and signs of decreased mechanical strength 
compared to its undegraded version.
Figure 4.3a. POSS-PCU nanocomposites implanted subcutaneously for 36 months 
exhibited no significant capsule formation.
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Figure 4.3b. The control siloxane implant and its surrounding capsule indicating a 
severe foreign body reaction.
4.3.2. HISTOPATHOLOGY
In this series of experiments, we found that the casted sheets of 2% POSS-PCU 
nanocomposites did not exhibit any capsule formation, indicating that the 
inflammatory cascade did not affect it as compared to the degree endured by its 
siloxane (figure 4.4) which elicited a massive foreign body reaction in one of six 
samples. The innermost capsular layer was formed by multiple layers of fibrin which 
initiated the influx of inflammatory macrophages. In this region, numerous 
eosinophils as well as foreign body giant cells (GCs) are present which suggest a 
foreign body reaction due to a persistent stimulus, probably microscopic fragments of
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degraded silicon. The continuing presence of the offending stimulus contributed to a 
chronic inflammatory state characterized by incoming vessels that constituted a 
vascularised capsule with a high likelihood to cause painful contractures necessitating 
removal later.
Figure 4.4. lOx magnification of the H&E-stained inflammatory capsule surrounding 
the siloxane control showing the innermost fibrin layer followed by 
inflammatory macrophages, fibroblasts and vascularisation.
Using van Tiemen’s classification system, the control siloxane microcomposite 
revealed a highly eosinophilic specimen (Grade III) with evidence of 
neovascularisation (grade II) as well as capsular thickness of greater than 15 cells 
(Grade III). In addition, the inflammatory cell distribution was a mixture of numerous 
macrophages, giant cells and even neutrophils (Grade IV), all of which indicate a 
severe foreign body reaction. Although there was no visible capsule surrounding
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POSS-PCU sheets, we could not conclude on its interaction with the immune system 
due to the lack o f histology in this specific instance. Nevertheless, current literature 
points to nanocomposites in general having diminised foreign-body reaction in vivo 
{Tanaka, 2002}. In any case, we are conducting further in vivo studies on these 
nanocomposites. nHopefully, this would shed more light on this matter.
4.3.3. SURFACE DEGRADATION
ATR-FTIR analysis o f the implanted 2% POSS-PCU sheets showed that the ‘Si- 
O ’ bonds at 1109 cm '1 wavelengths {Marcolli C, 1999} within the closed nanocage 
were intact in all the 6 samples o f the nanocomposite and on both surface and bottom 
in different regions o f the polymer. ‘Si-O’ bonds o f the control linear siloxane 
molecule bonded to PCU (figure 4.5b) and showed a mean decrease in the intensity of 
its S i-0  waveforms as compared to the Si-O bonds in the cyclic silsesquioxane 
molecules (figure 4.5a) indicating that its silicon-containing elements degraded and 
initiated a foreign body reaction {Van Tienen, 2002}. This would be attributable to 
the weaker silicon bonds in a conventional siloxane molecule with linear silicon atom 
configuration. Closed POSS-nanocages on the other hand are more compact and have 
increased bond strengths due to Van der Waals bonds, all o f which make it more 
resistant particularly to the oxidative enzyme; myeloperoxidase (MPO) that accounts 
for 95 % of the macrophage digestive enzymes {Hu, 2001;Voronkov MG, 1982}.
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Figure 4.5a. ATR-FTIR analysis of implanted 2%  POSS-PCU nanocomposites
before and after implantation showing no difference in amplitude at the 
Si-0 group wavelength of 1109 cm '1.
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Figure 4.5b. ATR-FTIR analysis of the degraded control siloxane following 
implantation showing a significant decrease in ‘Si-O’ wavelength 
amplitude.
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The polyurethane component within the POSS-nanocomposite also exhibited far 
greater resistance to in vivo degradation with no alteration to the carbonate carbonyl 
groups u(C=0) at 1740 cm '1 and the absence of its hydrogen-bonded variation at 1709 
cm '1. Urethane carbonyl groups at 1637 cm '1 were also resistant as were the C -0-C =0 
groups at 1253 cm '1 wavelengths {Seifalian, 2003} all which showed no difference 
between the pre-and post-degraded sample (figure 4.5a). An aromatic reference peak 
of 1591 cm '1 accounted for the C=C bonds of the methylene di(p-phenyl isocyanate) 
(MDI) hard segment. ATR-FTIR analysis of the control siloxane-polyurethane co­
polymer showed hydrolysis of the soft, amorphous segment carbonate carbonyl 
groups (C=0) and the ‘C -0 -C = 0 ’ groups with evidence of chain scission. These
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results indicate that the silicon molecules configured as POSS-nanocages form a 
protective network holding together all the constituents of the nanocomposite thus 
improving resistance to biodegradation and fragmentation.
SEM analyses on the explanted nanocomposite samples showed no significant 
difference in its surface morphology as compared to the undegraded control POSS- 
PCU nanocomposite. As shown in figure 4.6a, the surface o f the implanted 
nanocomposite showed a ‘cobblestone’ appearance with no evidence of pitting, 
Assuring or cracking compared to the obvious signs o f surface degradation in the 
control siloxane polymer which also showed significant fibrinogen adsorption to its 
surface (see figure 4.6b). The significantly decreased degradation o f the 
nanocomposite may be explained by two factors. Firstly, these implants elicited a far 
lesser degree of inflammation compared to the controls and secondly, POSS 
nanocages are known to have high resistance to oxidative degradation. This is an 
advantage of this biomaterial in vivo as the primary degradative enzyme of 
macrophages is myeloperoxidase (MPO). Based on all the available data, we 
hypothesised that the addition of POSS nanocages to the polyurethane gave it a 
protective effect by (1) denaturing inflammatory protein cognition o f the polymer and 
(2) greatly augmenting its biostability in the face o f oxidative enzyme degradation. 
This would explain its optimal interfacial biocompatibility.
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Figure 4.6a. Surface morphology of degraded 2% POSS-PCU nanocomposites
showing minimal evidence of surface degradation and the absence of 
fibroblast attachment compared to the control (shown in figure 4.6b).
Figure 4.6b. Surface morphology of siloxane showing significant surface degradation 
with evidence of fissures, cracks a heavy deposition of stellate-shaped 
fibroblasts. .
4.3.4. YOUNG’S EQUILIBRIUM CONTACT ANGLE
A Young’s angle of less than 90 ° is suggestive of a hydrophilic surface while 
values greater than 90 ° indicate hydrophobicity {Riedel, 2001}. As shown in figure 
4.7, we found that the equilibrium contact angle on 2% POSS-PCU nanocomposite 
was 82.6 ° as compared to 110° for siloxane {Mata, 2005}. This reveals the 
hydrophobic character of the nanocomposite. However, the receding contact angle (0r)
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values also indicate a hydrophilic component as well. This combination o f both 
hydrophobicity and hydrophilicity indicates that this nanocomposite is amphiphilic in 
nature. This is in line with concurrent with published literature which show the 
surfactant activity o f POSS molecules {Deng, 2002}. The standard deviations for this 
is not apparent as they lie very close to the mean values. In addition, the hysteresis 
angle is large, indicating the unstable surface free energy o f the nanocomposite. This 
is a measure o f the degree of surface roughness of the nanocomposite {Muller B, 
2001}.
Figure 4.7. Derivation of Young’s equilibrium contact angle using dynamic contact 
angle analyses showed the amphilic (combined hydrophobic and 
hydrophilic) nature of the POSS-PCU nanocomposite.
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4.3.5. FIBRINOGEN ADSORPTION
The in vitro fibrinogen adsorption tests performed to explain the minimal 
inflammatory behaviour of these nanocomposites showed a significant increase in 
fibrinogen adsorption to its surface as compared to the siloxane control (One-way 
ANOVA, p <0.01) as shown in figure 4.8. This corresponds to the existing literature 
which showed that nanocomposites proportionately adsorb proteins with increasing 
surface roughness {Muller B, 2001;Riedel, 2001}. This could in turn be due to the 
effect o f an increase in surface area and therefore it would be logical to assume that 
the formation of an inflammatory capsule in the case o f nanocomposites would be 
accentuated. Paradoxically however, nanocomposites have been shown to cause 
minimal inflammation in vivo both in this study as well as others {Tanaka, 2002}. 
The prevalent hypothesis is that proteins such as fibrinogen undergo conformational 
changes upon adsorption to these surfaces as a result o f large hysteresis angles as we 
have shown above.
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Figure 4.8. Fibrinogen direct ELISA showing significantly increased fibrinogen 
adsorption to siloxane as compared to POSS-PCU (One-way 
ANOVA, p <  0.01).
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4.4. DISCUSSION
Protein adsorption represents the first stage o f the interaction between implants 
and their biological interface. This is determined by the rate o f formation and 
thickness o f these protein layers as well as their conformation. The adsorbed proteins 
act as an information source for the immune system and are thus pivotal in 
minimising interfacial biocompatibility {Eberhart, 1987}. When silicone implants are 
placed in a biological system, thrombin converts soluble fibrinogen into an adsorbable 
form which adheres to the biomaterial. The integrin Mac-1 (CD-I lb/18) on 
macrophages then interact with the exposed P 1 and P2 epitopes on the D-domain of 
the denatured, adsorbable fibrinogen which acts as an opsonin once critical levels are 
reached {Hu, 2001}. The chronic inflammatory reaction {Hu, 2001} is further 
propelled by tumour necrosis factor-alpha (TNF-a ) and interleukin-6 (IL-6) {Mena, 
1995} and culminates in a foreign body reaction. The activated macrophages and 
tissue monocytes then produce angiogenic factors which form a thin vascular layer 
which sustains capsular proliferation {Rubino, 2001}. This causes an increased 
mucopolysaccharide and collagen production by the incoming fibroblasts {Robert
A.Freitas Jr., 2003}. Subsequently, a third layer o f external vascularity develops to 
sustain this capsule.
The resultant capsule becomes acellular within 4 weeks leaving only a fibrous 
framework to separate the implant from living tissue {Liu, 1992}. The extent to which 
this capsule is formed depends on the rate of release o f its constituents and how they 
react with the surrounding cells. The other factors are surface, shape {Carpaneda, 
1997}, differing elasticity, location and duration o f implantation {Robert A.Freitas Jr.,
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2003}. Once formed, a biological capsule can have four major outcomes; resorption, 
extrusion, integration or encapsulation with the latter being the most common 
outcome. Studies on peri-prosthetic tissue have found that initially, an inflammatory 
capsule is formed by proliferating CD-68 negative and vimentin-positive 
mesenchymal cells {Friemann, 1997} of macrophage / histiocyte origin {Luke, 1997}. 
On subsequent capsular contracture, the cells found were CD3/CD68 positive 
macrophages which correlated clinically with Baker’s classification {Kamel, 2001}.
In long-standing cases, dystrophic calcification {Peters, 2001;Yeoh, 1996} occurs.
In the case o f these POSS-PCU nanocomposites, we hypothesise that the two 
main factors responsible for the minimal capsular reaction seen in vivo with them are 
(a) a large contact angle hysteresis causing a conformational change in adsorbed 
fibrinogen (b) minimal POSS-PCU nanocomposite degradation and an absence o f 
fragmentation. In this experiment, both sample and control polymers were matched 
for surface and shape with both specimens implanted subcutaneously in sheep for 18 
months. Having accounted for these confounding factors, the only remaining cause for 
the difference in foreign-body reaction between both groups was the biological 
interactions o f the nanocomposite.
By the chemical integration o f POSS nanocores with the polymer, this increases 
its surface roughness and contact angle hysteresis as well. Previous studies on 
germanium-silicon (Ge-Si) nanopyramids showed that globulin conformation altered 
on contact with these surfaces due to a large contact angle hysteresis loop {Muller B, 
2001}, a similar result to the dynamic contact angle analysis on these POSS-PCU 
nanocomposites. It was postulated in these previous studies that this is due to the
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‘edges’ seen on the glabrous nanocomposite surface {Riedel, 2001}. This 
characteristic would have caused a conformational change in opsonic fibrinogen 
adsorption and affected macrophage recognition o f the PI and P2 epitopes on the 
fibrinogen molecule {Hu, 2001}. As macrophages barely recognised these 
nanocomposites, the process of inflammation was not carried through and no 
biological capsules were thus formed. In a parallel in vivo study, carbon 
nanocomposites implanted subcutaneously into the back of Wistar rats as tissue 
implants showed almost no inflammation {Tanaka, 2002} further supporting the 
theorical basis for its use at the tissue interface.
In both silicone and conventional polyurethane breast implants, polymeric 
particles have been found to be engulfed by inflammatory macrophages which 
eventually migrate to the lymph node {Katzin, 2005} and cause systemic 
manifestations; ‘silicone-osis’ {Englert, 2004}. At a more local level, a study by 
Lesesne and colleagues on breast implants found silicone fragments {Lesesne, 1997} 
mainly localised to the peri-implant tissue. These particles would explain some o f the 
systemic manifestations which persisted in patients even after implant removal. This 
remains a problem with silicone implants.
On the other hand, nanocomposites have far greater mechanical strengths {Zhang, 
2004} than their constituents with its strength based on the arrangement o f quantum- 
scale sizes of its nanocores {Alivisatos AP, 1996} within the matrix. These nanocores 
confer tensile strength to the composite as a result o f its nanoscale interfacial shear 
with the surrounding molecules to allow for efficient load transfer. According to the 
Griffin criterion, nanocomposites with cores below a critical length have mechanical
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strengths equivalent to a solid crystal, in spite o f being cracked or fissured. This holds 
true for nanocomposites and explains the relative immunity of nanocomposites to 
fracture {Gao H, 2003} and would explain its diminished propensity to cause capsular 
formation.
With reference to this POSS-PCU nanocomposite, there was no significant fall in 
the FTIR wavelength intensities o f both the soft and POSS-integrated hard segments 
o f the polymer after in vivo implantation. This suggests that this polymer is highly 
resistant to biological degradation. Our concurrent in vitro degradation experiments 
however suggests that even under accelerated hydrolytic and oxidative stresses, these 
POSS-PCU nanocomposites remained completely intact. This data conforms to 
current beliefs regarding nanocomposite behaviour in vivo.
In summary (table 4.2), POSS-PCU nanocomposites are ideal for use at the 
biological interface as tissue implants, biomedical devices and even vascular grafts 
due to the very low levels o f inflammation elicited by the host to it. We hypothesise 
that this is due to the intrinsic surface roughness o f the polymer causing increased 
contact angle hysteresis and conformational change in adsorbed surface fibrinogen; a 
key initiator for foreign-body reactions. We hope that these results would stimulate an 
entirely new generation of bioartificial implants with ‘stealth-like’ properties, possibly 
undetected by the immune system.
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Table 4.2. Summary o f the experimental study.
Parameter POSS-PCU nanocomposite Siloxane control
Capsule Absent Significant
Degradation No obvious macro- or 
microscopic signs of 
degradation.
Thinning of polymer sheets with 
microscopic evidence o f pitting, 
Assuring and cracking.
Si-0  bonds Negligible effect Significant decrease in ‘Si-O’ bonds.
Fibrinogen
adsorption
Significantly higher adsorption to POSS-PCU nanocomposites 
compared to siloxane. (One-way ANOVA, p < 0.001).
Wettability Amphilic (Hydrophobic + 
Hydrophilic)
Hydrophobic
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Chapter 5
5. Endothelialisation of polyhedral oligomeric 
silsesquioxane nanocomposites for microvascular tissue 
engineering: An in vitro study
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5.1. INTRODUCTION
Tissue-engineered vascular grafts can be constructed by using biopolymers coated 
with heparin, endothelial cells etc. or as truly biological grafts tissue-engineered in 
vitro prior to re-implantation {Teebken, 2001}. Polyethylene teraphthalate (Dacron™) 
and expanded polytetrafluoroethylene (ePTFE) have been the biopolymers of choice 
in the construction of synthetic vascular grafts to date. However, poor elastic 
properties (Salacinski, 2001c;Tai, 2000} and graft thrombogenicity have limited its 
clinical potential particularly at lower flow rates where patency has been shown to 
bear an inverse relationship to the internal diameter o f the grafts {Brossollet,
1992;Lau, 2001;Suma, 1999}. This may be reversed by lining these bypass grafts with 
ECs {Salacinski, 2000;Salacinski, 2001b}. Randomised clinical trials using 
endothelialised 7 mm internal diameter PTFE vascular grafts have shown primary 
patency rates of 83.7 % in lower limb bypass grafts at four years {Deutsch, 
1999;Meinhart, 2001}. Its success however depends on the initial seeding density, 
duration of culture and the capacity of the cells to proliferate on the biopolymer 
{Seifalian, 2002}.
Given the importance o f endothelialisation in vascular grafts, we sought to study 
the ability o f these nanocomposites to sustain endothelialisation. The work described 
in chapter 4, is indicative o f the fact that this nanocomposite elicits minimal 
inflammation, probably due of the conforming effects o f POSS on surface fibrinogen 
adsorption. However, optimising the surface concentration o f POSS is essential in 
order to promote endothelialisation following implantation as excessive amounts o f 
silica-based molecules could hinder endothelialisation. This was the question which
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needed to be answered.
Another concern is that at lower flow rates, the compliance mismatch between 
current bypass grafts and the native vessels has been hypothesised to be a cause of 
intimal hyperplasia; a major cause of long-term graft occlusion {Zilla, 1987}. PU are 
polymers with similar radial compliance characteristics to native vessels {Tai, 2000}. 
O f these, carbonate-based PU, unlike earlier generations of PU, do not possess ether 
or ester linkages and are hence less susceptible to degradation. Our own study using 
PCU grafts on the aorto-iliac vessels o f four beagle dogs over 36 months showed 100 
% patency, minimal intimal hyperplasia and no signs o f aneurysmal dilatation and 
most importantly, an ability to sustain endothelialisation {Seifalian, 2003}.
The latter characteristic prompted the linking o f POSS to PCU in order to achieve 
the synergy o f the compliance characteristics o f PCU and the platelet repelling action 
o f silica-based polymers {Berrocal, 2001}, which confers an anti-thrombogenic effect 
{Park, 2002}. Previous experience with this includes the use o f co-polymers o f PU 
and siloxanes in intra-aortic balloons which have relative haemocompatibility due to 
the dispersive force fields on its surface which maintains any adsorbed proteins in an 
unstable state {Nyilas, 1977}. However, siloxane-based vascular grafts have not been 
successful as the formation o f an EC lining on these constructs is sub-optimal 
{Hoffman, 1993}.
In this study, we assessed whether this nanocomposite is safe and compatible with 
in vitro cell cultures. Apart from indicating its safety as a biomaterial at the cellular 
level, such information would also serve as a measure o f its potential for developing
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bio-hybrid vascular grafts. As shown in figure 5.1, developing bio-hybrid vascular 
grafts would require the ECs to undergo four phases. These cells have to first remain 
viable within the culture medium exposed to POSS-PCU as well as on direct contact 
with the polymer (Phase I). Next, the ECs would have to adhere to the polymer 
surface, preferably within a short time, to minimise the complications associated with 
long-term cell cultures (Phase II). These adherent ECs would then need to proliferate 
at a steady rate (phase III) in order to achieve a confluent EC monolayer (Phase IV).
F igure 5 .1. Schematic representation of the stages of cell seeding on biomaterials.
Stages of Endothelialisation
IV. Confluence
o
I. Viability
o
II. Adhesion III. Proliferation
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5.2. MATERIALS AND METHODS
5.2.1. POLYMER SYNTHESIS 
Please refer to chapter 2.
5.2.2. PRIMARY ENDOTHELIAL CELL CULTURE
Using a previously described method {Seifalian, 2001}, Human Umbilical Vein 
Endothelial Cells (HUVECs) were extracted from umbilical cords procured within 24 
hours o f delivery using sterile collagenase (Boehringer Mannheim; from Clostridium 
Haemolyticum ). HUVECs were then grown in tissue culture using Cell Culture 
Medium (CCM) consisting o f 157 ml o f M l99 medium, 40 ml foetal bovine serum, 
4.8 ml 7.5 % sodium bicarbonate (Invitrogen, Paisley, Scotland, UK), 5 ml L- 
glutamine (200mM), 1.57 ml penicillin / streptomycin (5000 units of penicillin and 5 
mg/ml streptomycin (Sigma, Poole, Dorset, UK). Following incubation for 48 hours 
at 37 °C and 5 % CO2 , the confluent HUVECs were removed using 0.25% Trypsin -  
EDTA (Sigma-Aldrich Company Ltd., Poole, UK) and split in a 1:4 ratio. In our 
experiments, confluent HUVECs from passages 4 to 5 were used.
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5.2.3. CELL VIABILITY ANALYSIS
5.2.3.1. Direct contact method
1.0 x 105 fourth passage (P4) HUVEC suspensions in CCM were each placed in 
sterile 24-well culture plates (Helena Biosciences, Sunderland, UK) coated with 
circular sheets o f casted POSS-PCU with its edges sealed off with POSS-PCU liquid 
using a micropippete. This was then incubated at 37 °C and 5 % CO2 for 24 hours and 
48 hours respectively. Alamar Blue™ analysis (Serotec Ltd., Kidlington, Oxford, 
England) was then performed and its absorption spectra at 570 nm and 630 nm 
wavelengths were measured using a Multiscan MS spectrophotometer (Labsystem 
Multiskan MS; Labsystem, Helsinki, Finland) {Seifalian, 2001}. All tests were 
repeated four times in duplicate (n = 4) with uncoated standard polystyrene tissue 
culture wells serving as controls. In this experiment, the cell seeding density was 
higher than normal so as to optimise the sensitivity o f the Alamar Blue™ analysis 
system (Seifalian, 2001}.
5.2.3.2. Diluent extraction method
POSS-PCU was pulverised using a dismembranator (Mikro-dismembranator u,
B.braun biotech international gmbh). The powder was autoclaved, placed in CCM to 
constitute a 100 mg/mL solution o f POSS-PCU and then shaken at 200 rpm for 19 
days at 37 °C. Following exposure, the mixture was sieved, rinsed and centrifuged to 
extract the remnant CCM. 24-well plates seeded with 5.0 x 104 HUVECs were then 
incubated at 37 °C and 5% CO2 for 48 hours in 25, 50, 75 and 100 mg/ml o f the
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polymer-exposed CCM with plain CCM acting as the control. Following incubation 
for 0,6,12 and 24 hours, AlamarBlue™ analysis was performed as mentioned earlier 
(n = 4).
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5.2.3.3. High permeation liquid chromatography ( HPLC )
HPLC analysis was performed to assess whether any component of POSS-PCU 
leached out into the media following incubation. Powdered polymer was placed in 
sterile PBS for 90 days to allow for leaching o f the polymer if  any, before being 
centrifuged and filtered. The filtrated PBS was then subjected to HPLC analysis using 
a 30 mm gradient with the sample run at 20 cms/hr, through a Cig reverse plate to 
assess hydrophobicity (Varian Ltd., USA). The sample was run for 30 minutes using 
buffer solutions of (A) 0.1 % tri-fluroacetic acid/TFA in water and (B) 0.1 % TFA in 
acetonitrile. Plain PBS controls were used as the control group. This experiment was 
performed by the Department o f Biochemistry, Royal Free UCL Medical School, 
London, UK.
5.2.4. CELL ADHESION ASSAY
Fourth passage (P4) HUVECs were seeded at 3.5 x 105 cells/cm2 on sterile POSS- 
PCU sheets placed within standard 96-well plasma-treated polystyrene wells (Helena 
Biosciences Ltd., Sunderland, UK) as per ISO 10993 specifications {ISO part 5, 
1992}. HUVECs were then allowed to incubate at 37 °C and 5% CO2 before being 
subjected to AlamarBlue™ assays at 30, 60, 120, 180 and 240 minutes respectively (n 
= 4). As before, spectroscopic analysis at 570 and 630 nm was performed using the 
Multiscan MS spectrophotometer (Labsystem Multiskan MS; Labsystem, Helsinki, 
Finland). A parallel experiment was performed using plasma-treated polystyrene 
culture plates as the gold standard and conventional siloxane to elicit the difference in
152
EC adhesion between linear siloxanes and caged silsesquioxanes as well as to 
compare the endothelialising properties o f silsesquioxanes to standard cell culture 
plates. Alamar Blue™ was the preferred technique in this instance as it is non- 
cytotoxic, independent o f polymer, allows continous monitoring o f cells, assesses 
viability and is user-friendly. Moreover, it is the preferred assay in our laboratory as 
we have optimised the technique over time.
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As a measure of the hydrophilicity of the polymer, the water absorption index 
(WAI) o f POSS-PCU was determined. Thin strips of PTFE, PCU and POSS-PCU of 
equal dimensions were immersed in pure distilled water (Sigma Ltd., Dorset, UK) for 
1, 3 and 7 days. Their respective pre-immersion (mo) and post-immersion weights (mi) 
were measured and the WAI was determined using the formulae,
Water Absorption Index = (mi-  mo)/ mo x 100%
5.2.5. CELL PROLIFERATION ASSAY
Proliferation o f HUVECs on POSS-PCU over time was determined using 
PicoGreen® DNA quantisation assay (Molecular Probes Co., OR, USA); a vital dye 
which stains DNA fluorescent green. HUVECs were seeded onto glass petri dishes at
1.0 x 103 cells/cm2 containing culture media and incubated for 1, 3, 7, 11 and 14 days. 
The HUVECs were then extracted and reconstituted in 1 mL mixtures o f 10 mM tris- 
HC1 with 1 mM EDTA at pH 7.5 ( lx  TE) to form the sample while serially diluted 
calf thymus DNA served as the standards {Singer, 1997}. 100 pi aliquots o f these 
solutions were then mixed with 100 pi 1: 400 (v/v) dilution o f PicoGreen® dye in lx  
TE and incubated for 5 minutes. This was then excited at 485 nm and the emissions at 
538 nm were read. The amount o f DNA in the sample was then determined from the 
standards (data not shown) and based on the assumption that each cell contains 7.7 pg 
o f DNA, the number of cells was calculated.
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5.2.6. CELL CONFLUENCE MORPHOLOGY
5.2.6.1, Light microscopy
Fifth passage (P5) HUVECs were cultured on sterile, flat sheets o f the POSS-PCU 
for 48 hours at a seeding density of 3.5 x 105 cells/cm2 to assess cell confluence 
morphology. The cultured cells were then fixed with 4 % paraformaldehyde for 10 
minutes and carefully rinsed with PBS and stained with 0.1 % Toluidine Blue ( TB ) 
stain (Sigma Chemical Company, Poole, Dorset, UK) for 10 minutes before being 
washed off with PBS. The sheets were then examined under a confocal microscope 
(Nikon D-Eclipse C l, Japan) at 20x magnification to assess cell confluence on POSS- 
PCU qualitatively assess cell attachment to the polymer.
5.2.6.2. Electron microscopy
The morphology o f the proliferating ECs was studied using electron microscopy 
using the method alluded to in chapter 3 using P5 HUVECs cultured on sterile, flat 
sheets o f POSS-PCU for 48 hours again at a seeding density of 3.5 x 105 cells/cm2. 
The parameters assessed were the presence o f cell retraction, loss o f filopodia and a 
rounded cell appearance; indicators of impaired cell motility and morphogenesis 
{Park, 2002}.
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5.3. RESULTS
5.3.1. CELL VIABILITY
Cell viability on the polymer was assessed using both the direct contact and 
diluent extraction methods {Park, 2002}. Direct contact involved exposing HUVECs 
directly to the polymer while the indirect technique involved using CCM exposed to 
the polymer to culture cells. Analysis was performed using a vital dye; Alamar Blue® 
(AB) which viable cells metabolised from blue resazurin to pink resarufin and the 
change in colour was detected spectroscopically {Park, 2002}. Leaching from POSS- 
PCU into CCM was assessed using high performance liquid chromatography (HPLC).
5.3.1.1. Direct effect o f POSS-PCU
Direct contact studies showed that there was no significant difference between 
HUVEC viability on POSS-PCU and standard tissue culture plates following 
measurement with AlamarBlue™ assay at 24 and 48 hours o f cell culture (Two-way 
ANOVA; p = ns) as is shown in figure 5.2. This shows that HUVECs cultured 
directly onto POSS-PCU exhibited optimal cell viability for up to 48 hours.
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Figure 5.2. Direct contact analysis using Alamar Blue™ spectral absorption (ABSA) 
which showed no significant difference in cell viability between standard 
cell cultures and those on POSS-PCU (Two-way ANOVA, p = ns).
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5.3.1.2. Indirect effect o f POSS-PCU
AlamarBlue™ analysis o f the diluent extract o f POSS-PCU showed no significant 
difference (p = ns) in cell viability between the control group and cell cultures with 
varying concentrations o f the polymer extract (0, 25, 50, 75 and 100 mg/ml) at 6, 12 
and 24 hours respectively as is shown in figure 5.3. This indicates that no cytotoxic 
substance leaches out of POSS-PCU in vitro as ECs can remain viable on the polymer 
for the prolonged in vitro culture period that is necessary for two-stage seeding 
procedures.
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Figure 5.3. Diluent extraction analysis using Alamar Blue™  spectral absorption
(ABSA) showing no significant differences between varying doses of cell 
media incubated with the nanocomposite at 0, 6, 12 and 24 hours (Two- 
way ANOVA, p = ns). Mean and standard deviation values are tabulated 
below.
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Time 0 mg/ml 25 mg/ml 50 mg/ml 75 mg/ml 100 m g/ml
Ohrs 0.2215 ±  
0.053791
0.2215 ±  
0.045886
0.2365 ±  
0.083983
0.30375 ±  
0.047407
0.34475 ±  
0.031135
6 hrs 0.50325 ±  
0.076049
0.50325 ±  
0.066745
0.461125 ±  
0.104772
0.553375 ±  
0.131563
0.51575 ±  
0.101276
12 hrs 0.623375 ±  
0.09665
0.623375 ±  
0.09591
0.52325 ±  
0.134906
0.610375 ± 
0.147749
0.6305 ±  
0.117397
24 hrs 0.69825 ±  
0.013623
0.69825 ±  
0.030119
0.6485 ±  
0.134906
0.711 ±  
0.075825
0.68925 ±  
0.098872
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5.3.1.3. HPLC
HPLC analysis showed here was no evidence o f any substance leaching out the 
polymer on prolonged contact. This was in line with the results showing optimal cell 
viability in the diluent extraction method performed above.
5.3.2. CELL ADHESION
EC adhesion to the POSS-PCU sheets showed a significant increase in adherent 
viable cells to the polymer (53 % increase in spectral absorption over baseline values) 
within 30 minutes o f contact (student’s t-test, p < 0.05). Subsequent adhesion of 
viable ECs to the polymer reached saturation within 2 hours o f cell culture on the 
polymer (figure 5.4a). Compared to the minimal cell adhesion to medical-grade 
siloxane these results indicate that when silicon molecules are incorporated as closed- 
cage silsesquioxanes, they allow for improved EC adhesion to its surface and hence, 
endothelialisation. Two-way ANOVA analysis showed a very significant difference in 
EC adhesion between POSS-PCU and siloxane (p < 0.0001). There was no difference 
in EC adhesion between POSS-PCU and standard polystyrene cell culture plates.
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Figure 5.4a. Alamar Blue™ assay showing significant endothelial cell adhesion to 
POSS-PCU within 30 minutes o f contact (student’s t-test, p <0.05) and 
reaching saturation after 2 hours o f incubation. These values were 
significantly greater than endothelial cell adhesion to medical-grade 
siloxane (Two-way ANOVA, p < 0.0001). There was no statistical 
difference in EC adhesion between POSS-PCU and standard cell culture 
plates.
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The WAI o f silica nanocomposites was 28.54 % +/- 3.216 % as compared to PCU 
(6.194 % +/- 1.985 %) and PTFE (3.978 % +/- 3.218 %). Two-way ANOVA analysis 
(figure 5.4b) showed a statistically significant difference between these values (p < 
0.0001) indicating the greater hydrophilicity o f the nanocomposites compared to 
PTFE and PCU. WAI tests on medical-grade siloxane were not performed as the 
hydrophobicity o f siloxane per se is well documented. These results suggest that the
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improved endothelialising property o f the nanocomposite is attributable to its 
improved hydrophilic behaviour.
Figure 5.4b. Water absorption index (WAI) assays which show significantly higher 
water absorption indices and hence hydrophilicity o f POSS-PCU as 
compared to ePTFE and PCU (One-way ANOVA, p < 0.0001).
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5.3.3. CELL PROLIFERATION
Quantitative analysis of HUVEC proliferation on POSS-PCU polymers studied 
with PicoGreen®, showed a significant increase in mean EC proliferation at 1,3, 7,
11,14 and 21 days over baseline values (One-way ANOVA, p < 0.0001). There was 
no significant difference found between different repeats o f ECs for a given time 
(One-way ANOVA, p = ns). This study shows that the growth pattern of ECs on the 
nanocomposite (initial seeding density o f 1.0 x 10 cells per cm ) reached the 
exponential phase o f growth beyond one week in culture which was sustained at two
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weeks with a 60-fold increase in EC surface density finally reaching saturation 
beyond 14 days (figure 5.5). These results show that ECs are able to proliferate on the 
polymer even from very low seeding densities over the prolonged periods o f time 
necessary for two-stage seeding procedures.
Figure 5.5. PicoGreen assay showing significant increases in cell proliferation on 
POSS-PCU over 21 days (One-way ANOVA, p < 0.0001).
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Here, cell viability refers to the ability o f the cells to survive both in direct contact 
with or in the presence of culture media in contact with the nanocomposite. On the 
other hand, cell adhesion referred to the number o f cells actually adherent to the 
nanocomposite after the culture media was removed and the wells were gently rinsed 
with PBS.
In order to differentiate between these two parameters, AlamarBlue™ was added 
to the cell adhesion assay wells only after the original culture medium had been 
removed and gently rinsed at specified time periods to ensure that only those cells
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which were adherent, were present. Our previous studies have shown that the amount 
of dye metabolised by the cells is an indicator o f the number of cell adherent in this 
case {Seifalian, 2001}.
As for the cell viability assays, all wells contained AlamarBlue™ to begin with 
and the media was not changed for the 24 to 48 hour duration. The colour change 
from blue to pink was taken as a measure o f the overall metabolising capacity of these 
cells; an indicator o f their viability. If these cells were physiologically dysfunctional 
then accordingly the amount of dye metabolised would have been decreased. In this 
manner, AlamarBlue™ assays were used to distinguish between cell viability and 
adhesion.
5.3.4. CELL MORPHOLOGY
Light microscopic examination o f TB-stained ECs on POSS-PCU showed a 
reticulate pattern of confluence morphology by 48 hours o f culture (figures 5.6a & b). 
Higher magnification of these cells with a scanning electron microscope (SEM) 
showed morphological features o f proliferating cells, with the formation o f numerous 
cellular filopodia as well as the absence o f cell retraction and ‘rounded’ cells (figure 
5.7). These data suggest that ECs are ultimately capable o f forming confluent EC 
layers within POSS-PCU microvessels once implanted in vivo, through the process of 
neo-endothelialisation (endothelial cell proliferation into the graft from beyond the 
anastomotic site. Comparing these results with the published data on gelatine-coated 
plates (current gold standard), ECs on POSS-PCU had comparable characteristics
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although the presence of apoptotic bodies in this case suggests that POSS-PCU 
supports endothelialisation but not as significant as gelatine {Prasad Chennazhy K, 
2005}. Nevertheless, the use of silicon atoms as POSS instead o f siloxane does 
improve its endothelialisation.
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Figure 5.6a. Light microscopic analysis (20x magnification) of Toluidine Blue-
stained endothelial cells showing their confluence morphology on POSS- 
PCU at 48 hours.
Figure 5.6b. Toluidine Blue-stained HUVECs on POSS-PCU showing improved
cellular confluence by 6 days, compared to 48 hours (20 x magnification).
Figure 5.7. Scanning electron microscope pictures of endothelial cell adsorption
morphology on POSS-PCU showing the presence of a flat, spindle-shaped 
cells with numerous filopodia and the absence of cell retraction. This 
indicates the presence of viable, proliferating cells on POSS-PCU at 48 
hours (320x magnification).
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5.4. DISCUSSION
Studies have shown the clinical benefit o f lining PTFE vascular grafts with 
endothelial cells, particularly in lower limb arterial bypass grafts {Zilla, 1987} unlike 
native, uncoated polyethylene terephthalate grafts. Studies on the latter grafts have 
been shown to be a result o f decreased expression o f the fibronectin receptor; VLA-5 
{Cenni, 2001}. This has seen the increasing use of fibronectin motifs namely, RGD- 
peptides {Kidane, 2003}, cell adhesion peptides such as P-15 {Hamm, 2003} and 
titanium coatings which promote endothelial cell confluence on the surfaces o f 
conventional vascular prostheses {Lehle, 2003}.
Current generations o f siloxane co-polymers have two main limitations namely (a) 
stiffness {Ai, 2003} and (b) poor endothelial cell adhesion due to its high 
hydrophobicity {Zilla, 1991} One answer to this problem, is coating these surfaces 
with gelatine-glutaraldehyde cross-linkages {Ai, 2002}, titanium carboxonitride {Lehle, 
2003} and peptides {Lateef, 2002}. All these surface modifications have been shown 
to enhance EC seeding onto the graft surface but this involves a secondary coating 
procedure. An alternative is to incorporate low-adhesive silicon into higher adhesive 
polymers such as polyurethanes {Zilla, 1987} in a way which would improve overall 
EC adhesion whilst maintaining its viscoelasticity. Even so, seeding o f these grafts 
would require prolonged culture times with increasing risks o f infection to the graft.
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This necessitates the development of a vascular interface with optimal cell seeding 
and cytocompatibility in the cell culture environment as well {Wilsnack, 1976}. The 
cytocompatibility o f the entire nanocomposite may be explained by the inherent 
stability of the nanocomposite as all 8 of its reactive side-groups (R) o f POSS are 
fully reacted with PCU.
The polyhedral nature of the POSS molecule ensures greater integration between 
both soft and hard domains o f the polyurethane with a lesser chance o f substance 
degradation and leaching. All polymer sheets were casted at 70 °C which was well 
above the boiling point o f dimethyl acetamide (DMAC). This technique thus allows 
for complete evaporation of the diluent; DMAC and would further minimise the 
probability o f substance leaching into the media.
Thus, compared to existing silicone co-polymers {Ai, 2003;Hesse, 2003}, we 
found that the use o f a POSS-based nanocomposite improves cell adhesion 
characteristics. As these nanocages occupy minimal volumes within the polymer 
{Lichtenhan, 1995}, relatively greater surface areas o f PU are available which allows 
for improved endothelialisation. This would also confer a greater degree of polarity to 
the polymer which could explain its superior hydrophilicity to PCU.
These experiments also indicate that once adherent to its surface, ECs are also 
capable o f proliferating manifold in order to form a confluent monolayer. While the 
PicoGreen® assay showed the excellent proliferating characteristics o f ECs on the 
polymer, light microscopic analysis revealed how this occurred. Prior to achieving 
cellular confluence, the ECs aligned in a reticular manner. The intervening areas were
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subsequently filled in to achieve cellular confluence as shown in figures 5.6a & b.
Our data also showed that the quality o f cell adhesion and proliferation on the 
polymer was excellent. Qualitative data using SEM analysis clearly visualised the 
presence o f optimal cell-polymer interactions with the formation o f numerous 
filopodia at its surface, flattened ECs and no rounded cells. This suggests that these 
ECs are capable o f morphogenesis and have the ability to proliferate well.
As these set o f experiments have found ECs to be compatible with this polymer, 
further tests need to be performed on the optimal conditions o f cell seeding on this 
polymer. This would also include seeding smooth muscle cells (SMCs) and eventually, 
co-cultures of ECs and SMCs onto the polymer. Nevertheless, further tests using in 
vivo conditions would need to be performed before concluding on its overall 
biocompatibility and for its potential use in biomedical devices. In conclusion, POSS- 
PCU nanocomposites are compatible for seeding cardiovascular devices.
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Chapter 6
6. The anti-thrombogenic potential of a polyhedral 
oligomeric silsesquioxane (POSS) nanocomposite.
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6.1. INTRODUCTION
In the microvascular setting, the interplay between the components o f Virchow’s 
triad is essential. {Conte, 1998}. From the experimental standpoint, this has been 
exemplified thus far by many studies {Budd, 1991;Demiri, 1999;Harris, 2002}. For 
instance, polyethylene terephthalate has high platelet adsorption characteristics {Desai, 
1991} while PTFE micro vessels are far inferior to vein grafts {Schmedlen, 
2003;Teebken, 2001}. The initiation of the coagulation cascade in these cases is due 
to significant fibrinogen adsorption {Balasubramanian, 1999} with the resulting 
thrombus activation {Lin, 2004} in the short term and intimal hyperplasia (IH)
{Ballyk, 1998;Perktold, 2002} in the long term.
For now, autologous vein grafts are the grafts o f choice for microvascular repairs 
{Kannan, 2005} but in the case o f microvascular networks, the technical impossibility 
of dissecting out a capillary bed rule this out as an option in microvascular networks 
{Bourassa, 1994}. This has prompted us to develop a synthetic vascular interface 
which is anti-thrombotic and with the capacity to be microfabricated into a 
microvascular network.
While PTFE and Dacron™ have limitations, certain groups have turned to PU as 
they possess optimal physico-mechanical properties and are resistant to flex-fatigue 
{Lelah MD, 1986}. We have previously worked on PCU was shown to have superior 
resistance to both hydrolytic and oxidative degradation {Salacinski, 2002b} as well as 
similar compliance characteristics to biological vessels in both in vitro {Tai, 2000} 
and in vivo conditions {Seifalian, 2003}. However, even these polymers only have
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moderate haemocompatibility which need to be improved upon before use as small- 
diameter and micro-vessels.
As such, efforts are currently being made to improve upon the surface 
haemocompatibility of conventional polymers {Wetzels, 1999}. Studies by Silver and 
colleagues revealed that the haemocompatibility o f a surface depends on the 
wettability characteristics of its surface head-groups {Silver, 1999}. Therefore 
incorporating silicon, which repels platelet and fibrin adsorption due to their unstable 
surface free energy, onto a vascular interface would confer to it increased 
thromboresistance {Silver, 1999}. A disadvantage o f silicon-containing vessels 
however is that they are rigid and would have minimal radial compliance with a 
tendency to form intimal hyperplasia more rapidly. Further studies have also revealed 
that shorter and more mobile surface moieties have increased thromboresistance 
{Park, 2002;Silver, 1999} thus strengthening the need for the use o f nanoparticles.
As mentioned earlier, POSS {Lichtenhan JD, 1995} is a nanoparticle which can 
assemble at the atomic scale as they are larger than ions and smaller than macroscopic 
material {Fukushit, 2005}.
Researchers have since shown that these nanocomposite cubes may be 
incorporated as building block fillers or cores {Sanchez C, 2001} into other polymers 
to form hybrid inorganic-organic co-polymers with improved miscibility and hence, 
elasticity {Haddad TS, 1999}. In addition, optimal POSS dispersion within the 
polymer {Ribot F, 1999} serves as a reinforcing nanofiller with high surface coverage. 
Our hypothesis is that POSS-based nanocomposites would interact with coagulant
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proteins and platelets in such a manner as to repel them. Such prostheses would not 
need systemic anti-coagulation such as heparinisation, ideal in a microvascular 
network.
Prior studies have shown that POSS nanocomposites have the ability to self- 
assemble once mixed with other polymers {Lee YJ, 2004}. As we have combined 
POSS with a PU, the surface mobility o f the co-polymer should improve and hence 
reduce the urethane group’s functionality o f both protein and platelet adsorption 
responsible for activating coagulation .
This improves the surface mobility o f the co-polymer and hence potentially 
reduces the urethane group’s functionality o f both protein and platelet adsorption 
responsible for activating coagulation {Groth, 1995}. Our postulate is that a pendant 
silicon nanocage with foci o f silicon-rich areas serving as the scaffold would preserve 
the PU architecture sufficiently so as to maintain its compliant properties whilst 
conferring anti-thrombogenic properties. In this chapter, we focus on the luminal 
behaviour o f the nanocomposite (Kannan, 2006) whilst chapter 7 would be based on 
its bulk characteristics namely compliance and permeability.
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6.2. METHODS AND MATERIALS
6.2.1. POLYMER SYNTHESIS
As mentioned in chapters 2 and 3.
6.2.2. SURFACE CHARACTERISATION
Polymer samples for transmission electron microscopy (TEM) were prepared 
using thin slivers o f 2% POSS-PCU which were removed from the glass slide and 
placed in plastic moulds which were then filled with Lemix epoxy resin and 
polymerised in an oven at 70 °C overnight. 0.5 pm sections were cut using a diamond 
knife (Diatome) on a Reichert-Jung ultracut microtome and collected on 200HS, 
3.05mm copper grids (Gilder) coated with Butvar support film. The sections were 
viewed and photographed at up to 53,000 x magnification using a Philips CM 120 
transmission electron microscope at 80 kV to understand the composition o f the 
polymer. The elemental composition o f these regions were then analysed using energy 
dispersion X-ray analysis (EDXA). X-ray spectra and maps were also acquired using 
an EDXA DX-4 EDS X-ray microanalysis system. This test was done at the EM unit, 
Royal Free UCL Medical School, London, UK.
Using the data from the contact angle measurement alluded to in chapter 4 {Kim, 
2003}, the equilibrium angle was calculated.
174
The surface topography o f the 2% POSS-PCU nanocomposite was studied with a 
commercial Atomic Force Microscope (AFM) (Nanowizard, JPK Instruments, Berlin) 
using both contact and intermittent contact mode. For this purpose the nanocomposite 
was prepared by casting it on new glass cover slips and left to dry at 70 °C for 72 
hours before being carefully peeled off using fine forceps and wrapped in aluminium 
foil to avoid surface contamination. Contact imaging was performed with a 
commercial AFM cantilever (gold-coated Microlevers™, type C, Veeco Metrology 
Group, Sunnyvale, CA) at a scan speed o f 1 Hz at scan speed o f 2.5 Hz. Intermittent 
contact imaging was performed at a scan speed o f 1 Hz with a commercial non- 
contact silicon cantilever (Ultrasharp, NSC 12/50, type A, MikroMasch, Talinn, 
Estonia). These experiments were done in conjunction with the London 
Nanotechnology Centre, UCL, London, UK.
X-ray photoelectron spectroscopy (XPS) was performed by mounting pieces of 
the nanocomposite onto stainless steel stubs with double sided adhesive tape, leaving 
their surfaces exposed. Using a VG CLAM2 spectrometer (East Grinstead, UK) with 
a (non-monochromated) Mg Ka source (photon energy 1253 eV), survey scans were 
taken at a pass energy o f 100 eV and core level spectra at 20 eV with an electron take 
off angle of 60°. Elemental peak areas were used, with appropriate sensitivity factors 
to determine relative atomic concentrations. The sampling depth (into the surface) 
under the conditions employed for this work was approximately 5 nm. This 
experiment was performed at the Polymer Research Centre, Sheffield, UK.
SEM analyses o f the nanocomposite, was performed as described in chapter 3.
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6.2.3. THROMBOELASTOGRAPHY
Using a Thromboelastograph Coagulation Analyser (TEG®, Niles, IL, USA) 
calibrated at 37 °C, 4.5 ml o f blood was collected using the two-syringe technique in a 
citrated tube to constitute 3.8 % citrated whole blood (CWB) at 1:10 v/v, pH 7.4. The 
CWB is then gently inverted thrice to mix it and incubated for 15 minutes. In the 
meantime, 0.2 M calcium chloride was left to thaw at room temperature for 10 
minutes. TEG cups were coated with a thin, uniform layer of 2% POSS-PCU in 
DMAC and incubated at 50 °C to remove DMAC. These cups were then mounted 
onto the TEG analyser and 20pL calcium chloride was added to each cup followed by 
340 pL of blood. The mixture was then coated with 6 drops of mineral oil to prevent 
blood evaporation and finally mixed by gently lowering and raising the pin {Horacek, 
2002}.
Similarly, parallel analysis using poly (carbonate-urea) urethane (PCU) with 
empty polystyrene TEG cups as control was performed in comparison to 2% POSS- 
PCU. Each of these tests were performed using blood from healthy volunteers (n = 6). 
TEG tests on PTFE were not done as these high extrusion polymers did not allow the 
casting of a thin, uniform layer on the cups. Any other method o f coating the TEG 
cups with these polymers would have significantly altered the outcome and was hence 
not attempted. Tests on polyethylene terephthalate (Dacron™) were not performed in 
any o f these experiments as it is known that it is not the optimal material for smaller 
diameter grafts and micro vessels {Schmedlen, 2003;Teebken, 2002}.
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6.2.4. FIBRINOGEN ADSORPTION
Fibrinogen adsorption to POSS-PCU was determined using direct ELISA. The 
bases o f 24-well polystyrene plates were coated with flat sheets o f 2% POSS-PCU, 
PCU and PTFE (Goretex®, WL Gore Ltd., USA) with plain, uncoated polystyrene 
wells as controls. 100 pL o f 5 % semi-skimmed milk (Marvel™) in PBS solution was 
then placed in each well for 2 hours at 37 °C to block non-specific antibody binding. 
This solution was removed and the wells rinsed with 0.01% Tween in PBS solution. 
100 pL of human fibrinogen solution (310 mg/mL) was then placed in each well and 
incubated at 37 °C for an hour to allow fibrinogen adsorption to the polymers. This 
was then carefully rinsed again and replaced with 100 pL of a 1:1600 rabbit anti­
human fibrinogen HRP-tagged conjugated antibody (Dako Ltd, USA) in 2% serum 
bovine albumin for a further two hours. This enzyme complex was then removed and 
a solution of ortho-phenylamine diamine (ODP) in acid citrate buffer was then added 
to the wells and the colour change allowed for 3 minutes before the reaction was 
terminated with 100 pL o f 1% sulphuric acid. The wells were then exposed to an 
absorption spectrum of 490 nm to determine the readings ( Dynex MRV, Prior 
Laboratory Supplies Ltd, UK.). This experiment was performed with 4 repeats (n = 4). 
No experiments were performed on polyethylene terephthalate for the reasons 
mentioned above.
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6.2.5. ANTI-FACTOR XA ACTIVITY
Blood collected from healthy, normal volunteers without the use o f tourniquets 
was citrated with 3.8% (w/v) tri-sodium citrate. The samples were then centrifuged at 
250 g for 10 minutes and then re-centrifuged at 13,000 g for 30s using a 
microcentrifuge. This was followed by snap-freezing 250 ml aliquots o f the plasma in 
liquid nitrogen before being stored at -80 °C. Prior to thrombogenicity analysis, these 
aliquots of platelet-poor plasma (PPP) were pre-warmed at 37 °C {Williams, 2004}.
The anti-factor Xa activity o f 2 and 6 % POSS-poly(carbonate-urea)urethane(PCU) 
was studied using a factor X assay kit ( AMAX ACCUCOLOR™ kit, Trinity Biotech, 
USA ) with plain PCU and PTFE (Goretex Ltd., USA) as the controls. The base of 
0.28 cm2 well plates were sealed with solid flat sheets o f POSS-PCU, PCU and PTFE. 
Heparin standards were prepared by diluting heparin in PPP to form decreasing 
concentrations o f 1.0, 0.5, 0.25 and 0.125 IU/mL, constituting the heparin reference 
standard. The heparin solutions and PPP were diluted 1:2 in PBS to be used in the 
control and sample groups respectively. To this, 75 pL o f human anti-thrombin III 
was initially added to each well followed by 25 pL o f the 1:2 heparin solutions, in 
case of the control and PPP, in case o f the sample. This was allowed to incubate for 2 
minutes at 37 °C before adding another 75 pL o f bovine factor Xa and incubating it a 
further one minute in the same setting. Next, 75 pL of factor Xa substrate (MeO-CO- 
D-CHG-Gly-Arg-pNA) was added and re-incubated for 10 minutes at 37 °C.
Activated factor X (FXa) hydrolysed this substrate to release the chromophobe, para- 
nitro anilide (pNA). Thus, the amount o f pNA released is inversely proportional to the 
extent of factor Xa inactivation. The reaction was terminated by the addition o f 75 pL
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of glacial acetic acid. Then 100 jiL o f this mixture was analysed at 420 nm absorption 
band to detect pNA and compared to the blank reagent. The latter was prepared in the 
same manner except that the wells were filled with acetic acid first {Saito, 1997}. The 
anti-factor Xa property o f POSS-PCU was expressed as heparin equivalents per unit 
area (IU per cm ). All experiments were repeated 6 times and in duplicate (n = 6).
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6.2.6. PLATELET ADHESION
The bases o f 24-well polystyrene plates were sealed with flat sheets of the 
polymer and then hydrated in PBS for 24 hours. Next, 1.0 ml o f platelet rich- 
precipitate (PRP) at a concentration o f 1.3 x 106 platelets / pi was added and 
incubated at 37 °C for 30, 60 and 120 minutes in a shaker. The PRP was then removed 
and each container was then rinsed with PBS. The extract was counted immediately in 
a Coulter counter. PRP were also incubated in wells with PCU and PTFE while 
uncoated polystyrene wells were used as controls {Park, 2002}
The number of platelets attached to POSS-PCU was calculated from the difference 
between the number o f platelets in the PRP control and those left in the extract. The 
quantitative analysis o f platelets attaching to POSS-PCU was expressed using 
Salzman’s platelet retention index (PRI) {Salzman EW, 1963} as shown below.
PRI = (PLTi -  PLTef x 100%
PLTi
Where PLTi represents the concentration o f the platelet precipitate prior to adsorption 
and PLTe represents its concentration after adsorption.
Platelet adsorption morphology was analysed using scanning EM (SEM as 
described in chapter 3.
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6.3. RESULTS
6.3.1. POSS NANOCAGE DISTRIBUTION
In this thesis, we preferred to describe TEM analysis in this chapter as opposed to 
chapter 2 (synthesis and characterisation) as we felt that it would better illustrate 
surface behaviour patterns. TEM analyses on casted polymer sheets revealed that the 
darker areas o f the nanocomposite correspond to the hard segment o f the 
nanocomposite whereas the soft segment was optically less dense. EDXA mapping on 
these samples showed three specific regions; yellow silicon and oxygen-rich POSS 
segment(s) immediately surrounded by light purple areas of urethane which together 
constitute the hard segment and a dark purple area corresponding to the carbon-rich 
carbonate soft segment (figure 6.1a). TEM also showed that the silicon-rich POSS 
regions were distributed evenly throughout the hard segments o f the nanocomposite 
while the presence o f yellow speckled dots (silicon) within the amorphous domain 
also suggested POSS incorporation into the soft segment at the nanoscale. These 
POSS groups residing within the hard segment o f PCU extended into the soft segment 
to form nebulous patterns as shown in figure 6.1b indicating an exfoliated type of 
nanocomposite (Giannelis EP, 1999}. This shows that POSS nanocages act as cross­
linkers which form a 3-D net-like internal scaffold within the existing structural 
framework of the polyurethane hard segment, binding together the remaining 
constituents not unlike a ‘wire m esh’.
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Figure 6.1a. EDXA map o f 2%  POSS-PCU showing the distribution of POSS
(yellow) within the hard segment of the polymer (light purple) while 
softer segments correlate to purple areas of carbon. The red line 
represents the copper grid. On closer inspection, speckled yellow dots 
may also be seen within the soft (purple) segments of the polymer 
indicating that POSS molecules also interact with the amorphous 
carbonate segment.
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Figure 6.1b. TEM analysis of a cross-section of 2% POSS-PCU casted sheets
showing the distribution of silicon-rich POSS segments within the darker, 
hard segments of the nanocomposite whilst gradually encroaching the 
soft segments, typical of an exfoliated nanocomposite.
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6.3.2. WATER CONTACT ANGLE MEASUREMENT
2% POSS-PCU had an advanced contact angle o f 81 ± 2 °  and a receded angle of 
36 ± 5° which reveals a large difference between the advanced and receded angles; 
contact angle hysteresis (see figure 6.2) compared to conventional polyurethanes 
which is known to be in the region of 80 ± 1° without significantly large contact angle 
hysteresis. Known causes of a large hysteresis loop include surface roughness, 
microscale chemical heterogeneity and surface fabrication in an aqueous environment. 
All samples were dried and casted in a hot air oven at 70 °C which excludes an 
aqueous environment. TEM studies show chemical heterogeneity then the advanced
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angle is thought to be typical o f the low energy surface component and the receded 
angle typical of the high energy surface component. As such, atomic force 
microscopy (AFM) was performed to determine if  there was a significant topographic 
contribution.
Figure 6.2. The large contact angle hysteresis loop o f 2 % POSS-PCU 
nanocomposites.
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6.3.3. SURFACE TOPOGRAPHY
Surface visualisation of the nanocomposite with SEM at 5000x magnification 
(figure 6.3a) shows an uneven surface ultrastructure at the nanoscale with crystalline 
peaks protruding as obelisk-like structures. Corroborating evidence with AFM in 
contact mode shows that 2% POSS-PCU has three different phases: a crystalline-like
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phase and a two phase “pebble stone” blend. The smooth crystalline phase consists of 
domains that are 5-20 pm in size with a height of 1-6 pm compared to base level 
(figure 6.3b). The crystalline phase consists of well-defined peaks with some existing 
as nanopyramids {Riedel, 2001}. The pebble stone blend can only be observed at 
higher magnifications (figure 6.3c) and consist o f elevated domains that are 200-500 
nm in size and 100-200 nm in height (‘mushroom-like’ domes) {G.J.Fleer, 1993}, 
characteristic of an extended surface configuration (Jonsson, 2004}. The friction 
image shows that the elevations and depressions have different visco-elastic 
properties {Duan, 2002} and therefore can be considered as two separate phases.
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Figure 6.3a. SEM image of the microvessel lumen showing its surface
ultrastructure with the crystalline hard segments projecting out of its 
surface.
Peak
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Figure 6.3b. AFM image of 2% POSS-PCU at 25 x 25 pm resolution showing large 
peaks of up to 8000 nm high within the crystalline segment showing 
increased geometrical definition. The domes (300 to 500 nm high) and 
troughs are suggestive of POSS nanocage interaction with the 
amorphous, soft segment.
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Figure 6.3c. Microphase images of 2% POSS-PCU at the nanoscale revealing its 
extended surface (‘mushroom’ configuration) with 100 nm high 
elevations and corresponding depressions.
e:\p9 2% image 4
Z-range: 2.14 V
□
>
Friction image maps are obtained by the twisting of the cantilever that arises from 
forces on the AFM cantilever parallel to the plane of the sample surface. Further 
images were obtained in intermittent contact mode from transition zones between 
elevations and depressions. In intermittent contact mode the phase image shows the 
relative adhesion between the tip and sample in addition to height information. The 
depressions have lower adhesion compared to the elevations and therefore appear 
darker in figure 6.3d. This figure also shows the presence o f transitional intercalating 
zones between the POSS nanocore and the polyurethane matrix which possesses
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intermediate adhesion characteristics compared to the other domains. This is in 
contrast to the PCU control which shows the diminished presence of a nanopyramid 
crystalline phase and the absence of a two-phase ‘pebble stone’ blend (figure 6.3e).
Figure 6.3d. AFM on the 2% POSS-PCU nanocomposite surface showing the
nanoscale interaction between the POSS-rich dark segments and the 
brighter areas with relatively less POSS content specifically in the 
intermediate ‘zone of intercalation’.
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F igure 6 .3e. Surface topography of control PCU showing the absence of crystalline 
nanopyramids and a two-phase pebble-stone phase.
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6.3.4. SURFACE COMPOSITION
XPS survey spectra from POSS-PCU nanocomposite (figure 6.4) showed that the 
most prominent photoelectron peaks are due to carbon, oxygen and silicon.
Unlabelled peaks are due to carbon KLL Auger electron emission (-1000 eV), oxygen 
KLL Auger electron emission (-720 eV) and Si 2s photoemission (-150 eV). X-ray 
satellite peaks are evident on the low binding energy side of photoelectron (but not 
Auger electron) peaks. Traces of both chlorine and magnesium are also detected. 
Accurately assigning the latter is potentially questionable as its peak is rather weak, 
and may be due to another element, such as the selenium, ruthenium or iodine (the 
binding energy of Se 3d, Ru 4p and I 4d  are very close to that of Mg 2p). However, no 
other peaks typical of these elements were observed and therefore the most likely
z-range: 2.6 V
Vertical deflection
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candidate is magnesium. The elemental concentrations are tabulated along with figure 
6.4 for the two samples, the error in the quantification being in the order o f 1 atomic 
%. Additional narrow scans o f the carbon, silicon and oxygen peaks demonstrated no 
evidence o f chemically shifted environments, which indicates that there are no direct 
bonds between oxygen and carbon. The oxygen is therefore bound predominantly to 
silicon atoms which indicate the significant presence o f closed POSS cages (SigOn).
Figure 6.4. XPS surface analysis at 30° angle o f incidence showing an elemental 
silicon surface composition o f the luminal surface o f POSS-PCU 
microvessels o f 16 %. As the silicon (Si 2p) bonds o f POSS predominantly 
reside on the surface o f POSS-PCU, this indicates that the luminal surfaces 
of the microvessels are POSS - enriched.
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C Is 284.70 60714.7 59.238
O Is 532.70 62058.0 21.245
Si 2p 102.20 14154.5 15.966
Cl 2p 200.70 1048.0 0.433
Mg 2p 52.20 1534.0 3.118
The binding energy o f POSS nanocages [102.5 eV] in this case is similar to a 
polydimethylsiloxane (PDMS) polymer [102.4 eV] as compared to silicon metal [99.6 
eV] and silicon oxide [103.4 eV] {Briggs, 1983}. In order to rule out surface 
contamination by PDMS; a highly surface active contaminant commonly found in 
laboratories in the form for example, o f greases for vacuum joints. Working under the 
assumption that PDMS was a surface contaminant, we attempted to remove it by 
washing with «-hexane. The XP spectra did not change significantly after this 
treatment. The binding energy which resembles PDMS may be explained by the 
cyclohexyl side-groups attached to the primary POSS nanocage.
6.3.5. THROMBOELASTOGRAPHY (TEG)
TEG is a sensitive indicator o f thrombogenicity and we used these as screening 
tests to ascertain the anti-thrombogenic properties of POSS-PCU. We found that the 
polymer had a significantly lower maximum amplitude (MA) value(s) indicative o f 
decreased platelet bonding strength (p < 0.001, One-way ANOVA) as compared to 
control polystyrene and PCU. In addition, it was also found that the clots which 
formed on POSS-PCU were significantly unstable and lysed by 60 minutes compared
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to PCU or the control polystyrene polymer (p < 0.0001, One-way ANOVA). Both 
MA and LY60 results are shown in figure 6.5. These results may be due to either 
decreased fibrin binding strength to the polymer or lower fibrin adsorption to the TEG 
cup or a combination of both. In the following series of experiments, we sought to 
determine the cause of this behaviour. As mentioned earlier, these tests were not 
performed with PTFE and polyethylene terephthalate as it is not possible to evenly 
coat onto the TEG cups as is the case with PCU and POSS-PCU since PTFE and 
Dacron™ are high extrusion-based polymers.
Figure 6.5. Tests showing lower maximum amplitude values and increased clot lysis 
at 60 minutes of 2% POSS-PCU compared to PCU and the polystyrene 
control (n = 6).
<  60- One-way ANOVA (p < 0.001)
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One-way ANOVA (p < 0.0001)
Control
6.3.6. FIBRINOGEN ADSORPTION TESTS
Direct ELISA fibrinogen adsorption analyses (n = 4) to the various polymers 
showed that there was a significantly decreased fibrinogen adsorption to the 
polyurethanes (POSS-PCU and PCU) as compared to PTFE (p < 0.01, One-way 
ANOVA analysis) (figure 6.6). In the case o f POSS-PCU, this may again be attributed 
to the effect of POSS groups on the PCU surface which possess an unstable surface 
free energy and hence reduce both platelet and protein adsorption. Although we found 
no significant difference between POSS-PCU and PCU in terms o f fibrinogen 
adsorption, TEG analyses show that the strength o f the fibrin clot in POSS-PCU is 
much weaker as compared to PCU. This indicated that while the amount o f fibrinogen 
adsorbing to both polymers are similar, the binding strength is weaker in POSS-PCU 
compared to PCU alone. No comparisons were done with polyethylene terephthalate 
for the reasons discussed above.
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Figure 6.6. Fibrinogen adsorption direct ELISA tests on 2% POSS-PCU, PCU and 
PTFE (n = 4).
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6.3.7. ANTI-FACTOR XA ACTIVITY
Factor X (FX) is a crucial element of both the intrinsic and extrinsic coagulation 
pathways. Using the methods described earlier, we first compared the surface anti- 
FXa activity of 2% POSS-PCU to PCU and PTFE. On increasing the concentrations 
of POSS in PCU to 2% and then 6%, we found a proportionate increase in the anti- 
FXa activity of the co-polymer as compared to both PCU and PTFE (figure 6.7) 
which was statistically very significant (One-way ANOVA, p < 0.0001). These 
findings indicate that POSS-PCU nanocomposites inactivate FXa to a greater extent 
than PTFE {Seifalian, 2002} and PCU. It is important to note that PCU also exhibited 
some if not as significant, FXa inactivation. Correlating this with the AFM data 
suggests that increasing the nanoscale surface roughness of the polymer would
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enhance FXa denaturation and inactivation {Riedel, 2001}. Since we are primarily 
interested in graft material for smaller diameter (< 6 mm) and microvessels (< 1mm), 
no tests on polyethylene terephthalate were performed. It must be mentioned that here 
that 2 % POSS-PCU gained precedence over 6 % POSS-PCU as a vascular graft since 
the latter was markedly stiffer during radial compliance studies (chapter 7).
Figure 6.7. Incremental concentrations of POSS within PCU conferring greater anti- 
FXa activity (n = 6).
One-way ANOVA (p < 0.0001)
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6.3.8. PLATELET ADSORPTION TEST
Platelet adsorption onto casted sheets of POSS-PCU was significantly less than 
both PCU and PTFE sheets in vitro after 120 minutes in contact. Statistical analysis 
using two-way ANOVA showed significant difference (Two-way ANOVA, p < 0.05) 
in platelet adsorption by 120 minutes between POSS-PCU, PCU and PTFE as shown 
in figure 6.8. Given that the actual difference between POSS-PCU and the rest is less 
than 10 %, it also has to be noted that POSS-PCU does not significantly minimise 
adsorption quantitatively but the difference is the qualitative decrease in binding 
strength. This deduction is in keeping with both the TEG and ELISA results. These 
results indicate that POSS-PCU significantly repels platelet adsorption with increasing 
time to its surface compared to PTFE and PCU, an effect which would be amplified in 
a pulsative flow circuit or in vivo, where increased shear would wash away weakly- 
bonded platelets. In conjunction with the lower MA values obtained on TEG, this 
suggests that POSS-PCU has an anti-platelet effect by both repelling their surface 
adsorption and lowering the binding strength o f platelets to the polymer which 
correspond to the poor adsorption characteristics exhibited towards fibrinogen 
discussed above.
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Figure 6.8. Platelet retention indices on 2% POSS-PCU, PCU and PTFE at 30, 60 and 
120 minutes (n = 6) showing significant decrease in platelet adsorption to 
2% POSS-PCU compared to PCU and PTFE.
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SEM analysis performed on these samples at 120 minutes to assess platelet 
adsorption morphology revealed very few platelets adhering to POSS-PCU (figure 
6.9b) compared to the uniform, thick layer of platelets deposited on PTFE as shown in 
figure 6.9a. Against the ‘cobblestone’ background of the nanocomposite, it can be 
clearly seen that even the very few platelets which did adhere to the polymer, did so to 
the elevated POSS-poor ‘domes’ seen earlier on AFM. These images supported the 
PRI studies conducted on polymer-platelet adhesion which showed decrease adhesion 
to the nanocomposite.
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Figures 6.9a. SEM images of platelet adsorption on PTFE at 1250x magnification 
reveal uniform platelet adsorption on PTFE (Stage IV) after incubation 
for 120 minutes.
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Figures 6.9b. SEM images of platelet adsorption on 2% POSS-PCU at 640x
magnification showing minimal platelet adsorption at 120 minutes (Stage 
I) on 2 % POSS-PCU.
Figures 6.9c. SEM images of the control POSS-PCU ‘without’ any platelets,
showing the basic undulating morphology of the nanocomposite. Each 
bar code represents 10 pm. Figure 6.3c graphically depicts this 
undulating morphology better.
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Platelet adsorption patterns were then graded based on Cooper’s arbitrary 
classification scheme (table 6.1) {Ko, 1993). According to this scheme, there was 
very minimal platelet adsorption to the POSS-PCU nanocomposite and even those 
platelets that did adsorb, showed stage I patterns; round platelets with no pseudopodia. 
In contrast, platelet adsorption to PTFE was far greater with multiple layers of 
adherent platelets visualised even at lower magnifications. These platelets exhibited 
stage IV adsorption patterns in over 50 % of its surface area. These findings show that 
integrin activation on platelets {Groth, 1995} occurs to a lesser extent in POSS- 
nanocomposites as compared to PTFE. This improved haemocompatibility 
corroborates with previous studies on silicon-containing polymers (Silver, 1999}. 
Platelet adsorption tests on Dacron™ were not performed since they are known to 
possess relatively high platelet adsorption characteristics (Desai, 1991}, even 
significantly higher than PTFE.
Table 6.1. Cooper’s classification scheme for platelet adsorption (Ko, 1993}.
Stage Description
I Rounded platelets with no pseudopodia.
II Dendritic, rounded platelets with early pseudopodia formation.
III Spreading, dendritic platelets.
IV Spreading platelets and their hyaloplasms with prominent pseudopodial 
formation.
V Fully spread platelets over the entire surface.
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6.4. DISCUSSION
In the past, the anti-protein and anti-platelet actions o f silicon {Silver, 1999} have 
been negated by its relative stiffness to native vessels {Desai, 1991}, a contributory 
factor to intimal hyperplasia {Seifalian, 2003 ;Tai, 2000}. Combining it with more 
compliant polymers such as rubber {White, 1987} have been attempted but results 
have been suboptimal. On the other hand, nanoscale POSS {Lichtenhan JD, 1995} 
inclusion as a side-chain group {Nishino, 2004} should preserve the compliance of 
the co-polymer whilst further lowering its surface free energy (SFE), as 
nanocomposites have been shown in the past to have SFEs of less than 20 mJ/m 
{Schmidt, 2001;Schidmt, 1995}. These results are even lower than the SFE values o f 
the fluorinated PTFE molecule, the current biomaterial(s) of choice for small diameter 
{Nishino T, 1999} and microvascular grafts. A further advantage is that as 
experiments on dental materials have shown, unstable SFEs could also lower bacterial 
adhesion thereby creating an anti-bacterial surface action as well {Quirynein M, 
1995;Knorr, 2005}.
The factors which determine particle adsorption to a polymeric interface are (1) 
SFE, (2) surface morphology/configuration and (3) particle size. The SFE so often 
confused with hydrophobicity, {Blunden, 1994} is defined as the amount o f work 
required to increase the surface area o f a substance by 1 cm and is a measure o f its 
surface reactivity. For instance, air has a low SFE while water possesses high SFE 
values {Nagasawa A, 2004}. SFE measurements involve analysing the static and 
dynamic contact angles o f surfaces using a variety o f liquids {Gu GT, 2002}. Monte 
Carlo simulation studies have shown that hydrophobic surfaces are better at repelling
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larger particles and vice versa for hydrophilic ones. These researchers have also 
proved that polymers with extended surface configurations wherein its monomeric 
units overlap one another have lower particle adsorption particularly for larger-sized 
molecules such as proteins {Jonsson, 2004}. With respect to haemocompatibility, the 
primary proteins in question are fibrinogen and the coagulating proteins.
In the past, Feng and co-workers showed that the haemocompatibility of low- 
temperature isotope carbon (LTIC) is greater than conventional silicone polymers as it 
denatures or alters the conformation of adsorbed fibrinogen to a greater extent {Feng, 
1994}. Our contact angle measurements however indicate that unlike earlier silicones, 
these nanocomposites possess large contact angle hysteresis which has been shown to 
affect the conformation o f particles such as fibrinogen adsorbed to its surface 
{Tengvall, 1998}. Subsequent tests showed that fibrinogen also had decreased 
quantitative and qualitative adsorption to POSS-PCU surfaces as exemplified by 
direct ELISA and TEG respectively. While there was no significant difference in 
fibrinogen adsorption between PCU and POSS-PCU, there exist a marked difference 
in clot lysis times (p < 0.01) between the two polymers. This indicated that although 
the number o f adsorbed fibrin molecules is similar in quantity, their binding strength 
to the nanocomposite is much lower, possibly due to a conformational change in 
adsorbed proteins over time. Studies are currently underway to quantify the exact 
conformational change utilising ellipsometry and neutron scattering. This may also 
explain the lower platelet adsorption and maximum amplitude (MA) values to the 
nanocomposite compared to PCU because platelet adsorption requires a stable 
configuration o f fibrinogen formation {Flynes, 1991;Sixma, 1991}.
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Using polyurethaneureas based on 4,4'-diphenylmethane diisocyanate and 
polytetramethylene glycols, Groth and co-workers had reported that platelet and 
protein adsorption increases proportionately with urethane and urea concentrations 
{Groth, 1995} within the hard segments. This study shows that platelet and protein 
adsorption to the POSS-PCU nanocomposite was low in all regions including the 
crystalline segment. This is corroborated by the undulating platelet adsorption 
topography and the evidence o f low-grade platelet adsorption (Cooper grades I and II) 
to the nanocomposite that was observed with SEM. This reversal is attributable to the 
presence of silicon-rich POSS nanocages occupying the hard segment of the 
nanocomposite and concurrently replacing both urethane and urea and so reducing its 
concentration.
While the protein-/platelet-repellent nature o f this nanocomposite is due to its high 
contact angle hysteresis, the cause for the degree o f hysteresis can be attributed to 
either its nanoscale chemical heterogeneity and/or surface topography. TEM and 
EDXA analyses reveal the heterogenous nature of the polymer surface at the 
nanoscale with the POSS-nanocages preferentially residing within the hard segments 
of the nanocomposite with extensions to the soft segment as well. Based on X-ray 
photoelectron spectroscopy (XPS) analyses on silicon-germanium nanocomposites, 
Muller and co-workers believed that nanoscale surface roughness or topography was 
the prime factor responsible for this hysteresis {Muller B, 2001} as compared to 
surface composition. Based on this background, XPS surface analyses o f was 
performed on 2 % and 6 % POSS-PCU wherein there was an increase in elemental 
surface silicon content from 16 % to 18 %. Interestingly, there was no difference in 
contact angle hysteresis between the two nanocomposites, suggesting that surface
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topography due to the POSS-induced surface reorientation was the main determinant 
o f contact angle hysteresis in this case.
Surface topography may be broadly classified into the mushroom-, brush- or 
pancake- profiles {GJ.Fleer, 1993}. The former two varieties have extended 
configurations wherein they rise out o f the surface whereas pancake-type profiles 
have collapsed or flattened surfaces with the highest monomer density within two 
lattice spaces o f the surface. Extended surfaces can extend up to ten lattice spaces (A 
lattice space may be defined as the space bounded by atoms/molecules with identical 
surroundings to one another) from the surface with the self-attractive hydrophobic 
constituents closer to and the hydrophilic constituents further away from the surface 
{Jonsson, 2004}, the degree to which depends on the nature of the contacting surface. 
Monte Carlo simulation studies indicate that polymers with extended configurations 
would repel particle adsorption better than collapsed ones as long as the ratio of 
particle size to polymer layer is 4 or greater {Malmsten, 1998}. This strengthens the 
argument for the inclusion o f nanofillers onto interfaces in contact with large 
molecules such as proteins. The use o f such nanomaterials would increase this ratio 
significantly and so improve protein repulsion and in case o f blood, platelets as well. 
Interestingly, such nano-engineered surfaces would be able to better adsorb very small 
particles such as low-molecular weight heparin whilst repelling the larger coagulant 
proteins, making them ideal at the vascular interface. In this case, the extremely small 
size of silicon in the form of POSS nanocages (1-3 nm) (Xiang K, 1998} would 
further increase the ratio of particle size to polymer layer and thereby accentuate both 
platelet and protein repulsion.
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Tapping mode AFM studies on these POSS-PCU nanocomposites revealed a 
nanoscale extended surface configuration with a ‘mushroom/dome-like’ profile. Its 
surface nanoarchitecture is such that POSS-rich hard segments were found to reside 
closer to the surface as depressions while the more hydrophilic soft segments rise 
from the surface as elevations which is in keeping with existing data on polymers 
possessing both hydrophobic and hydrophilic elements namely be being amphilic in 
nature. The lower adhesion exhibited between the contact probe of the AFM and the 
darker, depressed areas also corresponded to the decreased platelet and protein 
adsorption behaviour on SEM to the depressed areas of the nanocomposite while the 
brighter, elevated regions show relatively higher adhesion characteristics.
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As a significant proportion o f this 2% POSS-PCU nanocomposite surface consist 
of peaks at the microscale and domes at the nanoscale, it would be not be wrong to 
expect increased overall surface protein adsorption. Similar studies on globulin 
{Muller B, 2001} and macrophage {Riedel, 2001} using silicone-germanium 
nanocomposites had shown that although these so-called peaks or ‘nano-pyramids’ 
{Riedel, 2001} exhibited increased protein adsorption, the adsorbed proteins were 
actually inactive as this nanoscale roughness contributes to large contact angle 
hysteresis {Muller B, 2001}. This would also explain why FXa inhibition is present 
although to a lesser extent, in the control polymer (PCU) as it showed microscale 
surface roughness on AFM studies. Interestingly, there is a proportionate increase in 
FXa inhibition on increasing POSS nanocage concentrations as this would increase 
surface nanostructure density and contact angle hysteresis further which would in turn 
accelerate protein denaturation.
While we agree with previous work that this anti-thrombogenic effect is a result o f 
the surface morphology of nanocomposites, AFM experiments on these POSS-PCU 
nanocomposites and the PCU controls also reveal that the addition of nanofillers is 
necessary in creating these nanostructures in the first place. In all, both surface 
composition and morphology are a must in order to elicit this protein-repellent 
activity.
Assays to show irreversible protein adsorption to the polymers were not 
performed as we felt that testing them in a dynamic setting using pulsatile flow was 
more physiological. These tests are currently under way as further investigations on 
these nanomaterials are performed in addition to the surface ellipsometry and neutron
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scattering studies described earlier. In any case, if  all our results thus far hold true in 
vivo, thrombus formed on POSS-PCU grafts would be unstable and weak with lower 
propensity for thrombus propagation and vessel occlusion. Animal studies using the 
rabbit central ear artery microvascular model are also being performed to establish 
this fact.
This represents the first reported literature o f the anti-thrombogenic effect of 
POSS-PCU nanocomposites. This group o f polymers are only now being 
commercialised in industry, principally within aerospace-based applications and has 
thus far, few if any practical biomedical applications as of yet. It not only possesses 
the anti-platelet and anti-protein effects o f existing siloxane co-polymers but in 
addition behaves as a surface anticoagulant as well. POSS-incorporated macro- and 
micro-vascular interfaces could remove the necessity to heparinise devices like the 
heart -lung machines and artificial capillary beds. This approach could also provide a 
simpler chemical alternative compared to current methods o f improving small 
diameter and microvascular graft patency. There even is the possibility of tagging 
molecules such as nitric oxide (NO) {Duan, 2002} as side-chains directly to the POSS 
nanostructure to enhance its haemocompatibility even further. These findings could 
open entire vistas of use for silicon nanocomposites in medicine particularly as 
thromboresistant macro- and micro-vascular interfaces in vivo.
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Encouraged by our results, we fabricated 2% POSS-PCU as microvessels for use 
as interpositional microvascular grafts and the building blocks o f an artificial capillary 
bed {Kannan, 2005}. As far as vessel fabrication is concerned, the ability o f POSS to 
self-assemble predominantly on the surface would mean that the bulk of the polymer 
would consist o f polyurethane molecules cross-linked by POSS nanocages which 
preserves radial compliance and should hypothetically enhance its resistance to 
degradation {Salacinski, 2002b}. This is could be a further advantage of POSS-PCU 
nanocomposites. From the manufacturing point of view, polyurethanes being low- 
extrusion polymers remain as stable liquids with the ability of either dip-coating or 
extruding them into prostheses. These are still early days to comment on the clinical 
success of these nanomaterials but for certain, the future is very bright.
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Chapter 7
7. Smart biomimetic nanocomposite microvessels: Building 
blocks of an artificial capillary bed.
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7.1. INTRODUCTION
Vein grafts are the current microvascular graft o f choice but as a component o f a 
microvascular network, it is limited by donor-site morbidity and the technical 
impossibility o f dissecting it out as a microvascular network {Bourassa, 1994}. While 
current prosthetic materials are not suitable, we believe that the answer lies with a 
new generation o f nanocomposites incorporating silicon in the form of POSS 
molecules.
POSS molecules may be incorporated as building blocks {Sanchez C, 2001} into 
other polymers to form hybrid inorganic-organic co-polymers with improved 
miscibility and hence elasticity {Haddad TS, 1999}, an effect demonstrated by 
previous studies {Lee YJ, 2004}. Optimal POSS dispersion within the polymer {Ribot 
F, 1999} imparts greater mechanical strength to the co-polymer by virtue of its 
surface coverage {Hays JN, 2000} and mobility {Sanchez Munoz, 2003}.
Based on the previous chapters, we have found that this translates into resistance 
to degradation, improved biocompatibility, and anti-thrombogenicity. In this final 
chapter, we combine all the attributes o f this nanocomposite in order to identify the 
optimal design for microvascular prostheses. This microvessel would (a) serve as a 
substitute for small arteries (Zdrahala RJ, 1996) and (b) allow for diffusion-limited 
exchange when placed into a microvascular network. This chapter emphasises 
primarily on the bulk properties of the microvessel namely, permeability and radial 
compliance.
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7.2. METHODS AND MATERIALS
7.2.1. POLYMER SYNTHESIS
Please refer to chapter 2.
7.2.2. FABRICATION
Polyurethanes are low extrusion polymers with the ability to remain stable in the 
liquid state for prolonged periods. While extruding these polymers have proved 
successful in vessels o f above 3 mm in internal diameter, dip-coating remains the 
primary method of fabricating microvessels (< 1mm) {Chen, 1999}. This technique 
depends upon the homogeneity, viscosity and concentration o f the coating polymer as 
well as the type o f mandrel used {Arcaute K, 2003}. When using this method, 
achieving a uniform coating on the mandrel depends upon consistent polymer flow 
patterns on the mandrel.
Previous studies have proven that polyurethanes may be made porous by placing 
them in non-solvent solution like water which leach into it and create pores as shown 
in figure 7.1a. The objective o f this study was to determine the ideal method of 
fabricating microvessels with similar compliance characteristics to native small 
arteries using a combination o f dip-coating and coagulation. By varying the 
concentration of POSS-PCU mixtures, the ideal viscosity and homogeneity for dip- 
coating with the polymer was ascertained in the first phase o f fabrication as well as
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the technique of dip-coating. In the second phase, the polymer-coated mandrels were 
coagulated in a variety of solutions to achieve ideal compliance and porosity 
characteristics.
Figure 7.1a. The principle of solvent and non-solvent/weak solvent exchange during 
the coagulation of POSS- PCU nanocomposite in dimethylformamide 
(DMF) to form porous, viscoelastic microvessels.
POSS-PCU
0.8mm mandrel
+  DMAC
Coagulant
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Figure 7.1b. The mechanised device used to dip-coat POSS-PCU microvessels at the 
rate of 10 mm/s (B).
7.2.2.1. Dip coating
When a mandrel is dip-coated into a viscous polymer solution, the thickness of its 
coating (e) depends on the equilibrium between its viscosity and capillary retention 
forces occurring at its meniscus. In Landau’s Law, this value is symbolised by the 
term ‘capillary number (NCa)’ which is the ratio of the liquid viscosity (rj) and dipping 
velocity (u) to the surface tension o f the liquid ( y). Using an extension of this law for 
higher velocity dipping of cylindrical conformations (equation 1), the Nca of the 
varying polymer concentrations used to dip-coat was indirectly derived to assess the 
ideal setting for dip-coating POSS-PCU microvessels {Rebouillat S, 2000}. In this 
case, higher dipping velocities referred to the dipping velocities being greater than
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polymer flow subject to gravity.
e/(e + R) = 1.32 (iiu/-/)2'3 = 1.32 ( A ) , / 3 Equation 7.1 {Rebouillat S, 2000} 
where R is the radius o f the mandrel.
In order to determine the optimal solute concentration of POSS-PCU to dip-coat 
these microvessels, a 23 % (w/v) working nanocomposite solution of POSS-PCU was 
diluted in DM AC to form 17, 14, 11 and 6 % (w/v) solutions o f POSS-PCU. These 
mixtures were then stirred to form homogenous solutions and left to stand in air-tight 
containers for 3 months at room temperature. 800 pm diameter stainless steel 
mandrels (Venflon BD Ltd., UK) were then dip-coated vertically into varying 
polymer concentrations at a rate o f lcm/s using the mechanised device as shown in 
figure 7.1b. The mandrels were then left to stand for a further 5 minutes to allow 
excess polymer to flow away. They were then coagulated in distilled water (DW) at 
50 °C for 24 hours {Chen, 1999} before being dried in an oven at 70 °C for 48 hours. 
The completeness and uniformity o f these microvessels were then studied on gross 
morphologic examination and later, scanning electron microscopy (SEM).
In a parallel experiment, the 800 pm cylindrical stainless steel mandrels were dip- 
coated with a standard solution o f 11.5 % (w/v) POSS-PCU solutions using either the 
single- or double-dipping technique and pre-coating the mandrels with either the non­
solvent dimethyl formamide (DMF) or oil. This was to ascertain the ideal technique of 
mandrel preparation necessary to fabricate these micro vessels.
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7.2.2.2. Coagulation
Once a thin layer of POSS-PCU was deposited onto the mandrels, it was placed in 
different non-solvent or slow solvent solutions at 25 °C for 24 hours to form grafts of 
varying porosities. The coagulants used were 100 % distilled water (DW), 10 to 50 % 
(w/w) DMF-water mixtures, 10 to 90 % (w/w) ethanol-water mixtures and 2.5 to 10 
% (w/w) sodium bicarbonate (NaHCCh). Following immersion in these solutions, the 
mandrels were left to dry for 7 days in an incubator at 37 °C before being peeled off as 
a whole to form complete single-lumen, porous microvascular prostheses.
7.2.2.3. Quality control
Using a scanning electron microscope system (Philips SEM Model 501, 
Netherlands) the surface and cross-sections o f all the fabricated 800pm diameter 2 % 
POSS-PCU micro vessels were analysed in order to determine their vessel wall 
thicknesses, external diameters, internal diameters, mean pore sizes, pore size 
distributions and pore morphologies. The wall thickness o f these microvessels were 
taken at four perpendicular points on four different microvessels fabricated in the 
same way (n = 4). The mean wall thickness with its standard deviation was calculated 
for each corresponding method o f graft fabrication. Only microvascular grafts 
consistently fabricated with uniform diameters throughout its length and relatively 
smooth inner lumen without bulk cavities {Chen, 1999} were selected for further 
testing.
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7.2.3. VESSEL WALL ANALYSIS
7.2.3.1. Hydraulic conductivity (K)
The hydraulic conductivity o f optimal, quality-controlled, unused fabricated 800 
pm POSS-PCU microvessels was determined by connecting them to a permeameter; a 
closed circuit consisting o f a vertical pressure column of distilled water (DW) at 37 °C. 
The microvessels were clamped at one end and placed at the bottom the water column. 
By adjusting the height o f the water column, the pressures within the system were 
regulated with the help o f an intraluminal Millar Mikro-tip pressure transducer. The 
microvascular grafts were then exposed to these pressures and the seepage of DW at 
the mean physiological pressures of 70 mmHg and 100 mmHg through the walls of 
the micro vessels (n = 6) {Miyamoto, 1999} were measured over one minute. The 
mean hydraulic conductivity and standard deviations were calculated based on 
Darcy’s Law {Baish, 1997} shown below. All values were expressed as cm/s/cmH20.
Q = -K.A.(Ah / t) Equation 7.2
Where ‘Q ’ represents the quantity of water seepage in mL, ‘K ’ is the hydraulic 
conductivity, ‘A ’ is the surface area exposed in cm , ‘Ah’ is the height o f the water 
column in cms and ‘t ’ is the microvessel wall thickness in cm.
7.2.3.2. Radial compliance
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Radial compliance o f these microvessels was determined using a flow circuit 
consisting of a fluid reservoir, a temperature regulator, flexible medical-grade tubings, 
an electromagnetic pump, an arterial flow waveform conditioner, a Transonic medical 
flowmeter system (HT207; Transonic Medical System, Ithaca, NY, USA) and a 
Millar Mikro-tip catheter transducer (Millar Instruments, Houston, Texas, USA) via a 
Y-connection port (Salacinski, 2002a} to measure the intraluminal pressures in 
mmHg. 40 mm long segments o f 800 pm internal diameter POSS-PCU microvessels 
were then longitudinally stretched by 10 %, so as to mimic conformational changes 
expected within an in vivo system, before being connected to the flow circuit using 
commercially available 21G intravenous cannulae (Venflon BD Ltd, UK) and placed 
in a water bath. The flow circuit was then filled with clinical-grade native citrated 
blood (0.40 haematocrit) at 37 °C maintained using a heat exchanger (Portex, Hythe, 
UK) taking care to evacuate any air within the system which could cause damping. On 
initiating pulsatile flow at a frequency of 1 Hz, physiological mean pressures o f 30 to 
70 mmHg were achieved whilst maintaining the pulse pressure at 39.633 (± 3.952) 
mmHg throughout the tests. Both anterior and posterior microvessel wall motion with 
each pulse was assessed using a 7.5 MHz linear array Duplex probe and an echo- 
locked wall tracking system (Walltrack; Pie Medical Systems). The data was then 
interpreted using analogue-to-digital data acquisition recording system (ADC/Maclab; 
AD Instruments, Hastings, UK).
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As the control, freshly harvested arteries (aorta and femoral artery) and veins 
(inferior vena cava and femoral vein) from cadaveric rats were used in comparison to 
these POSS-PCU micro vessels. These grafts were obtained in accordance with 
animal research guidelines. All experiments were repeated 6 times for each pressure 
range using different sets o f microvessels (n = 6). Unlike our previous experiments 
with the MyoLink® vascular grafts (Salacinski, 2002a;Tai, 2000}, we found no need 
to pre-clot these POSS-PCU microvessels as there was no significant leakage o f blood 
through their walls. This may be explained by the microporous nature of the 
microvessel walls. The radial compliance {Tai, 2000} of the microvessel walls were 
calculated using the formula,
Radial compliance = (Ds -  DT) x 104 Equation 7.3
(Ps -P d). Dd
Where Ds refers to the systolic diameter, Dd is the diastolic diameter and (Ps -  Pd) 
represent the pulse pressure within the pulsatile flow circuit.
7.2.3.3. Burst strength
Using unused quality-controlled 800 pm diameter POSS-PCU microvessels 
fabricated in the same manner as those used in the water permeability experiment, the 
microvessels were clamped at one end and connected to a pressure system. The graft 
was subjected to increasing pressures o f up to 300 mmHg using a syringe driver 
connected to a DW column to determine whether excessively high blood pressure 
within physiological limits would cause rupture o f these nanocomposite microvessels.
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All experiments were repeated 6 times using different microvessels (n = 6).
7.3. RESULTS
7.3.1. MICROVESSEL FABRICATION
The uniform thickness o f a fabricated microvessel affects its radial compliance 
and hydraulic conductivity which in turn affects flow-limited nutrient exchange 
{Levick, 2000}. The factors affecting microvessel wall thickness during any dip- 
coating process are as follows,
i) Polymer dispersion
ii) Polymer viscosity
iii) Dipping technique
iv) Mandrel preparation
v) Coagulating solution
vi) Molecular weight (Mw) o f polymer
As only one type o f polymer; 2% POSS-PCU nanocomposites were used for all 
fabricating purposes, the effect o f molecular weight (Mw) in this case is redundant.
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7.3.1.1. Polymer dispersion
On leaving to stand at room temperature in a sealed container for 90 days, POSS- 
PCU nanocomposite solutions at 23 % (w/v) in dimethyl acetamide (DMAC) 
remained stable and exhibited no evidence of clumping, degradation, change in flow 
characteristics or colour change. This held true for all its dilutions in DMAC; 17, 14,
11 and 6 % (w/v).
7.3.1.2. Polymer viscosity
Effect of the concentration o f polymer POSS-PCU used to dip-coat was assessed 
by diluting the working 23 % (w/v) solution o f the polymer in DMAC to form 17, 14 
and 11 % POSS-PCU in DMAC solutions. As shown in figure 7.2, vessel wall 
thickness, assessed by SEM at 640 x, decreased significantly once the polymer was 
diluted to a 17 % solution but with a great degree o f variation. On further diluting the 
polymer, the vessel wall formed was o f more predictable thickness and uniformity 
with lesser degrees o f variation. Using a version o f Landau’s Law meant for high 
speed dipping of cylindrical mandrels, the capillary number (Nca) o f the polymer was 
derived for these varying solutions. It was found that the ideal Nca for dip-coating 
POSS-PCU was between 0.0136 and 0.0146. At concentrations below this, we found 
that the polymer did not sufficiently coat the mandrel to form complete vessels as its 
intrafacial surface tension was greater than its interfacial tension.
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Figure 7.2. Effect of dip-coating POSS-PCU concentration (% w/v) on vessel wall 
thickness showing that when the capillary number (Nca) (derived from 
Landau’s Law) is between 0.0136 to 0.0146, a mean microvessel wall 
thickness of 32 to 34 pm with the least standard deviation can be 
consistently obtained (n = 16).
250
150
100 (n = 16)
% (w/v) POSS-PCU
POSS-PCU
concentration 11 % 14% 17% 23 %
Capillary No. 
(Landau’s Law) 0.013655 0.01464 0.01662 0.1156
222
7.3.1.3. Dipping technique
We compared single and double dip-coating of these grafts using a standard 
concentration o f the polymer and at a dipping velocity o f 1 cm/s in all cases. SEM 
studies showed that double dip-coating these grafts resulted in excessively thickened 
and non-uniform walls with poor coagulation particularly towards its inner lumina. As 
the compliance improves with the formation of a porous graft, double dip-coating 
would affect graft compliance. Hence in all subsequent cases, single dip-coating was 
the preferred method.
7.3.1.4. Mandrel preparation
Using standard stainless steel 800 pm mandrels manufactured industrially, we 
assessed whether pre-coating these mandrels with hydrophilic and hydrophobic 
liquids such as DW and oil respectively would affect the polymer deposition on the 
mandrel with non- precoated mandrels as controls. SEM analyses o f these grafts 
showed that pre-coating these mandrels increased the non-uniformity o f its walls 
compared to the control group. This may be attributed to rapid surface coagulation o f 
the uneven pre-coated mandrel on contact with the polymer thus creating a glabrous 
template for further coagulation. The uneven surface pre-coating was caused by the 
fact that the pre-coating solution was not sufficiently viscous to evenly coat the 
mandrel. Therefore, we found no need to pre-coat these mandrels prior to dip-coating.
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7.3.1.5. Coagulating solution
When the nanocomposite solution was placed in a weak coagulating solvent such 
as DMF or ethanol, DMAC which is the diluent in this case, seeped out into the 
solution in exchange for this weak solvent thus creating a porous structure. The 
solubility o f the coagulating solution was directly proportional to the rate and 
magnitude o f pore formation and hence wall thickness. SEM analysis o f POSS-PCU 
coagulated by different solvents revealed that ethanol/DW mixtures from 10 to 50 % 
(v/v) as well as DMF/DW mixtures greater than 20 % (v/v) did not form complete, 
porous and uniform microvessels. Porous POSS-PCU grafts were formed only with 
those coagulated with DW, NaHC0 3  or lower concentrations o f DMF. Thus greater 
the solubility, the more rapid coagulation occurs, thereby improving graft porosity. As 
this was a relatively rapid process compared to coagulation at higher DMF 
concentrations, it prevented increased ‘creep’ o f the polymer and the formation o f lop­
sided, non-uniform vessel walls as shown in figure 7.3 whereby wall thickness 
variance was greater with slower coagulation.
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Figure 7.3. The effect o f coagulating solvent (DMF) solubility on the wall thickness 
and radial uniformity o f POSS-PCU microvessels. Bartlett’s test for equal 
variances indicated a significant variation (p < 0.001) in microvessel wall 
thickness with decreasing coagulant solubility while microvessel wall 
thickness was significantly lower (One-way ANOVA, p < 0.0001) when 
coagulated with weaker solvents.
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O f all the dip-coated grafts, only coagulation in DW, 10 %DMF and NaHC 0 3  
formed complete, porous microvessels. SEM analyses o f these surfaces showed the 
effect o f differing coagulating solutions on luminal architecture. DMF-coagulated 
vessels exhibited pore sizes between 8 to 40 pm with interpore distances. These pores 
were non-uniform, irregular with large bulk cavities (figure 7.4a). Unlike 
microcomposites such as conventional polyurethanes {Chen, 1999}, acidic coagulants 
such as DMF induced varying capillary pressures within the nanocomposites, which
225
contribute to the ‘wrinkled’ surface appearance when coagulated with acidic salts 
{Harrup M, 2002}. Such a surface would cause turbulent flow and would be unsuited 
as vascular grafts.
DW is a rapid coagulator o f the polyurethane component o f the polymer. Once 
dip-coated in DW, pore formation in exchange for DW occurs within minutes. As 
mentioned above, this prevents excessive polymer creep (sagging) and forms a porous 
sponge-like material. Pore formation was found to be more uniform compared to 
DMF with regular interpore distances, pore sizes and shapes. However, as shown in 
figure 7.4b, excessive coagulation in certain areas leads to the formation o f bulk 
cavities on the lumen {Chen, 1999}. In clinical practice, such graft lumina would 
again increase turbulence as in the case o f DMF and be more thrombogenic. This 
should be avoided as far as possible.
Coagulating the POSS-PCU dipped microvessels in 5 % NaHC 0 3  solutions at 50 
°C were found to create uniform micropores between 0.5 and 2 pm with regular 
interpore distances as shown in figure 7.4c. In addition, there was no evidence o f bulk 
cavity formation {Li, 2001}, unlike DW coagulation, on SEM with 5 % NaHC 0 3 - 
coagulated POSS-PCU. This is due to the more controlled release o f DMAC into the 5 
% NaHC0 3  solution to form a microporous graft with greater pore inter-connectivity. 
For the second part o f this experiment, we utilised only POSS-PCU microvessels 
which were fabricated by single dip-coating followed by coagulation in 5% NaHC 0 3  
as only these microvessels had passed our stringent quality control criteria; (a) 
uniform wall thickness, (b) uniform pore formation and (c) smooth inner lumina 
devoid o f bulk cavities to minimise turbulence.
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Figure 7.4a. SEM images of the luminal architecture of 14 % (w/v) solution of
POSS-PCU coagulated in 10 % DMF
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Figure 7.4b. SEM images o f the luminal architecture of 14 % (w/v) solution of
POSS-PCU coagulated in DW
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Figure 7.4c. SEM images o f the luminal architecture of 14 % (w/v) solution of POSS-
PCU coagulated in 5% NaHC03 solution.
7.3.2. MICROVESSEL WALL
7.3.2.1. Hydraulic conductivity
The hydraulic conductivity of these 800 pm diameter POSS-PCU microvessels 
was measured using a water-column permeameter at mean pressures of 70 and 100 
mmHg respectively. At 70 mm Hg, their mean hydraulic conductivity was found to be 
9.0 (± 1.789) x 10'7 cm/s/cmH20 while at the higher pressure of 100 mmHg, the 
measured values were 8.833 (± 1.602) x 10'7 cm/s/cmH20. The absence of any 
significant difference between these two values suggests that hydraulic permeability
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o f these microvessels were independent o f wall shear stresses, similar to arterioles 
{Williams, 1999}. Furthermore, these results mirror the in vivo hydraulic permeability 
o f biological capillary beds which are in the region o f 2.4 to 9.8 x 10'7 cm/s/cmFhO 
{Neal, 2002;Pocock, 2001}.
7.3.2.2. Radial compliance
We found that 0.8 mm diameter POSS-PCU microvessels coagulated with 5% 
NaHCO} aqueous solution exhibited very similar compliance characteristics at 
varying pressures o f 30 to 70 mmHg (pulse pressure o f 40 mmHg) to rat arteries 
(internal diameter 1mm). The overall mean compliance values o f the synthetic 
microvessels was 4.478 (± 0.09095) % per mmHg x 10'2 as compared to 4.605 (±
1.166) % per mmHg x 10' , which were very similar. In stark contrast, rat veins 
exhibited very low compliance values with no evidence o f increasing radial 
compliance with increasing pressures. The pulsatile waveform obtained throughout 
the physiological pressure ranges (figure 7.5a) was also found to be very similar to rat 
arteries indicating similar visco-elastic properties between the two.
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Figure 7.5a A typical pulse waveforms distension of POSS-PCU microvessels at low- 
pressure, low-flow states (30 mmHg)
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On further analysing the data, the compliance curves of these synthetic POSS- 
PCU microvessels mirrored the pressure-responsive (anisotropic) patterns {Tai, 2000} 
of rat arteries with high values at lower pressure and gradually reaching a plateau at 
mean pressures in excess of 50 mmHg. Two-way ANOVA analysis showed that there 
was no statistical difference between the 5% NaHC0 3 -coagulated POSS-PCU 
microvessels and the rat arteries although on extrapolation o f the curve towards even 
lower pressures, the difference between the biological and synthetic microvessels 
would eventually have become significant. Unlike the non-pressure responsive 
(isotropic) compliance characteristics of MyoLink® grafts, the more uniform and 
homogenous pore sizes and structure within these nanocomposites {Wang RZ, 2001} 
do not follow the linear correlation associated with Hooke’s Law, a characteristic 
which may be explained by this porous system behaving like a ‘net’. This would
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further decrease the likelihood o f intimal hyperplasia, particularly at low-flow states 
as these ‘smart’ microvessels virtually mirror the pressure-responsive radial 
compliance characteristics o f biological microvessels (figure 7.5b).
Figure 7.5b Mimicking the micro arterial pressure-responsive compliance curve 
using synthetic POSS-PCU microvessels.
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The curve equations for both synthetic and biological microvessels are given below, 
POSS-PCU microvessels; y = 228e(-°,26x) + 2.56 
Rat artery; y = 485e(‘° 131x) + 4.3 
Rat vein; y = 6.321e('0 052x) + 0.093
We postulate that the reason for the anisotropic compliance characteristics o f the 
POSS-PCU microvessels is due to the deformation of the POSS nanofillers within the
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polyurethane matrix. As the ‘S i’-containing materials such as polydimethylsiloxane 
(PDMS) and POSS have a lower glass transition temperature (Tg) than polyurethanes , 
the difference in visco-elasticity at 37 °C contributes to bi-axial deformation o f the 
POSS nanofillers into an ellipsoid {Mark JE, 2003;Mark JE, 2003}. Superadded by 
the fact, that the Si-O bonds are very flexible and able to bend from 110° to 180° 
{Mark JE, 2004}, ellipsoid deformation o f POSS nanofillers occurs and hence, the 
similarity o f its compliance trends to elastin-rich arteries.
7.3.3.3. Burst strength
We found that the 35 pm thick vessel walls o f POSS-PCU microvessels treated 
with 5% NaHCO .3 and DW could withstand pressures o f up to 200 mmHg while the 
more porous 10% DMF-coagulated grafts burst at 60 mmHg. The lower vessel wall 
strengths o f the DMF-coagulated vessels are due to its large and non-uniform pores 
acting as stress-points along the vessel wall resulting in rupture in these areas. On the 
other hand, DW and NaHC 0 3  coagulation ensure more uniform pore formation and 
hence greater wall strength. In addition, these microvessels have increased radial 
compliance and hence ability to accommodate rising pressures.
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7.4. DISCUSSION
Studies have shown that porosity is inversely proportional to the molecular weight 
o f the polymer {Wan ACA, 2001}. This would mean that POSS-PCU grafts have 
lesser porosity than M yoLink® grafts and hence radial compliance for the same wall 
thickness. Therefore in order to preserve radial compliance, POSS-PCU grafts have to 
be thinner-walled but not excessively permeable. Achieving this depends on the 
amount and method o f polymer deposition on the mandrel as well as the method o f 
coagulation to form a porous microvessel.
Once the POSS-PCU coated mandrels were immersed in a coagulating medium 
such as water, it underwent demixing and gelation. Demixing refers to the separation 
o f the domains within the polymer while gelation fixes these domains in their 
separated phases thus creating a porous system {Wijmans JG, 1983}. The pore 
morphology o f the graft depends on the type o f coagulant and its solubility. As 
mentioned earlier the slower the exchange o f the diluent (DMAC) for the coagulant 
molecule, the less porous the microvessel would be. This was exemplified in the 
experiment with varying concentrations o f DMF. Furthermore when coagulation was 
more controlled following base-catalysis with NaHCCh solutions, optimal pore 
characteristics with the absence o f bulk cavities were obtained compared to DW 
(rapid coagulator); a result supported by existing data on nanocomposites.
In nanocomposites, pore formation is accentuated as a result o f the increase in the 
quantity o f dynamic voids due to thermally-induced polymer chain rearrangement 
{Pope EJA, 1986}. Nitrogen sorption studies on metallic silsesquioxanes have also
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shown via the Hovarth-Kawazoe equation that nanocomposites can possess very high 
pore volumes o f up to 0.22 ml/g and yet have tiny pores o f 6 A {Maxim N, 2001}. 
Therefore although its pore sizes may be small, permeability would still be maintained, 
compared to a larger-pored material. This would explain the reason for the significant 
water permeability (table 7.1) in these POSS-PCU structures. Although their pore 
sizes were less than 1.6 pm  in diameter, the presence of a nanoporous network in 
these polymers would allow fluids to traverse through it. Interestingly, water 
permeability o f DMF-coagulated POSS-PCU grafts was lesser in spite o f them having 
greater pore sizes o f up to 24 pm further emphasising the importance o f pore 
interconnectivity. We thus fabricated microvessels with very thin walls (30 to 40 pm) 
using a weakly basic coagulant solution o f 5 % NaHC 0 3  in order to optimise its 
porosity and compliance in order to simulate nature.
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Table 7.1. The effect o f coagulating solutions on the pore morphology o f POSS-PCU 
microvessels was studied using neutral (DW), basic (5% NaHC 0 3 ) and 
acidic (DMF) solutions respectively. Our data shows that coagulating in 
basic 5% NaHC 0 3  solutions during fabrication allows for arteriolar-like 
hydraulic permeability within the POSS-PCU microvessels with the most 
uniformly distributed pores.
Coagulating solvent Pore sizes Water
permeability
Luminal pore morphology
POSS-PCU in DW 0.4 -  2.0 
pm
1.494 +/-
0.5828
ml/min/cm2
Random micropore formation. Bulk 
cavities o f up to 60 pm present. 
Rugged and glabrous luminal surface.
POSS-PCU in 5% 
N aH C 03
0.4 -  1.6 
pm
2.645 +/-
0.8436
ml/min/cm2
Even, uniform micropore distribution 
with no bulk cavities.
POSS-PCU in 10% 
DMF
8 - 4 0  pm Nil Variable larger pores with no evidence 
o f bulk cavities.
Hydraulic conductivity (HC) o f a porous medium, the microvascular graft wall in 
this case, is the measure o f water efflux through its pores per unit time and pressure. 
Studies have shown that the capillary filtration coefficient (CFC) in a capillary bed 
depends on the HC of its constituent microvessels and independent o f its vascular tone 
and number {Bentzer, 2001}. Bates and colleagues found that the mean microvascular
n
HC in single perfused frog mesenteric microvessels was 2.4 to 2.6 x 10' cm /s /cm ^ O  
{Neal, 2002}. These values increased significantly with the action o f vascular 
endothelial growth factor (VEGF) up to 9 x 10"7 cm/s/cnrd-UO {Pocock, 2001}. A 
more in-depth analysis o f the HC o f frog mesenteric microvessels by Williams 
showed that there was no significant difference in HC between the venular and
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arteriolar component o f the capillary bed at very low-flow states. However, when 
these microvessels were exposed to higher pressures o f up to 30 cm H2O, there was an 
exponential increase in the HC o f venules compared to the arterioles with maximal 
values o f up to 96.8 x 10'7 cm/s/cmH20 in the former. It was hence deduced that 
venular HC is proportional to wall shear stress while arteriolar HC is virtually 
independent {Williams, 1999}.
Based on Darcy’s Law, the HCs o f these POSS-PCU microvessels which were 
measured based on the principles o f a permeameter, were found to be similar to 
existing HC data on biological microvessels. In addition, their HC values were 
independent o f mean pressure and wall shear stress, similar to arteriolar HC and 
unlike the post-capillary venules. Given that the summative HC of a microvascular 
network depends on the HCs o f its component microvessels, these nanocomposite 
microvessels are ideal as the building blocks o f a microvascular network.
We postulate that as the pore sizes in these polymers are miniscule, nutrient 
exchange is diffusion-limited and not flow-limited which should permit oxygen 
diffusion and glucose mass transport across this man-made vascular interface. These 
experiments were performed at higher pressures o f 70 and 100 mmHg as in an 
artificial tissue flap, these microvessels would need to be anastomosed directly to a 
high pressure arterial system and should function physiologically in such high-flow  
environments. The high pressures o f above 200 mmHg required to rupture these 
microvascular grafts also support its feasibility to be used within a high pressure 
arterial system. Further tests will now be carried out to assess whether these 
micro vessels obey Krogh’s diffusion model as well {Piiper, 1986}.
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In terms o f radial compliance, MyoLinkCR) (PC 1 ) crafts exhibit isotropic radial 
compliance characteristics independent o f the pressure applied fTai, 2000} whereas 
with the addition o f a nanofiller to PCU, improved dynamic compliance is conferred. 
This is a result o f the formation o f uniform pore sizes which are well interconnected 
and spaced leading to the formation o f a three-dimensional scaffold which behaves 
like a fcgart:er stocking’. This is augmented by the ability o f POSS nanocages to 
conform to an ellipsoid configuration {Mark, 2004} at the molecular level. These 
factors thus allow the POSS-PCU microvessels to function similarly to the elastin 
network of biological arteries {Burton AC, 1954} and in this experiment, rat arteries. 
Just as in biological microvessels, these synthetic microvessels exhibited anisotropic 
compliance {Roach MR, 1957;CaroCG, 1978} with its value progressively 
decreasing with increase in mean pressures. However, rat veins had dismal radial 
compliance values possibly due to the very low amounts o f elastin within these 
biological microvessels. Parallel studies involving DMF coagulation with the same 
nanocomposite showed poor compliance values with no consistent pattern over the 
ranges tested. This underlines the importance o f both material and fabrication in 
determining the overall behaviour o f vascular grafts {Li, 2001}. In the long-term, 
such microvcssels would also prevent the formation o f intimal hyperplasia.
From a surgeon’s perspective, there is no need o f pre-clotting ; Salacinski, 2002a; 
Tai, 2000} these microvessels to form a fibrin mesh or potentially heparinising them 
which makes it very convenient as it is virtually ready for use as an off-the-shelf 
prosthesis. Moreover, such fibrin clots within an already very small lumen would 
almost occlude it and precipitate thrombosis. This is due to the fact that the pore size
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of these microvessels (< 1.6 pm) is much smaller than the average diameter of a red 
blood cell (RBC). Its nanoporous nature should also exclude vessel wall scarring by 
connective tissue invasion |Uchida, 1989} as well as reduce vessel wall tethering, 
thus preserving its radial compliance in vivo, provided they do not degrade.
Our results in chapter 3 on in vitro degradation o f this POSS-PCU nanocomposite 
indicates greater resistance to degradation compared to PCU alone. Nevertheless, 
these are facts which can only be proved conclusively in a microvascular animal 
model to study degradation, biocompatibility and compliance characteristics. The 
effect o f vascular tone and its regulation within the microcirculation will also need to 
be elicited. These nanocomposite microvessels have since been implanted into an in 
vivo model to elicit its patency rate.
The goal of any researcher fabricating an artificial vascular graft is to mimic 
nature’s vessels. While the surface should prevent thrombus formation 
(thromboresistance), the bulk o f the graft must provide strength (burst strength) to the 
conduit and allow the continued propagation o f a pulse waveform (compliance) 
throughout the vessel. To this end, these nanocomposite grafts address the 
fundamental problems limiting contemporary grafts by providing a thrombus- 
repelling surface (chapter 6) and a biomimetic bulk, simulating arterial pulsations. In 
addition, from the tissue engineering perspective, they would serve well as 
components o f a microvascular network due to its permeability characteristics.
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Chapter 8
8. Summary & Future Prospects
The reconstructive ladder in reconstructive surgery has always been the rubicon 
by which surgeons have adhered to. At the pinnacle o f that hierarchy is free tissue 
transfer, a successful method o f achieving soft-tissue cover. However, it has attendant 
morbidities such as loss o f function, donor-site defects and in some cases, sub-optimal 
cosmesis. To this end, the development o f an artificial capillary network as a 
forerunner o f artificial tissue is a very exciting prospect as (I) it would provide an 
ideal vascular bed for chronic non-healing wounds and (2) make possible an off-shelf- 
altemative to free tissue transfer without the associated morbidity.
As alluded to earlier, the creation o f an artificial capillary bed is currently limited
by the absence of viable microvascular prosthcses as the patency rates o f PTFE and 
Dacron graft are dismal at lower flow rates. In this thesis, I sought to identify and 
develop a suitable material for the fabrication o f microvessels as the first stage in a 
broader effort, to create a man-made capillary bed. A nanocomposite o f silsesquioxane 
and carbonate-based polyurethane (POSS-PCU) was chosen for this purpose as 
nanocomposites have potentially improved degradative resistance and reduced protein 
adsorption, an advantage when attempting to decrease thrombogenicty. In order to 
negate the relative non-elasticity o f silica-based polymers, silsesquioxane was linked 
to an elastic polymer; polyurethane. In particular, carbonate-based polyurethane (PCU) 
was chosen as the absence o f toluene diamine, a component o f conventional 
polyurethanes, in PCU minimises the risk of carcinogenicity.
The development o f an ideal microvascular graft involves identifying the right 
polymer and then optimising its fabrication into the graft itself. I began this process by 
bulk and surface characterising POSS-PCU using DSC, stress strain studies, NMR
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and FTIR spectroscopy. NMR showed that the POSS nanocube linked up to the hard 
segment o f PCU by the simple addition o f POSS during the polymerisation o f PCU. 
The point o f linkage was at the diol side-chain o f the POSS nanocube and the NH-CO 
component o f PCU. By varying the amount o f POSS added, its concentration 
increased arithmetrically. This consistently held true for both single- and twin-diol 
side-chain variants o f the POSS molecule. Mechanical experiments indicated that the 
incorporation o f POSS into the primary polymer; PCU conferred greater structural 
homogeneity throughout the POSS-PCU nanocomposite as compared to PCU alone.
In vitro degradation studies revealed that POSS-PCU was resistant to an entire 
range o f oxidative and hydrolytic enzymes whilst retaining its visco-elastic properties. 
FTIR, scanning electron microscopy, stress-strain studies and DSC demonstrate that 
the POSS nanocores shield the soft segment(s) o f the polyurethane, responsible for its 
compliance and elasticity, from all forms o f degradation principally oxidation and 
hydrolysis. POSS incorporation hence provides an optimal method by which 
polymers may be strengthened whilst maintaining their elasticity, making them ideal 
as vascular prostheses particularly at low flow states.
When placed in an in vivo environment for 36 months, POSS-PCU exhibited 
minimal degradative changes on FTIR with no capsule formation in all 6 samples as 
compared to the siloxane control in 16.7 % o f cases. This was corroborated with SEM 
studies which showed stress cracks, fissures and pits on the siloxane control whereas 
POSS-PCU had none o f these changes. Contact angle analyses indicated that POSS- 
PCU is an ampiphilic polymer with a large contact angle hysteresis which could 
theoretically cause proteins such as fibrinogen to undergo conformational changes
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thereby altering epitope-macrophage interaction; the initiator o f the inflammatory 
cascade. Ellipsometric studies are currently under way to study this in greater detail.
At a cellular level, cytocompatibility studies were conducted using endothelial 
cells. The parameters studied were viability, adhesion, proliferation and confluence 
morphology. Cells were able to survive for up to 3 weeks in a POSS-PCU medium 
without any evidence o f toxicity. HPLC confirmed the absence o f any leaching from 
POSS-PCU in an aqueous environment. These results suggest that once placed in vivo, 
POSS-PCU grafts would be able to neo-endothelialise without causing any adverse 
effects on the host.
On studying the behaviour o f POSS-PCU at the vascular interface, it was found 
that POSS confers an anti-thrombogenic surface action by inhibiting fibrin formation. 
Screening tests with TEG suggested a decrease in fibrin clot strength which was 
corroborated with fibrinogen ELISA, indicating significantly decreased fibrin 
adsorption compared to PTFE. However, there was no significant difference in fibrin 
adsorption between PCU and POSS-PCU. Interestingly, factor Xa assays revealed that 
with increasing concentrations o f POSS, its surface anti-coagulant properties 
increased compared to PCU alone. Based on this, it was deduced that the unstable clot 
formation on POSS-PCU was due to a qualitative alteration in protein adsorption as 
opposed to a quantitative decrease. Based on information garnered on contact angle 
analysis earlier, 1 postulated that this behaviour was attributable to its inherent surface 
roughness as a result o f POSS integration. This was confirmed on AFM studies which 
showed that surface roughness was directly proportional to POSS content. A potential 
application would be the obviation o f the need for systemic anti-coagulation when
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using POSS-PCU as vascular access devices.
Having identified POSS-PCU as a suitable material for microvascular prostheses, 
we sought to determine the optimal design and fabrication technique. Using the 800 
pm internal diameter microvessel graft model as a starting point, different methods 
including electrospraying and dip-coating were used to coat the mandrels. In addition, 
the coagulating solution necessary to create a microporous lumen was determined. 
Each fabrication model was then subjected to radial compliance, burst strength and 
hydraulic permeability testing to optimise a consistent and reproducible fabrication 
technique. It was found that single dip-coating o f the mandrel in a 14 (w/v) % solution 
o f POSS-PCU in DM AC at a speed o f 1 cm/s followed by coagulation in a 5 % 
NaHCCfi solution created the id e a l’ microvessel, closely mimicking micro-arterial 
compliance and hydraulic permeability. Achieving these attributes was possible due to 
the POSS-mediated reorganisation within the polymer composite. We are currently 
awaiting the final results from an animal model study using these microvascular 
prostheses.
With the culmination o f this work, the first phase in our effort to build an artificial 
capillary bed is completed. Having developed a polymer suitable as the building 
blocks o f a synthetic microvascular network, efforts are now being concentrated on 
using microfabrication technology to recreate the microvascular environment using
POSS-PCU and fuse it into the host using tissue-engineered scaffolds, stem cells and 
angiogenic factors. As these materials are safe, resistant to degradation, compliant, 
allow neo-endothelialisation, bio-compatible and anti-thrombogenic, the probability 
o f microvascular occlusion is lower. If  successful in the long run, the clinical
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implications would be tremendous as the ability to ‘grow’ tissue in vitro would do 
away with tissue transfers and even, transplantation.
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